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Abstract
Glucose deprivation involved in hypoglycaemia has been associated with neurotoxicity and
cell death. It is hypothesised that this neurotoxic process is initiated by a fall in cellular
ATP concentration and a dysfunction of the Na+/K+ ATPase pump. Consequently the
plasma membrane depolarises, opening the VGCC and allowing an excessive influx of
calcium, which initiates glutamate release, ROS generation and the opening of the MTP.
This intracellular activity subsequently triggers the apoptotic machinery necessary to
promote irreversible cell death.
In this study, primary cultures of embryonic rat striatal neurones were exposed to
hypoglycaemia for periods between 1 hour and three days. Mitochondrial respiratory
function and cytoskeletal integrity were affected. However several observations were
found that conflicted with the general consensus of the mechanisms involved in
hypoglycaemia-induced cell death. Evidence was obtained that there was :-
1. No calcium influx upon hypoglycaemia, indicating that the cell membrane does not
depolarise
2. No glutamate toxicity
3. No ROS toxicity
4. No MTP involvement
5. DNA fragmentation independent of caspase activity
6. Reversal of cell damage upon the replacement of glucose
7. A decrease in intracellular calcium concentration upon glucose replacement
These data suggest that the removal of glucose from striatal cultures does not cause cell
death but triggers the cell to enter a quiescent state with sufficient energy to maintain
resting membrane potential but also with morphological, mitochondrial and DNA
modifications. In conclusion striatal cells possess a neuroprotective mechanism against
prolonged glucose deprivation and remarkably can recover metabolically with repaired
DNA.
Chapter One. Introduction
1. Cell Death
In contrast to the rapid turnover of cells in proliferative tissues, neurones commonly
survive for the entire lifetime of the organism. This enduring nature of neurones is
necessary for maintaining the function of cells and as a consequence cell death must be
regulated and controlled. However, acute insults associated with ischaemia and traumatic
brain injury and neurodegenerative diseases, such as Alzheimer's disease (AD),
Huntington's disease (HD) and Parkinson's disease (PD) are connected with substantial
loss of neurones. Indeed, understanding the mechanisms which lead to neurodegeneration
is vital in preventing unwanted cell death. Ultimately, this understanding will provide
targets for pharmacological intervention to improve the clinical outcome of patients
suffering from neurodegenerative disorders and brain injury.
The type of cell death depends on many factors, namely, cell type, the triggering stimuli,
the severity of the stimulus and the age of the tissue (Martin et al., 2000). Numerous
signal transduction pathways which are engaged in cell death are highly influenced by
these factors, however, it has not yet been illustrated whether these signal pathways
converge onto a specific target, universal for all cell types. In neuronal cells excitotoxicity
is a well established and documented mechanism and refers to the cytotoxic action,
mediated by excessive stimulation of excitatory amino acid (EAA) receptors (Olney and de
Gubareff, 1978; Choi and Rothman, 1990; for review, Meldrum and Garthwaite, 1990).
Evidence strongly suggests that excitotoxicity is the predominant mechanism of cell death
in numerous acute and chronic neurodegenerative diseases (Choi, 1988). The precise
pathway remains to be clarified, although it is apparent that the presence of a high
concentration of EAAs and an increased sustained level of intracellular calcium are
essential components (Choi, 1988).
Two pathways leading to cell death were characterised and termed apoptosis and necrosis.
They were originally thought of as distinct but recent evidence suggests that these
pathways can interact (Colborne et al., 1999- see section 1.4). Both apoptosis and necrosis
can be induced by the same agents, and have been observed in excitotoxicity-mediated cell
death (Bonfoco et al., 1995; Qin et al., 1998). Necrotic cell death occurs in the early
period of acute intense insults, whereas cell death with apoptotic characteristics
occurs with less intense insults and at much later stages after the toxic event (Bonfoco et
al., 1995;Kerretal., 1972;Wyllieetal., 1980).
1.1 Necrosis
Necrosis initiated by toxic insults causes internal energy failure within the cell with passive
cell swelling and as a result membrane lysis occurs. Typical changes include swelling of
the cytoplasm and organelles, especially the mitochondria, defects in membrane
permeability and ion transport proteins as well as impairments in oxidative
phosphorylation. Only minor changes in the nucleus are evident with chromatin clumped
in irregular configurations (Kerr et al., 1995). The cell's contents are released, such as
reactive oxygen species and this is accompanied by an inflammatory response, which
includes leukocytic infiltration and tissue oedema. Consequently surrounding cells die
(Grooten et al., 1993).
1.2 Apoptosis
Apoptosis is derived from the Greek word describing the process of leaves falling from
trees, or petals falling from flowers. It is a fundamental requirement for embryogenesis,
organ metamorphosis and tissue homeostasis (Imai et al., 1999), and can be described as a
programmed process as it is regulated at protein and gene level.
The concept of apoptosis was introduced 29 years ago (Kerr et al., 1972). It occurs in the
nervous system under both physiological and pathological conditions. During
development, for example, a significant proportion of neurones die by apoptosis to permit
matching cell numbers with their targets (Oppenheim, 1991). Apoptotic cell death has also
been described after acute insults to the brain, such as traumatic brain injury (Rink et al.,
1995) and ischaemia (Li et al., 1995b; Krajewski et al., 1995; Chen et al., 1996), as well
as in chronic degenerative conditions, such as PD, AD and HD (Hartley et al., 1994;
Portera-Cailliau et al., 1995, Mattson et al., 2000a).
The morphological and molecular characteristics of apoptosis are distinguishably different
from necrosis. The main features are cell shrinkage, membrane blebbing, chromatin
condensation arid genomic fragmentation. Unlike necrosis, the external and internal
membranes of cells undergoing apoptosis are preserved, therefore safely sealing the cell
contents and protecting the surrounding region until phagocytosis occurs. In tissue where
apoptosis has occurred, intermingling healthy and dying cells are observed.
Apoptotic signalling includes three stages: signal induction, propagation via a protease
cascade, and execution. The signal induction stage varies with the stimulus, but converges
on common propagation and execution stages. The end result of apoptosis is degradation of
various cellular proteins, such as nuclear lamins and cytoskeletal components, and the
breakdown of the DNA into internucleosomal fragments. Ultimately, the cell and its
contents are broken down to membrane-bound fragments that are phagocytosed by
adjacent cells (Hale et al., 1996; Rosen and Casciola-Rosen, 1997).
The propagation stage of apoptosis is complex and requires specific mediators depending
on the death-inducing stimulus and cell type (Woo et al., 1998). The cytoplasmic
compartment of cells contains the core apoptosis machinery in a latent or sequestered form
(Takahashi and Earnshaw, 1997), and it has become apparent that the activation of this
machinery depends on a multiple post-translational mechanism (For review, Porter, 1999).
1.2.1 Caspases
Caspases are synthesised as inactive proenzymes that require proteolytic activation.
Activation of one caspase can lead to the cleavage and activation of additional molecules
of the same or other proteases, leading to an amplified protease cascade (Tewari et al.,
1995). The caspase family are thought to be the fundamental regulators of apoptotic cell
death. Many of their genes were originally identified in the nematode Caenorhabditis
elegans, in which three genes, ced-3 (ced, cell-death abnormal), ced-4, ced-9 are thought to
play critical roles (Ellis and Horvitz, 1986). The genetic and environmental factors that
trigger neuronal apoptosis may be different in various physiological and pathological
settings, but the core of this execution program is highly conserved from worm to human.
The caspase family has been divided into three major components: the B-celllymphoma-2
(Bcl-2) family proteins, the cysteine aspartic proteases (caspases), and the apoptotic
protease-activating factor-I (Apaf-l) protein that relays the signals integrated by 8cl-2
family proteins to the caspases (Adams and Cory, 1998).
The first caspase, initially discovered as a cytokine-processing enzyme, was designated
interleukin-I ~-converting enzyme (ICE). Since then over 14 new caspases have been
cloned (Thornberry and Lazebnik, 1998). Caspase-I and caspase-l l have been shown to
function mainly in cytokine production (Li et al., 1995a), whereas caspase-2, -3, -6, -7, -8,
-9, -10 and -12 are involved in the regulation and execution of apoptosis (Kuida et aL.,
1996; Hakem et al., 1998).
When cells undergo apoptosis, these caspases become activated through one or two
sequential proteolytic events that cleave the single peptide precursor into large and small
fragments. This forms the active enzyme which is subsequently highly regulated
(Thornberry and Lazebnik, 1998). There are currently two well characterised caspase-
activating cascades that regulate apoptosis: one is initiated from the cell surface death
receptor activated by ligands such as tumour necrosis factor-a (INFa) and the other is
triggered by changes in mitochondrial integrity (for review, Konopleva and Andreef, 1999;
Depraetere and Golstein, 1998; Song and Steller, 1999).
Some caspases are activated during the early phase of apoptosis. These upstream caspases,
such as caspase-6 and 12, can then activate "effector" caspases such as caspase-3 either
directly or indirectly. These effector caspases can then activate endonucleases that cleave
DNA into oligonucleosome-sized fragments (Arends et al., 1990; Nagata, 2000), and can
also cleave various substrate proteins that may co-ordinate the cell death process (Lazebnik
et al., 1994; Lazebnik et al., 1995).
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Figure 1.1
Pathways involved in apoptosis. Following signals via either activation of death receptors or cellular damage,
upstream regulators caspase-S, Bid and Bax are triggered. Bax translocates to the mitochondria initiating the
release of cytochrome c which binds to APAFI and triggers caspase-9. Calcium ions and ROS can also
cause the release of cytochrome c by activating the MTP. Caspase-S triggers the activation of caspase-3.
Caspase-3 has various substrate which ultimately cleaves the nuclear DNA, such as PARP, DFF and CAD.
The caspase cascade triggered by alteration of the mitochondria has been intensely
investigated. This cascade begins with Bax activation and is followed by cytochrome c
release, Apaf-l activation, the cleavage of caspase-9 and the activation of caspase-3. This
cascade has been confirmed in vivo, as shown by the recent results from the gene knockout
experiments. In Apaf-l knockout mice, caspase-9 and caspase-3 cannot be activated in
response to various apoptotic stimuli, even though cytochrome c release still occurs.
Likewise, caspase-3 activation is abolished in caspase-9 knockout mice (Hakem et al.,
1998; Kuida et al., 1998; Yoshida et al., 1998; Cecconi et al., 1998).
1.2.1.1 Bax
The Bcl-2 family of proteins includes both pro-apoptotic and anti-apoptotic members
(Pellegrini and Strasser, 1999). The best-studied anti-apoptotic member is Bcl-2. An
overexpression of Bcl-2 in cell cultures and in transgenic mice increases resistance of
neurones to death induced by excitotoxic, metabolic and oxidative stress (Martinou et al.,
1994; Guo et al., 1998). The mechanism by which Bcl-2 proteins control cell death is not
clear, but it may involve interactions among other family members or associations with
mitochondria, resulting in altered ion movements across mitochondrial membranes (Green
and Reed, 1998).
Bcl-2-associated X-protein (Bax) is the best characterised pro-apoptotic Bcl-2 family
member. Bax translocates to the mitochondria, inducing mitochondrial dysfunction and
caspase activation, hence neurones lacking Bax are protected against apoptosis (White et
al., 1998). Various apoptotic stimuli can induce the translocation of monomeric Bax from
the cytosol to mitochondrial membrane (Hsu et al., 1997), where it inserts as a homodimer
(Gross et al., 1998). It is thought that this stimuli can trigger a conformational change,
exposing the N- and C- termini of Bax, that appears to be required for its insertion into
mitochondria (Nechushtan et al., 1999). It is unclear whether Bax homodimerisation is a
cause of its translocation or a consequence of its insertion nevertheless, dimerisation is
strongly associated with cell death. Bax has been shown to directly induce the release of
cytochrome c from isolated mitochondria in a cell-free system and in K+- or serum-
deprived cerebellar granular cells (Desagher et al., 1999; Rosse et al., 1998). The
mechanism underlying the function of Bax is not dear, although there is evidence that Bax
possesses ion channel-forming activity which is inhibited by Bcl-2 (Schlesinger et al.,
1997).
1.2.1.2 Cytochrome c
Cytochrome c is a 12kDa protein that functions in the mitochondrial electron transport
chain. It is a soluble protein that is localised in the mitochondrial intermembrane space and
is loosely attached to the surface of the inner mitochondrial membrane (Gonzales and
Neupert, 1990). At physiological ionic strength, cytochrome c diffuses in the aqueous
phase between the inner and outer membrane of the mitochondria, between complex III
and complex N (Gupte and Hackenbrock, 1988).
Cytochrome c has been described as a necessary component for apoptosis (Kuida et al.,
1996). The mechanism by which cytochrome c is released from mitochondria remains to
be determined, although it is thought that the mitochondrial permeability transition pore is
involved (see section 1.3). In addition, it has been reported that cytochrome c can be
released from the mitochondria early in apoptosis before mitochondrial depolarisation and
the activation of caspases (Kluck et al., 1997; Kroemer et al., 1998).
1.2.1.3 Caspase-9
Once released cytochrome c binds to its two cofactors, Apaf-l and procaspase-9, which are
both cytosolic proteins (Srinivasula et al., 1998). Apaf-l binds to ATP and hydrolyses it to
ADP. This hydrolysis, however, does not have any function consequently if cytochrome c
is absent (del Peso et al., 1997). Likewise, cytochrome c will bind Apaf-l in the absence
of ATP. However, this complex is unstable and inactive. In contrast, in the presence of
cytochrome c, the binding and hydrolysis of ATP/dATP promote the formation of a
multimeric Apaf-llcytochrome c complex. This multimeric complex is fully functional in
recruiting and activating procaspase-9 (Zou et al., 1999; Srinivasula et al., 1998; Li et al.,
1997). Activated caspase-9 is subsequently released from this complex to eleave and
directly activate downstream caspases such as caspase-3, and -7. In addition, caspase-9 is
capable of indirectly activating caspase -2, -6, -8 and 10 (Green, 1998; Zou et al., 1997;
Slee et al., 1999).
The activation of caspase-9 can be regulated by two possible mechanisms. Firstly, anti-
apoptotic proteins, such as Bel-2 and Bel-XL that are tethered to the outer mitochondrial
membrane, could prevent cytosolic Apaf-llprocaspase-9 activation indirectly by blocking
the translocation of cytochrome c from the intermembrane space (Green, 1998).
Alternatively, it has been reported that Bel-XLmight inhibit caspase-9 activation directly by
binding to Apaf-l (Adams and Cory, 1998).
1.2.1.4 Caspase-3
Caspase-3 proenzyme is proteolytically processed by caspase-9 (Li et al., 1997). It has
been proposed to be the main effector of apoptosis in neurones and astrocytes (Keane et
al., 1997). Significantly, apoptosis is completely absent in certain tissues of caspase-3
knock-out mice; during development within the CNS, massive hyperplasia with distortion
of cytoarchitecture was evident by embryonic day 12 (Kuida et al., 1996). This phenotype
was attributed to a lack of cell death.
Caspase-3 can cleave specific cellular proteins. These include protein kinase C (Hugunin et
al., 1996), DNA-dependent protein kinase (Han et al., 1996), and sterol regulatory
element binding protein (Wang et al., 1996b), as well as the cytoskeleton component actin
(Mashima et al., 1997). The DNA binding enzyme poly ADP-ribose polymerase (PARP)
is certainly the best characterised substrate for caspase-3. PARP is a nuclear enzyme that
modifies cellular proteins in response to DNA damage (Kaufmann et al., 1993; Casciola-
Rosen et al., 1995). Its cleavage by caspase-3 may interfere with DNA repair mechanisms
that would otherwise counteract apoptotic DNA degradation (Martin and Green, 1995).
Likewise, cleavage of cytoskeletal proteins such as actin, may cause membrane blebbing
and cellular fragmentation, leading to the appearance of apoptotic bodies (Martin and
Green, 1995). Caspase-3 may promote cell death via the activation of caspase-activated
deoxyribonuclease (CAD), a key DNA-cleavage enzyme responsible for DNA
fragmentation during apoptosis. It is suggested that caspase-3 activates CAD by cleaving
and releasing the CAD inhibitory protein that normally binds CAD (Enari et al., 1998).
1.3 Mitochondria and the Mitochondrial Penneability Transition Pore (MTP)
Mitochondrial changes are pivotal in the cell death decision in many cases (Kroemer et al.,
1998). Increasing evidence suggests that the mitochondrion is a point of convergence for
death stimuli, and is a necessary step in apoptosis. Signals triggered from extracellular
stimuli cause mitochondrial membrane depolarisation and trigger the release of apoptotic-
inducing proteins from the mitochondria (Green and Reed; 1998; Susin et al., 1996;
Zamzami et al., 1996a).
Mitochondria are the main source of ATP and playa central role in cellular homeostasis. A
membrane potential maintained across their inner membrane by the transport of hydrogen
ions from the internal (matrix) space to the intermembrane space, is important in
maintaining a pore, termed the membrane permeability transition pore (MTP), in a closed
position. The MTP may be of crucial importance in the development of cell damage and
has been characterised in isolated mitochondria (Hunter and Haworth, 1979), in vitro
(Kristal and Dubinsky, 1997) and in vivo (Fennel et aI., 2001).
The pore is voltage dependent and acts as a tightly regulated inner membrane channel to
permit the passage of molecules up to 1500 Da in size. Its composition is not yet defined
although it is thought to be associated with adenine nucleotide translocase of the inner
membrane, the matrix specific cyclophilin D (Halestrap et al., 1998) and porin of the outer
mitochondrial membrane.
Mitochondria maintain, and precisely regulate, intracellular calcium homeostasis by
sequestering and releasing calcium. If cytosolic calcium concentrations become too high,
as following excessive neuronal firing or severe energy shortage, the subsequent
mitochondrial calcium overload will initiate the opening of the MTP pore (Zoratti and
Szabo, 1995). This calcium-dependent formation of the MTP pore represents an abrupt
increase of permeability to solutes normally impermeable to the inner membrane, causing
osmotic swelling and rupture of the outer mitochondrial membrane, with concomitant loss
of Ca2+, K+, Mg2+ and mitochondrial proteins (Green and Reed, 1998; Kroemer et al.,
1998). In addition, oxidant chemicals have been shown to promote the onset of the MTP.
Thus, the importance of the MTP in the propagation stage of apoptotic signalling is
substantial, given that MTP opening could potentially be the principal mechanism involved
in the release of cytochrome c (Zarnzami et al., 1997; Kroemer, 1997).
1.4 The Apoptosis-Necrosis Continuum
It has recently been argued that there are more than two forms of cell death and that
apoptosis and necrosis are not mutually exclusive but rather they exist as a continuum of
cell death phenotypes (Portera-Cailliau et al., 1995; Portera-Cailliau et al., 1997; Martin
et al., 1998: Roy and Sapolsky, 1999). This hypothesis arose from observations that
features of each type of cell death coexisted in the excitotoxically injured adult striatum
(Portera-Cailliau et al., 1995).
Morphologically distinct types of apoptosis have been described which differ in their
molecular determination. Unlike "classical apoptosis", where DNA fragmentation and
chromatin condensation are principal outcomes, a form of apoptosis where only slight
chromatin condensation occurs and vacuolisation is the primary event has been reported
(Zakeri et al., 1995). It is suggested that these morphologies are two extreme situations
and the intermediate apoptotic-like situations could exist.
Other evidence suggests that neuronal death can still occur despite the fact that DNA
fragmentation is prevented and chromatin condensation is partially blocked by caspase-
inhibitors (Miller et al., 1997). In another model, overexpression of Bax initiated
potentially damaging processes such as membrane blebbing, decreased protein synthesis,
and even a slight condensation of the chromatin, but DNA fragmentation, cleavage of
caspase substrates such as PARP and late stages of chromatin condensation were blocked
(Xiang et al., 1996).
It is also interesting to note that apoptotic activity occurs outside cell death. For example,
caspase-l cleaves the precursor of IL-l ~ to its mature form (Thornberry et al., 1992) as
well as having a role in apoptosis (Miura et al., 1993). Also, caspase-3 activation has been
observed upon activation of peripheral T cells in the absence of cell death (Miossec et al.,
1997) and in lens cells, the activation of caspases is apparently required for nuclear
disintegration and does not produce death (lshizaki et al., 1998).
It is therefore evident that there are multiple pathways leading to cell death, and some cells
may have the required components whilst others may not, hence, care should be taken
when classifying mechanisms of cell death (Sloviter, 2002).
1.5 The Dependence of Cell Death on ATP
The existence of apoptotic cells adjacent to necrotic cells suggests that common
microenvironmental signals may be involved in both forms of cell death (Martin et al.,
1998). It is thought that availability of ATP is the primary factor within the tissue that
determines whether apoptosis or necrosis takes place, i.e. cell death within the tissue is
determined by the energy supply (Richter et al., 1996; Eguchi et al., 1997; Leist et al.,
1997). Indeed, in cells where both necrosis and apoptosis can occur, apoptosis fails when
ATP levels drop below 15-25% of control cells (Lieberthal et al. 1998). In addition, a
number of reports have demonstrated that necrosis is dominant in severe ischaemic cases
where ATP levels are completely abolished, whereas apoptosis dominates in milder insults,
where ATP is still present (Stroemer and Rothwell, 1998; Nakajima et al., 2000).
Therefore the concentration of ATP within the tissue is the determining factor in the nature
of the cell death mechanism.
In a study to determine at which stage of apoptosis ATP was required, oligomycin, a
blocker of mitochondrial ATP synthesis, was added at different times after triggering cell
death with staurosporin. It was deduced that ATP was required immediately before the
characteristic nuclear changes, perhaps to ensure that nuclear collapse, the packaging of
chromatin, and DNA degradation occur before cell lysis (Leist et al., 1997). Alternatively,
it is possible that the reduction of ATP inhibits the Apaf-l-mediated activation of
procaspase-9. However, it is not known whether the necrotic pathway observed under low
ATP conditions is caspase-independent (Kawahara et al., 1998).
2 Hypoglycaemic Neurotoxicity
The effects of hypo glycaemia on the brain have been studied since the early 1930s. almost
a decade after the discovery of insulin by Frederick Banting (Pillai and Panchagnula,
2001). The brain is uniquely dependent on the availability of glucose as essentially all of
it's metabolism is derived from plasma glucose rather than alternative substrates (Mobbs et
al., 2001; Sokoloff, 1992). Glycolysis is the main source of ATP hence when glucose is
removed a decrease in ATP is observed (Kahlert and Reiser, 2000). ATP is the cell's
source of energy, whereby all energy-requiring reactions utilise ATP. ATP levels have
shown to decrease in hypoglycaemia in in vitro and in vivo models (Mattson et al., 1993;
Madl and Royer, 1999; Santos et al., 1996; McGowan et al., 1995). The brain utilises
mainly glucose as a substrate for the generation of the ATP required for normal function.
Since the brain cannot store significant carbohydrates, a steady glucose supply is required
from the blood. Glucose transport into the brain is mediated by a facilitative-diffusion-type
transport system A constant availability of blood glucose must be within a specific
concentration range (-5mM) (Oster and Singer, 1999). If blood glucose levels in the brain
fall to the range of2.0-2.5mM, a slowing of brain activity occurs indicated by a slowing of
the electroencephalogram (EEG), but if levels fall below 1J,lM,brain ATP levels decrease
to an extent where metabolic changes occur leading to permanent damage (Agardh et al.,
1981; Wieloch et al., 1984), including the degradation of phospholipids, nucleic acids and
nucleotides (Agardh et al., 1981; Chapman et al., 1981) and an elevation in free fatty
acids.
Acute hypoglycaemia in diabetes patients is associated with neurological manifestations
such as dizziness, behavioural changes, seizures, stupor, coma, or hemiparesis (Malouf and
Brust, 1985). These may be transient, but irreversible neuronal damage develops when
hypoglycaemia is severe and prolonged (Agardh et al., 1982; Kalimo et al., 1985).
Hypoglycaemia is also particularly common in the first few hours after birth (Land et al.,
1994).
The phenomenon of hypoglycaemia-induced toxicity is of clinical importance. as it not
only accounts for the neurological outcome of insulin overdose in diabetic patients, but is
likely to contribute profoundly to the brain damage associated with ischaemia and
neurodegenerative diseases. Moreover, it has been reported that the distribution of
hypoglycaemia-induced damage to the caudoputamen is only marginally different from the
distribution of damage via an ischaemic insult (Kalimo et al., 1985). It is therefore
beneficial to consider data from all energy-deficiency models, such as ischaemia and brain
trauma, when studying hypoglycaemia, in order to gain a wider regard for events occurring
in neuronal damage and protective mechanisms which may be employed. However, one
must be cautious when comparing data from different energy failure models as particular
differences are sometimes quite profound, such as ATP levels (Norberg and Siesjo, 1976;
Agardh et al., 1981; Wieloch et al., 1984), pH of the tissue environment (Pelligrino,
1981; Siesjo, 1981) and differences in amino acid release (Auer and Siesjo, 1988).
It is known that particular brain regions are more vulnerable to hypoglycaemic damage
than others. The cerebral cortex, the hippocampus and the striatum have all shown to be
predominately susceptible to metabolic failure (Kiessling et al., 1984; Agardh et al.,
1981).
2.1 The Theory of Hypoglycaemia-induced Cell Death
A hypothesis of the mechanisms involved in hypoglycaemia-induced cell death has been
proposed, (Figure 1.2), in order to devise a model for the basis of designing drugs to
prevent distinct cellular events occurring which initiate irreversible cell damage (Siesjo,
1992; Siesjo, 1993).
This hypothesis proposes that: the depletion of glucose availability from neurones causes a
decrease in ATP levels, which results in an insufficient amount of energy required for the
function of the sodium-potassium ATP-dependent pump (Na+IK+-ATPase pump). The
Na+/K+-ATPase pump maintains the membrane at resting potential, allowing an
equilibrium between internal and external concentrations of both Na+ and K+. The
maintenance of this equilibrium consumes -40% of energy production in the brain, a
surprisingly large percentage part of the total (Astrup et al., 1981; Whittam, 1962). A
depletion in ATP, therefore, causes a collapse of ion gradients and as a consequence the
cell gains sodium and simultaneously loses potassium, causing the membrane to depolarise
and the voltage-dependent ion channels to open (Harris et al., 1984; Szatkowski and
Attwell, 1994; Martin et al., 1994) (see Figure 1.2). An opening of the voltage-gated
calcium channels causes an influx of calcium which increases intracellular calcium levels
that then can trigger a multitude of events, such as the release of excitatory
neurotransmitters (Garthwaite and Garthwaite, 1986), activation of calcium-dependent
kinases (Favaron et al., 1990) and phospholipases (Farooqui et al., 1991), nitric oxide
production (Alagarsamy et al., 1994), formation of free radical compounds (Sun et al.,
1979), activation of calcium-dependent endonucleases (Arends et al., 1990) and lethal
alterations in cytoskeletal organisation (Schlaepfer and Zimmerman, 1985). As a result
various cascades are triggered which can cause permanent dysfunction of neurones leading
eventually to their death. How soon this depolarisation occurs depends upon factors such
as the type of insult, the severity of insult (Jiang and Haddad, 1992) and temperature
(Taylor and Weber, 1993).
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Figure 1.2
A schematic representation of events occurring in neurones subjected to a hypoglycaemic insult. Upon the
removal of glucose the ATP concentration decreases, the Na+/K+ ATPase pump becomes dysfunctional and
the plasma membrane depolarises. Calcium enters via the VGCCs initiating numerous cascades, including
the release of EAA, activation of calcium-dependent kinases and phospbolipases, release of calcium from
internal stores, the formation of arachidonic acid, nitric oxide and free radicals and triggering apoptosis via
MTP activation and caspase activity.
2.2Calcium
Transient changes in intracellular calcium levels are very important ID intracellular
signalling. Fluctuations in cytoplasmic calcium levels in neurones have been shown to
regulate neuronal excitability, neurotransmitter release, metabolic reactions and gene
expression (For review: Verkhratsky and Peterson, 1998; Mattson et al., 2000b).
However, it is understood that the excessive increase in intracellular calcium concentration
([Ci+]i), either as a result of influx of extracellular calcium through plasma membrane
voltage and receptor operated calcium channels, or by the release from calcium stored in
intracellular pools. contribute significantly to cell death (Hass, 1983; Siesjo, 1981;
Tymianski and Tator, 1996).
An extensive foundation of research has proved that toxic levels of intracellular calcium
play a major role in neuronal cell death. Both in vivo and in vitro studies of energy-
deficiency in models. such as cerebral ischaemia. support the association between calcium
influx and damage to neural tissue (Choi, 1985; Deshpande et al., 1987; Silver and
Erecinska, 1990; Simon et al., 1984; Uematsu et al., 1989; Uematsu et al., 1988).
Glucose deprivation leads to a marked and rapid increase in [Ca2+]i in cultured
hippocampal neurones (Mattson et al., 1993; Knopfel et al., 1990; Tekkok et al., 1999)
and cortical neurones (Cheng and Mattson, 1991). An increase in intracellular calcium
levels was observed in brains of acutely hypoglycaemic rats (Harris et al., 1984).
Elevated [Ca2liis thought to initiate a trigger for both necrosis (Choi, 1987) and apoptosis
(Ojicius et al., 1991) in neurones. The effect of the calcium ionophore, A23187, was
investigated using primary cultured cortical cells. Cell death in cells incubated with <1J..lM
of A23187. appeared to show characteristic features of apoptosis (Takei and Endo, 1994;
Gwag and Canzoniero, 1999). whereas cell death occurring in cells incubated with higher
concentrations showed necrotic characteristics (Emery and Lucas, 1995; Gwag and
Canzoniero, 1999). This indicates that the severity of insult and the secondary phenomena
precipitated by calcium excess is critical in determining the mechanism of cell death. The
most studied secondary phenomena triggered by calcium excess include formation of
reactive oxygen species (Dumuis et al., 1988), the formation of nitric oxide (Lipton et al.,
1993) and the activation of calcium-dependent enzymes that degrade DNA (Ojicius et al.,
1991).
Whether calcium influx leads to irreversible cell damage may depend on the capacity and
speed of intracellular calcium buffering systems, the attainment of critical concentrations
of calcium in intracellular compartments and the mode of entry. The mechanisms of cell
calcium buffering systems are dependable on cell type (Mattson et al., 1989) and species.
For example, human cortical neurones are more capable of buffering a calcium load
compared to rat neurones (Mattson et al., 1991b).
2.2.2 Intracellular Calcium Stores
Calcium entry from the extracellular space delivers most of the calcium ions for signalling
in neurones, however, intracellular sources provide an important source of calcium ions.
The established calcium stores within neurones are the endoplasmic reticulum (ER) and the
mitochondria.
The most characterised calcium stores are represented by specialised portions of the ER
which are capable of accumulating and storing calcium ions (Pozzan et al., 1994; Kostyuk
and Verkhratsky, 1994). ER stores have calcium pumps (SERCA -sarco(endo)plasmic
reticulum ATPase) and intraluminal calcium-binding proteins, such as calbindin and
calreticulin. An electrochemical gradient towards the cytoplasm can develop as the
concentration of calcium in the stores exceeds the concentration outside the store, thus
releasing calcium ions into the cytoplasm through calcium release channels.
There are two major groups of calcium release channels that have been characterised
(Henzi and MacDermott, 1992). Both are ligand-operated with high calcium permeability
and their actions are controlled by specific binding of either inositol (1, 4, 5)-triphosphate
(JP3receptors) or calcium ions (ryanodine receptors). The IP3 receptor releases calcium in
response to IP3 resulting from the breakdown of membrane phospholipids initiated by
numerous hormones, neurotransmitters and growth factors (Berridge, 1993).The ryanodine
receptor is activated in various tissues by caffeine, calcium and cADP ribose (McPherson
and Campbell, 1993). Both these receptors are found in overlapping populations of
neurones throughout the nervous system, but also exhibit clear differences in relative and
in subcellular localisation (Martone et al., 1997).
Alterations of ER-mediated calcium homeostasis are sufficient to induce apoptosis (Lin et
al., 1997). Indeed, calcium released from intracellular stores in response to pro-apoptotic
stimuli can exacerbate neuronal damage. For example, it has been reported that calcium is
released from ryanodine stores in PC12 cells in hypoglycaemic conditions (Chung and
Hong, 1998) and the depletion of ER calcium stores has been observed in hippocampal
neurones following transient cerebral ischaemia in gerbils (Kohno et al., 1997).
2.3Glutamate and Glutamate Receptor Activation
Glutamate is a dicarboxylic amino acid and acts as an excitatory neurotransmitter in the
CNS (Nakanishi, 1992). It is widely and fairly uniformly distributed within the CNS where
it is stored in vesicles within the presynaptic terminal, to be released under normal
physiological conditions by calcium-dependent exocytosis when the cell becomes
depolarised.
Glutamate binds to membrane receptors, of which there are four distinct classes
characterised by different pharmacological profiles and mechanism of action (Dingledine
et al., 1988). N-methyl-D-aspartate (NMDA), a-amino-3-hydroxy-5-methyl-isoxazole-
propionate (AMPA) and kainate glutamate receptors are termed ionotropic, i.e. contain
intrinsic membrane cation channels and are named according to the exogenous selective
agonists that specifically bind to them. The other class of glutamate receptors is termed
metabotropic, as they are coupled to G-proteins which mediate their response through
intracellular second messenger systems.
It is widely accepted that excessive elevations in [Ca2Ji mediate the neuronal degeneration
caused by excitotoxic glutamate receptor stimulation (Choi, 1985; Schinder et al., 1996).
Early experiments demonstrated that local injections of glutamic acid resulted in cell death
in various different brain regions, including the striatum, and this toxicity was a direct
effect of EAA ionotropic receptor stimulation (Olney and de Gubareff 1978). In addition,
a low concentration of glutamate was found to kill a large proportion of neurones in culture
and calcium entry was shown to be necessary in the initiation of excitotoxic mechanisms
(Choi, 1988). Since then numerous studies have confirmed that excessive glutamate
receptor stimulation has a deleterious neurotoxic effect (Uematsu et al., 1991; Goldberg &
Choi, 1993; Tymianski et al., 1993; Randall and Thayer, 1992; Hansen and Zeuthen,
1981).
In addition to excessive EAA receptor stimulation, during neurotoxic conditions, such as
ischaemia, there is an activation of sodium channels which induces the release of glutamate
via the reverse transport of glutamate by the glutamate transporter (Taylor et al., 1995).
Therefore a higher concentration of glutamate is present within the extracellular space.
Recent evidence has also suggested that glutamate release is induced by chloride channel
activation induced by cell swelling during hypoxia (Phillis et al., 1997) and that nitric
oxide also has the ability to enhance vesicular glutamate release during hypoxic condition
(Katchamn and Hershkowitz, 1997).
The importance of metabotropic glutamate receptors (mGluR) in neurotoxicity has
recently been exposed. There are currently eight subtypes of mGlu receptors, mGlul-
mGlu8, which are divided into three groups. The activation of Group I mGluRs is likely to
have significant effects on the intracellular signalling in neurones exposed to ischaemia or
hypoglycaemia. For example, the activation of mGluRs mobilises IP3, which acts on the
IP3 receptors to release Ca2+ from the ER, hence, increasing the [Ca2+]j concentration
(Nakamura et ai, 2000). However, the activation of mGluRs has been reported to either
contribute to, or protect against, cell death in various systems (Copani et al., 1995; Bond et
al., 1998).
Further evidence arises from the demonstration that toxic effects of EAAs were reduced by
NMDA receptor antagonists (Goldberg and Choi, 1993). It is apparent that NMDA
receptors playa predominant role in excitotoxicity because they have a high permeability
to calcium and release calcium from internal stores. However, recent evidence suggests
that non-NMDA receptors are also involved in this type of toxicity, especially in cases of
chronic neurodegeneration (Nellgard and Wieloch, 1992).
Severe insulin-induced hypoglycaemia causes a marked increase in the release of
glutamate and aspartate (Sandberg et al., 1986; Wieloch, 1985b; Butcher et al., 1987;
Engelsen et al., 1986). Glutamate and aspartate release has also been shown in in vitro
models of hypoglycaemia (Williams et al., 1995).
2.4 Mitochondria
Mitochondria act as fast calcium buffers and have recently been thought of as dynamic
calcium stores which are directly involved in determining calcium signals. Calcium enters
downhill of the electrochemical gradient through a mitochondrial calcium uniporter, which
is driven by a huge negative membrane potential (-160mV) created across the inner
mitochondrial membrane. The Na+/Ca2+ exchanger as well as the permeability transition
pore (MTP), control calcium efflux. The increase in intramitochondrial calcium levels is
transient and calcium begins to leak out when [Ca2+]j recovers down to the resting level
after the end of the stimulus.
Calcium is sequestered into the mitochondria matrix, depolarising the mitochondrial
membrane potential. As a result ATP synthesis, which is driven by a proton
electrochemical gradient generated by the electron transport chain, significantly decreases
and may be completely inhibited (Jacobus et al., 1975). It is known that mitochondria
sequester calcium from the cytoplasm after glutamate stimulation, and that this mechanism
has been reported to fail due to a reduction in ATP synthesis during excessive glutamate
stimulation (Budd and Nicholls, 1996). Calcium loading of the mitochondria has also been
reported to indicate damage to the plasma membrane calcium extrusion pathways (Ward et
al., 2000). If mitochondria continue to sequester intracellular calcium and become
eventually overloaded, the opening of the MTP would occur, resulting in the extrusion of
mitochondrial calcium (Taylor et al., 1999). The pore opening also uncouples the electron
transport system, resulting in increased free radical production. A drop in cellular ATP
levels, coupled with increased generation of free oxygen radicals leads to cell death.
The involvement of the MTP is thought to be of great importance in ischaemia and
hypoglycaemic-induced death, because not only does the opening of the pore disrupt
normal functioning, but it also causes a release of proteins involved in the initiation of cell
death cascades (Kroemer et al., 1998; Lemasters et al., 1998; Budd and Nicholls; 1996).
2.5 Reactive Oxygen Species (ROS)
Mitochondria are a major physiological source of reactive oxygen species (ROS), which
are generated during mitochondrial respiration. ROS, e.g. superoxide, hydrogen peroxide
and hydroxyl radicals, are formed when dioxygen is not completely reduced to water
during respiration, and can give rise to secondary ROS, such as peroxynitrite and lipid
peroxides. However, a number of enzymes exist within cells that can induce the production
of ROS, e.g. cyclooxygenases, lipooxygenases and nitric oxide synthase (NOS), which
generates nitric oxide (NO). NO toxicity may arise from inhibition of mitochondrial
respiration and/or reaction with superoxide to form peroxynitrite (Gunasekar et al., 1995).
Various forms of stress such as hypoxia and UV radiation are also sources of ROS.
A state of moderately increased levels of intracellular ROS is referred to as oxidative
stress. ROS are capable of causing oxidative damage to macromolecules leading to lipid
peroxidation, oxidation of amino acid side chains, formation of protein-protein cross links,
oxidation of polypeptide backbones resulting in protein fragmentation, DNA damage, and
DNA strand breaks. Cells respond to these adverse conditions by modulation of their
antioxidant levels, induction of new gene expression, and protein modification. The
production of ROS in mitochondria is regulated by a number of antioxidant enzymes
within the mitochondria. These enzymes include phospholipid hydroperoxide glutathione
peroxide (~HGPx), classical glutathione peroxidase (cGPx), and Manganese-superoxide
dismutase (Mn-SOD) (Ursini et al., 1985).
In hypoglycaemia, ROS production is an important component mediating cell damage.
Elevated levels of intracellular calcium can activate phospholipase A2 leading to a
generation of the free fatty acid, arachidonic acid, (Kukreja et al., 1986) and the
metabolism of arachidonic acid consequently produces ROS and lipid peroxidation
(Verity, 1994). An increase in free fatty acids has been demonstrated in the cortex of rats
which were subjected to severe hypoglycaemia (Wieloch et al., 1984). In addition, in
mouse striatal cells, exposed to 30 minutes of glucose deprivation, glutamate induced the
release of arachidonic acid by the activation of NMDA receptors, AMPA and metabotropic
receptors (Williams et al. 1995).
ROS, that are generated in excess in mitochondria via a number of stimuli, act as mediators
of the apoptotic signalling pathway (Zamzami et al., 1996a; Garcia-Ruiz et al., 1997;
Nomura et al., 1999). For example, the peroxidation of a protein termed cardiolipin, via
ROS activation, in the mitochondria results in the dissociation of cytochrome c from
mitochondrial inner membranes, providing the initial step in the release of cytochrome c
from the mitochondria (Nomura et al., 2000).
2.6 ATP Sensitive Potassium Channels
ATP-sensitive K+ channels (K-ATP channels) form a unique class of potassium channels
which are thought to couple the metabolic state of the cell to its electrical activity (Noma,
1983; Ashcroft and Gribble, 1998). K-ATP channels are negatively regulated by
intracellular ATP, hence a decrease in the nucleotide concentration leads to channel
activation. They are found in a wide variety of tissues and regulate functions such as
hormone secretion (Bernardi et al., 1993), excitability of neurones (Ashford et al., 1990)
and cytoprotection during ischaemia (Amoroso et al., 1990).
The K-ATP channels consist of two types of subunit, an inwardly rectifying subunit
(Kir6.1 or Kir6.2) and a sulphonylurea receptor subunit (Inagaki et al., 1995; Sakura et al.,
1995). In neurones, K-ATP channels exist in many brain regions, including the striatum
(Dunn-Meynell et al., 1998; Zhu et al., 1999), and have been reported to exist in the
mitochondrial membrane (Ashford et al., 1990; Debska et al., 2001).
The existence of K-ATP channels in neurones which are in control of energy homeostasis,
such as hypothalamic neurones (Ashford et al., 1990), is apparent but it is unclear why
such channels should be present in neurones not associated with energy homeostasis. One
possible explanation is that K-ATP channels may playa role in neuroprotection, whereby
low ATP concentrations lead to channel opening, efflux of intracellular K+ and cellular
hyperpolarisation (Fellows et al., 1993). Indeed, it was reported that in hippocampal
neurones, K-ATP channels are activated during hypoglycaemia with a reversible increase
in activity (Zawar and Neumcke, 2000).
2.7 Classification of Hypoglycaemic Cell Death
The classification of hypoglycaemic cell death is debatable and it is probable that there is
no specific form of cell death limited to hypoglycaemic neurotoxicity. Ferrand-Drake et
al., observed ultrastructural changes in cells comprising of both necrotic and apoptotic
features after in vivo hypoglycaemia (Ferrand-Drake et al., 1999).
It is hypothesised that depending on cell type and duration of glucose deprivation, different
pathways will be switched on, eventually deciding the phenotype of cell demise. The
following are examples of cellular events occurring in response to glucose deprivation,
which provide evidence for this hypothesis.
In cultured striatal neurones, 10 minutes of glucose deprivation induced a progressive,
slow membrane depolarisation, and the amplitude of this depolarisation was dependent on
the duration of hypoglycaemia Periods of hypoglycaemia under 30 minutes caused
reversible membrane potential changes, whereas periods over 30 minutes caused
irreversible membrane depolarisation (Calabresi et al., 1997a). In slice cultures,
hypoglycaemia caused a depression in synaptic transmission in the striatum after five
minutes (Calabresi et al., 1997c).
In cultured cortical cells, after a 6-8 hour period of glucose deprivation, ultrastructural
investigation showed neuronal swelling and some disintegration. These morphological
changes increased over subsequent hours and this slow development of injury is similar to
that seen following the exposure of cortical neurones to exogenously administered
glutamate (Monyer et al., 1989). Similar observations were also seen in dentate gyrus
granule cells. In addition, morphological examination revealed a dendro-somatic, axon-
sparing damage, characteristics also observed in excitotoxin-induced neuronal damage
(Schwarcz et al., 1983).
It has also been reported that immediately after the hypoglycaemia insult, the most
significant change is the dispersion of polyribosomes. These changes correlate with the
autoradiographically demonstrated absence of protein synthesis observed in most brain
structures after insulin-induced hypoglycaemia (Kiessling et al., 1984; Kiessling et al.,
1986).
2.7.1 Apoptotic Characteristics
Apoptotic-like characteristics and machinery have been reported in every energy-depleted
model described to date. In comparison to necrotic characteristics these features are more
focused upon as it is thought that cells showing apoptotic features have a higher survival
potential. For example, DNA fragmentation following 24 hours of insulin-induced
hypoglycaemia was observed in the hippocampus (Ferrand-Drake et ai, 1999). Bax was
found to be upregulated in neurones destined to die after global ischaemia (Krajewski et
al., 1995; Chen et al., 1996) and in the transient forebrain ischaemia model in the gerbil,
it was observed that Bax immunoreactivity peaked at 72 hours, prior to DNA
fragmentation, in the CAl region of the hippocampus. (Hara et al., 1996; Iwai et al.,
1995). Caspase-3 activation has been found in a number of neuronal toxicity paradigms,
including traumatic brain injury (Yakovlev et al., 1997), neurotrophin withdrawal (Keane
et al., 1997; Taylor et al., 1997; Yakovlev et al., 1997), serum and potassium deprivation
(Miller and Johnson, 1996), glutamate excitotoxicity (Du et al., 1997) and chemical
ischaemia (Allen et al., 1999). Colocalisation of DNA fragmentation and elevated
caspase-3 immunoreactivity was detected in a majority of neurones in the CAl region and
striatum at 72 hours after transient global ischaemia (Chen et al., 1998).
In most in vivo models, morphological and molecular changes consistent with apoptosis,
including caspase activation, expression of pro-apoptotic genes and release of cytochrome
c, are detected in the penumbra region surrounding the acute insult. This suggests that
apoptosis is associated more with cells exposed to less abrupt energy deficiency, and also
that these cells can be rescued by therapeutic intervention (McManus et al., 1993; Goto et
al., 1990; Dimagl et al., 1999). It was observed that in the striatum there was a relatively
high density of apoptotic cells from 6 through to 7 days after hypoxic-ischaemic insult
(Nakajima et al., 2000), suggesting that apoptosis is also predominantly associated with
reperfused cells. In another study, evidence of apoptosis was found only 1 to 4 days after
cerebral hypoxia-ischaemia in the granule cells of the inner layers of the dentate gyrus
(Pulera et al., 1998). However, it has been acknowledged that cells possessing apoptotic
morphology even exist in the ischaemic core (Nakajima et al., 2000).
2.8 Reperfusion Damage
Reperfusion damage refers to the further damage caused to existing cells when ATP is
reintroducted into the system via a reperfusion of either oxygen or glucose or both.
Therefore, despite restoration of normal neuronal oxygen tension or/and glucose content,
the reperfusion period can be associated with additional neuronal injury (Siesjo, 1992;
Kalimo et al., 1985).
It is suggested that after a period of severe cellular energy shortage, the MTP may be
activated at reperfusion. The subsequent uncoupling of the electron transport chain and the
loss of free radical scavengers may lead to a surge of calcium-activated cellular
degeneration and free radical damage, causing necrotic cell death as well as mitochondrial
dysfunction, that promote additional sodium and calcium entry (Kristian and Siesjo, 1996).
For example, during the reperfusion phase after cerebral ischaemia, calcium accumulates
in mitochondria, and a burst of free radical formation occurs, conditions that favour the
activation of the MTP (Almeida et al., 1995). Indeed, calcium concentrations were shown
to be significantly higher in reperfused cells when compared with calcium levels of
neurones subjected to oxygen-glucose deprivation (Taylor et al., 1999). It is not 'known
whether the calcium overload starts before or after the transition to irreversible cell
damage. This provides further evidence that factors other than energy failure are operative
during the post-insult period, such as excitatory transmitters. Indeed, NMDA receptor
antagonists have been protective after the insult period (Wieloch et al., 1985b; Tasker et
al., 1992) and the deafferentation of glutamatergic cortico-striatal input prevents the
development of irreversible nerve cell injury within the striatum during the recovery period
after 30 minutes of hypoglycaemia (Linden et al., 1987).
An increase in the activity of pro-apoptotic components is apparent after reperfusion. It
was reported that 24 hours after reperfusion following 1 hour of middle cerebral artery
occlusion, the population of caspase immunoreactive cells was significantly increased. In
addition, Bc1-2 immunoreactivity was localised in the cytoplasm of the penumbra where
the cells were still viable. Bcl-2 positive neurones were few after 5 hours of reperfusion,
but at 24 hours Bc1-2 expression was weak and thinly scattered in few neurones of the
penumbra, whereas the expression of Bax and cytochrome c staining was strong, and was
evident in the core where many neurones were already dead. TUNEL-positive cells were
clearly observed at 8 hours after reperfusion and progressively increased at 24 hours
(Prakasa Babu et al., 2000).
Reported morphological observations after reperfusion include dendritic blebbing and
pronounced somatic and mitochondrial swelling in CAl slices subjected to oxygen and
glucose deprivation and then reperfused (Taylor et al., 1999). Swollen neuronal
membranes are seen in cortical cells after a resupply of normal oxygen and glucose
following a 6-8 hour ischaemia insult (Goldberg & Choi, 1993). After 24 hours of recovery
following transient focal ischaemia, neuronal shrinkage, nuclear condensation and
fragmentation apoptotic bodies were observed in affected areas (Prakasa Babu et al.,
2000).
3 Protection from Hypoglycaemia-induced Cell Damage
3.1 Calcium Modulation
The idea that calcium entry is the final common pathway of cell death has provoked an
enormous amount of research on the prevention of high [Ca2+]i and consequent prevention
of cell damage. In addition, it has been reported that neuronal survival is not determined
primarily by the degree of neuronal calcium loading. Instead, it has been proposed that the
main determinant of calcium toxicity is the route through which calcium ions gain access
to the intracellular space, and the signalling cascades initiated along the specific route
(Sattler et al., 1998). Hence, blockade of calcium entry to the intracellular space has
involved both VGCCs, intracellular calcium stores and glutamate receptors.
3.1.1 Calcium Channel Blockade
Voltage-gated calcium channels (VGCC) can be at present classified into at least six types
named L, N, P, Q, R, T which are distinguished by their particular electrophysiological and
pharmacological properties (Randall 1998).
The blockade of VGCC has been shown to have neuroprotective effects against damage
caused by focal ischaemia (Germano et al., 1987; Jacewicz et al., 1990; Mohamed et al.,
1985). In particular, there is a family of L-type calcium channel antagonists which have
been widely used in numerous toxicity models. Nicardipine has shown protective effects in
cerebral ischaemia models (Alps et al., 1988; Alps, 1992; Rami and Krieglstein, 1994) as
well as in vitro models of hypo glycaemia (Hayashi et al., 1993). It has also been shown to
inhibit K+-induced increase in [Ca2Ji in synaptosomes and hippocampal cells (Kobayashi
et al., 1992). Nimodipine was reported to prevent toxicity in hippocampal cells, against
glutamate (Hara et al., 1990) and cerebral ischaemia (Steen et al., 1983; Kawaguchi et al.,
1999) and nifedipine has been shown to significantly reduce neuronal apoptosis induced by
mitochondrial inhibitors (Keller et al., 1998).
3.1.1.1 Extracellular/Intracellular Calcium Chelation
Omitting calcium from the bathing solution or adding calcium chelators provides
information on whether neuroprotection is a result of removing calcium before, during or
after a neurotoxic insult.
In hippocampal and cerebellar brain slices, toxicity induced by glutamate was abolished
when calcium was omitted from the bathing solution (Tymianski, 1994). BAPTA-AM is an
exogenous chelator which is cell permeable. Its buffering activity has been shown to be
neuroprotective in depolarised CAl pyramidal neurones (Tsubokawa et al., 1994;
Tsubokawa et al., 1993). It has also been shown to prevent mitochondria ROS
accumulation, membrane depolarisation and apoptosis (Keller et al., 1998). EGTA, a
cellular impermeable calcium chelator, prevented toxicity induced by glutamate in rat
hippocampal cells (Hara et al., 1993).
Calcium-binding proteins,such as calbindin-Dge and calmodulin, have been proposed to
function as neuroprotective agents due to their ability to buffer [Ca2+]j. For example, a
systemic administration of kainate was shown to cause an induction of calbindin- D28Kin
cortical and hippocampal astrocytes (Mattson et al., 1995). In addition, cultured
hippocampal astrocytes and PC12 cells expressing the calcium binding protein, calbindin-
D28K,were less vulnerable to excitotoxic insults (Mattson et al., 1991a; McMahon et al.,
1998).
3.1.1.2 Blockade of Intracellular Stores
The ER can contribute to the calcium overload by releasing calcium (Wei and Perry,
1996). Treatment of neurones with agents that suppress ER-mediated calcium release has
been reported to protect cells against excitotoxicity (Frandsen and Schousboe, 1991).
Blockers of the IP3 receptors have provided neuroprotection against ischaemia. The IP3
antagonist, TMB-8, is reported to be neuroprotective in cerebellar cultures from calcium-
dependent glutamate-induced excitotoxicity (Malcolm et al., 1996). TMB-8 has also been
used in vivo to reduce neuronal damage in ischaemic stroke. The size of necrotic tissue was
reduced by about 90% in TMB-8 treated animals, even if the administration is delayed for
6 hours (Chiou and Hong, 1995).
Blockade of the ryanodine receptor-regulated intracellular calcium store in PC12 cells
provided protection against glucose withdrawal, indicating that calcium release from
ryanodine stores, rather than calcium influx, may be the major source of [Ca2+]j induced by
glucose deprivation (Chung and Hong, 1998).
The blockade of ryanodine receptors with dantrolene significantly decreased the rise of
[Ca2+]j in neuronal cultures induced by NMDA (Frandsen and Schousboe, 1991; Lei et al.,
1992; Mody and MacDonald, 1995), depolarisation (Simpson et al., 1995), mitochondria
inhibitors (Keller et al., 1998), and trauma (Yoon et al., 1996). Dantrolene has also been
shown to be neuroprotective in vivo (Zhang et al., 1993;Wei and Perry, 1996).
3.1.2 Glutamate Receptor Antagonism
Compounding evidence supporting the involvement of glutamate neurotoxicity in
neurodegeneration stems from both in vitro and in vivo studies. Neuronal damage in the
striatum of animals, which have been subjected to severe insulin-induced hypoglycaemia,
can be reduced by decortication (Wieloch et al., 1985a). The glutamatergic input to the
caudatoputamen was abolished by unilateral ablation of the overlying cortex, prior to the
hypoglycaemic insult, and a drastic decrease in the number of injured neurones was
observed after one week (Linden et al., 1987). This neuroprotection is thought to arise
because of the degeneration ofthe excitatory amino acids (EAA) innervation to the caudate
neurones, resulting in a dramatic decrease of EAA receptor activity (Wieloch et al.,
1985a;Westerberg and Wieloch, 1986).
Studies with NMDA-receptor antagonists have also illustrated potent neuroprotection
against excitotoxicity in energy failure injury. Goldberg & Choi demonstrated that the
administration ofa wide selection ofNMDA antagonists, e.g. D-APV, CGS 19755, MK-
801, during the exposure period of oxygen-glucose deprivation, blocked both acute
neuronal swelling and late neuronal degeneration in cultured cortical cells (Goldberg &
Choi, 1993). Local injections of an NMDA receptor antagonist, AP7, in the caudate
nucleus after 30 minutes of insulin-induced hypoglycaemia, reduced 90% cell death,
following one week of recovery, compared to that in saline-injected animals (Wieloch,
1985b).
Reports have shown that the administration of non-NMDA receptor antagonists did not
protect cortical cultures from glucose-deprivation, even at maximum concentrations
(100fJM - ImM) (Monyer et al., 1989). This is in agreement with the excitotoxicity
theory, which proposes that neurotoxicity is predominantly mediated by NMDA glutamate
receptors. However, in an investigation into the effects of post-hypoglycaemic glutamate
receptor blockade on neuronal necrosis, the NMDA receptor antagonist, MK801, and
AMPA-receptor antagonist, NBQX, administered separately or in combination, decreased
neuronal damage in the striatum when given to rats after a severe insulin-induced
hypoglycaemic insult (Nellgard and Wieloch, 1992). This implies that AMPA receptors
are involved in late secondary degeneration.
Tetanus toxin, a compound which blocks calcium-dependent vesicular transmitter release,
was found to possess neuroprotective properties comparable to that of NMDA antagonists,
i.e. attenuated glutamate efflux and neuronal injury following glucose deprivation and
combined oxygen-glucose deprivation (Monyer et al., 1992). This provides further
evidence that the prevention of glutamate release increases cell survival. During the
recovery period tetanus toxin must be immediately present in the glucose-containing wash
to provide substantial protection from membrane injury in organotypic hippocampal
culture, whereas MK801 protects even if the administration is delayed for 30 minutes into
the recovery period (Tasker et al., 1992).
3.1.3 MTP Blockade
The MTP may be manipulated by a variety of drugs. The most common drug used is
cyclosporin A (CsA). CsA possesses two properties, it inhibits the opening of the MTP by
binding to cyclophilin D within the inner mitochondrial pore (Connem and Halestrap,
1994) and it inhibits a phosphatase, calcineurin. However, CsA, has been shown to have
both an anti-apoptotic (Zarnzami et al., 1996b) and a pro-apoptotic action (McDonald et
al., 1996; Mosieniak et al., 1997). The mechanisms by which CsA exerts pro-apoptotic
effects are yet undefined. It is known. that it causes TUNEL staining with plasma
membrane blebbing in neuronal cultures (McDonald et al., 1996) and has direct effects on
neuronal excitability and synaptic transmission in hippocampal slices (Wong et al., 2000).
CsA has shown to be effective in many models of neuronal degeneration induced by a
variety of stimuli, such as transient ischaemia (Yoshimoto and Siesjo, 1999; Matsumoto et
al., 1999) and mitochondria complex I inhibitor induced cell death (Seaton et al., 1998).
It has been demonstrated that CsA can exert its neuroprotective effect before, during and
hours after the insult is given. This property of CsA is especially important when
considering the therapeutic window of treatment of ischaemia.
The mechanism by which CsA exerts neuroprotective properties is not completely
understood at present. It may be a combination of inhibiting both the MTP and calcineurin.
By inhibiting calcineurin, CsA can alter the phosphorylation and function of many protein
substrates including cytosketetal proteins, synapsin 1, protein phosphatase inhibitors,
protein kinase A, ion channels, receptors, transcription factors and NOS (Steiner et al.,
1992). However, the calcineurin inhibitor, FK506, which does not interact with the MTP,
has failed to produce neuroprotective effects in certain energy deprived systems (Scheff
and Sullivan, 1999; Ferrand-Drake and Wieloch, 1999).
Rats treated with CsA 5 minutes before or immediately after a traumatic cortical brain
injury showed a significant reduction in the amount of cortical damage 7 days following
the insult. Results showed a 50% reduction in the size of the injury with a low dose pre-
treatment and a 40% reduction with a post injury treatment (Scheff and Sullivan, 1999).
The same experiments were repeated using FK506. The results showed that FK506 failed
to protect animals against cortical damage (Scheff and Sullivan, 1999). CsA also
significantly reduced the number of swollen mitochondria in the dentate gyrus and
prevented DNA fragmentation from severe hypoglycaemic-induced insults. Again, FK506
did not prevent mitochondrial damage or DNA fragmentation (Ferrand-Drake and
Wieloch, 1999). These experiments suggest that neuroprotection by cyclosporin A, in
energy depleted conditions, is likely to be caused by blockade of the MTP and not
calcineurin.
Trifluoperazine (TFP) has also been proposed to be an inhibitor of the MTP but blocks
MTP via a mechanism distinct from CsA, possibly by the inhibition of phospholipase A2
(Hoyt et al., 1997). Trifluoperazine is an inhibitor of calmodulin and may exert more
general inhibitory effects by competing for calcium ions binding to specific calcium
recognition sites as well as inhibiting the activation of ca1cineurin (Levin and Weiss,
1979). In a study where glutamate-induced mitochondrial depolarisation in cultures of
forebrain neurones was investigated, results showed that TFP inhibited or delayed the
onset of glutamate-induced mitochondrial MTP in intact neurones (Hoyt et al., 1997).
3.1.4 ROS Scavenging
It was first reported that free radicals had a role in excitotoxicity when Dykens and
colleagues demonstrated that kainate-induced damage in cerebellar neurones was reduced
following the administration of the anti-oxidant, superoxide dismutase (Dykens et al ..
1987). Since then, anti-oxidants have been shown to protect against apoptosis induced by a
variety of agents in different cell types.
The administration of superoxide dismutase, was shown to improve the survival of
superior cervical ganglion neurones subjected to glucose deprivation (Saez et al., 1987)
and following cerebral ischaemia, transgenic mice carrying the human superoxide
dismutase gene, showed a reduced level of ischaemic damage compared to wild-type mice
(Kinouchi et al., 1991). Also, the over-expression of superoxide dismutase in mice was
shown to protect against quinolinic acid and kainate acid neurotoxicity in the striatum
(Schwartz, 1998).
Free radical spin traps, such as PBN, are compounds which react with free radicals to form
more stable products. Administration of these compounds to excitotoxicity models have
shown to be effective in attenuating damage, such as ischaemic lesions (Phillis and
Clough-Helfman., 1990), and striatal NMDA-induced lesions (Schulz et al., 1995). In
addition, PBN and the inhibitor of lipid peroxidation, U-83836E, were shown to protect
cultured striatal neurones against damage induced by glucose deprivation (Nakao et al.,
1996).
Pyrrolidinedithiocarbamate (PDTC) as a free radical scavenger has been used in many
systems and proved to be effective in protecting tissue from ROS toxicity. Apoptosis
induced by the mitochondrial complex I inhibitor, MPP+ in PCl2 and SK-N-MC
dopaminergic cells was decreased in cells that had been pretreated with PDTC. In this
study it was suggested PDTC's neuroprotective mechanism of action was inhibition of the
production of hydroxyl radicals (Seaton et al., 1997).
As well as preventing the production of hydroxyl radicals, PDTC has also been associated
with the production of inducible nitric oxide synthase (iNOS). The overproduction of nitric
oxide has been proposed to be an important factor in neurotoxicity. In rat forebrain slices
deprived of oxygen and glucose, PDTC inhibited the induction of NOS (Moro et al.,
1998). The inhibition of NOS has also been shown to decrease ischaemic damage both in
vitro (Cazevielle et al., 1993) and in vivo (Moncada et al., 1992).
It has been reported recently that apoptosis .can be blocked by inhibition of the generation
of ROS in mitochondria by the overexpression of the enzyme phosholipid hydroperoxide
glutathione peroxide (PHGPx) (Nomura et al., 1999). The enzyme PHGPx is a unique
intracellular antioxidant enzyme that directly reduces peroxidised lipids that have been
produced in cell membranes (Ursini et al., 1985). Mitochondrial PHGPx suppresses
apoptotic cell death activated by a deprivation of glucose (Nomura et al., 1999).
3.1.5 K+-ATP Channel Activation
K+ channel openers, such as diazoxide and (-)-cromakalim, have been shown to protect
cultured hippocampal neurones against excitotoxicity (Abele et al., 1990), amyloid-B (AP)
toxicity (Goodman and Mattson, 1996) and, reduced the depolarisation of neocortical
pyramidal cells induced by short-term hypoxia (Pissarek et al., 1998).
The proposed mechanism of diazoxide-mediated neuroprotection effects is activation of K-
ATP channel which would attenuate membrane depolarisation by hyperpolarising it, and
suppressing Ca2+ influx through voltage-dependent channels. Indeed, (-)-cromokalin was
shown to prevent cell death induced by either oxygen-glucose deprivation or glutamate
toxicity in hippocampal cultures, and this prevention was associated with regulating
calcium homeostasis (Lauritzen et al., 1997).
It has also been suggested that K+ channel openers have an antioxidant neuroprotective
action independent of their effect on K+channel (Goodman and Mattson, 1996).
3.1.6 Modulation of the Apoptotic Execution Pathway
The intervention of components of the apoptotic execution pathway has resulted in the
prevention of cell death in most models described. The administration of Z-DEVD-FMK,
an inhibitor of casapse-3 activity, significantly decreased DNA fragmentation and neuronal
death in the CA 1 region of the hippocampus up to 7 days after ischaemia. When
administered intracerebroventricularly, after transient brain injury in rats, Z-DEVD-FMK
showed marked neuroprotective actions, as indicated by both improvement of neurological
recovery and reduction of DNA fragmentation (Yakovlev et al., 1997). It has also been
shown that caspase-3 inhibitors reduce infarct volume and neurological deficits in mice
subjected to focal cerebral ischaemia (Nomura, 1998) or direct excitotoxic insults (Hara et
al., 1997).
In an in vitro traumatic injury model, it was reported that the simultaneous inhibition of
NMDA receptors, with MK-801, and caspase-3 activity, using Z-DEVD-FMK resulted in
significantly greater protection than either treatment alone (Allen et al., 1999). This
provides further evidence that excitotoxicity plays an important role in the initiation period
of apoptosis.
The protective effects of inhibiting caspase-3 are observed even after the toxic event. In a
serumlK+ deprivation model of toxicity in cerebellar granule cells, Z-DEVD-FMK
provided protection after 12 hours of serum/K" deprivation and retained these protective
effects after 48 hours (Eldadah et al., 1997). This indicates during the recovery period
caspase-3 is still active, and cell death via apoptotic mechanisms still occurs.
The overexpression of the anti-apoptosis protein, Bcl-2, has been shown to prevent
apoptosis in response to various stimuli (Yang et al., 1997; Kluck et al., 1997, Vander
Heiden et al., 1997; Liu et al., 1997). This effect is thought to be due to prevention of the
mitochondrial membrane depolarisation during apoptosis (Zarnzami et al., 1996b) perhaps
by inhibiting the MTP or suppressing oxidative stress (Bruce-Keller et al., 1997). It has
also been suggested that Bel-2 and its family member, Bel-XL,inhibit cytochrome c release
(Yang et al., 1997;Kluck et al., 1997;Zarnzami et al., 1996a; Susin et al., 1996; Vander
Heiden et al., 1997), either directly or indirectly, by regulating the flow of ions ineluding
calcium, across the mitochondrial and ER membranes (Kluck et al., 1997). This indicates
that Bcl-2 is an important stabiliser of calcium homeostasis (He et al., 1997). Indeed, it
has been shown that an overexpression of Bcl-2 in an in vivo model of hypoglycaemia
protects hippocampal cells, even after 24 hours of hypoglycaemic insult (Lawrence et al.,
1996).
3.2 Alternative Substrates
Neurones can utilise alternative substrates to glucose for the synthesis of ATP during
hypoglycaemia. The brain contains the enzyme system required for the metabolism of a
range of substrates, including ketone bodies (Owen et al., 1967; Fourest-Fontecave et al.,
1987), lactate (Maran et al., 1994), fatty acids (Evans et al., 1995), glycerol and amino
acids (Weithop and Cryer, 1992). It is apparent that different brain regions may vary in
which non-glucose substrate they use during hypoglycaemia, but regardless of type,
endogenous substrates must be rapidly mobilised in sufficient amount to supply the cells
with enough substrate to uphold the ATP necessary for ionic pumping (Wieloch et al.,
1984).
In the absence of glucose, exogenous pyruvate can be effectively utilised as a substitute
substrate (Kauppinen and Nicholls, 1986). The final product of glycolysis in aerobic
conditions is pyruvate, which enters the Krebs cycle (Figure 1.3). In anaerobic conditions,
pyruvate is converted to lactate. Both pyruvate and lactate can be used as fuel molecules,
however, during hypoglycaemia oxygen is present, therefore only pyruvate is produced.
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FIGURE 1.3
The tricarboxylic acid cycle (TeA). This simple view of a component of aerobic respiration shows the
metabolites involved in the TeA cycle and pyruvate and glutamate as energy substrates entering the TeA
cycle. Glutamate is reversibly converted to a -ketoglutarate by aspartate transaminase by which aspartate is
produced. It also shows the enzyme succinate dehydrogenase which is reduced by XTI in cell viability
assays (Chapter Two).
Energy failure is thought to be less severe during hypoglycaemia, compared to ischaemia,
because of the capacity of the brain to oxidise endogenous non-glucose fuels (Koretz et al.,
1994). In addition, there is a predominant release of aspartate into the extracellular fluid in
hypoglycaemia, which differs from the rise in extracellular glutamate found in ischaemia
(Auer and Siesjo, 1988). In hypoglycaemia, it has been shown that glutamate catabolism is
favoured over glutamate synthesis in the TeA, and therefore glutamate is used as an
alternative energy source.
Astrocytes may contribute markedly to local cerebral fuel homeostatic mechanisms at
times of metabolic stress in the brain (Magistretti, 1982), probably by releasing pyruvate
for local neuronal oxidation. It has also been thought that astrocytes alone are capable of
partially oxidising free fatty acids and producing ketone bodies (Edmond et al., 1987).
Hence, it is hypothesised that at times of high circulating fatty acids levels. such as are
seen during hypoglycaemia, astrocytes metabolise fatty acids to form ketone bodies which
are easily taken up by neurones via the monocarboxylate carrier and substantially oxidised.
It is thought that only in mild cases of hypoglycaemia can alternative substrates to glucose
provide the metabolic demands of the brain. In acute hypoglycaemia, it may be that no
other substrate can ameliorate the detrimental effects of hypoglycaemia, and because
profound hypoglycaemia causes tissue alkalosis resulting from the ammonia formed from
the dearnination of amino acids, the consumption of metabolic acids, and the absence of
lactic acid formation, this may be a significant cause of irreversible cell damage (Auer,
1986).
4.Cellular Recovery from Energy-Depletion
Cells employ specific protective mechanisms during energy failure, which ameliorate
irreversible damage and prolong the survival of the cell. The understanding of these
mechanisms is critical in the event of therapeutic pharmacological intervention and
improving neurological outcome following an energy-deficient insult.
4.1 Recovery of Protein Synthesis
Protein synthesis is controlled by calcium homeostasis within the ER (Brostrom and
Brostrom, 1990; Paschen, 1996). It is an energy consuming process and becomes impaired
with the reduction of ATP. The suppression of global protein synthesis is a common
response to metabolic stress, for example, protein synthesis impairment was observed in
the brain after insulin-induced hypoglycaemic damage. After 30 minutes of severe
hypoglycaemia there was a complete inhibition of amino acid incorporation into proteins
of the cerebral cortex, hippocampus, and the striatum (Kiessling et al., 1984).
However, inhibition of protein synthesis appears not to be indicative of irreversible
damage. In the same experiment, all animals which had 30 minutes of insulin-induced
hypoglycaemia were allowed to recover for 75 minutes and partial restoration of protein
synthesis was reported (Kiessling et al., 1984). The absence of protein synthesis was
autoradiographically observed in cortical cells after hypoglycaemia, and again this did not
appear to signify an irreversible change, since the neurones were shown to recover both
structurally and metabolically (Auer et al., 1985b;Kiessling et al., 1986).
It is interesting to observe studies where cells have survived when treated with a protein
synthesis inhibitor, e.g. cycloheximide, and subjected to a toxic insult. It has been
suggested that protein synthesis inhibitors prevent apoptotic cell death by inhibiting the
machinery to activate the apoptotic process (Goto et al., 1990).
Inhibition and recovery of protein synthesis show a remarkable regional difference. Indeed,
it has been shown that after transient global ischaemia, protein synthesis was completely
suppressed but recovered in non-vulnerable areas, such as the cerebellum, but not in
vulnerable ones, such as the hippocampus (Bodsch et al., 1985; Thilmann et al., 1986).
This contradicts data stating that if protein synthesis was suppressed, apoptosis will be
suppressed and all cells would recover. It has been suggested that the ability to recover
depends on whether regions have a more efficient glucose supply during hypoglycaemic
conditions, e.g. transport sites with a higher affinity for glucose (Ratcheson et al., 1981).
4.2 DNA Repair Proteins
In adult neurones, DNA damage can be generated either as a result of endogenous
deamination, depurination, oxidation, polymerase misincorporation hydrolysis, alkylation
or x-ray irradiation (Lindahl, 1993; Gobbel et al., 1998; Wallace, 1988). Such damage
occurs at a frequency too high to be compatible with life and must be corrected efficiently
by DNA repair mechanisms. Repair of non-replicating DNA is expected to be of particular
importance in neurones because these cells are among the longest-living cells in the body
and show high rates of spontaneous DNA mutation (Andrew et al., 1997).
It is generally accepted that regardless of the specific type of DNA injury generated, the
cell's response follows the common principles: the damaged region is recognised, it is
removed, a DNA polymerase synthesises a new strand, and a ligase replaces the lost
information to restore the DNA to the original state.
Recognition of damaged DNA necessitates a very wide range of repair enzymes specific to
the individual lesion. There are two established predominant pathways involved in
repairing DNA damage which exist in the brain (Coudore et al., 1997); the nucleotide
excision repair pathway (NER) (Setlow and Carrier, 1967), and the base excision repair
pathway (BER) (Lindahl, 1971). NER handles rather infrequent lesions, whereas BER is
essential for recovery from spontaneous DNA damage (Seeberg et al., 1995). Both are
ATP-dependent processes.
NER is the most versatile DNA repair system in mammalian cells, since it recognises and
processes all the lesions tested, at least in vitro. It is a multistep process that has been
dissected into two broad stages: first recognition, incision and excision of the lesion and
the DNA polymerisation through the gap, followed by ligation to restore the strand
continuity (Wood, 1996). The BER pathway is the most important cellular protection
mechanism responding to oxidative DNA damage, whether it occurs from reactive oxygen
species formed during normal metabolism, or from exposure to exogenous agents. The key
enzymes in the BER are DNA glycosylases, which remove different types of modified or
damaged bases by cleavage of the N-glycosylic bond between the base and the
deoxyribose moieties of the nucleotide residues. Different DNA glycosylases remove
different kinds of damage, and the specificity of the repair pathway is determined by the
type of glycosylase involved. Once the base is removed, a DNA polymerase fills the
resulting gap, and the strand is sealed by DNA ligase (Seeberg et al., 1995).
The mismatch of bases is another form of damage that occurs to DNA. DNA mismatch
repair is the process by which incorrectly paired nucleotides in DNA are recognised and
repaired. Mismatches in DNA may arise as replication errors, and as a result of base
damage. The expression of DNA mismatch repair proteins in neurones may therefore
represent a part of an intracellular genetic program activated by DNA damage and directed
either to recognise and repair it, or to signal the presence of the damage to the apoptotic
machinery.
A four-fold increase of DNA repair synthesis after 30 minutes of cerebral ischaemia
suggests that nuclear DNA damage is repaired (Tobit a et al., 1991), and that the damage
in DNA is repaired with time. The following sections describe the role of four particular
genes involved in DNA repair.
4.2.1 XRCC1
The DNA protein x-ray repair cross-complementing group 1 (XRCC1), plays a central role
in the DNA BER pathway (Thompson et al., 1990), which is responsible for repairing
damage by interacting with DNA ligase III and with DNA polymerase ~ (Caldecott et al.,
1996; Kubota et al., 1996).
The XRCC1 protein has multiple roles in repairing base damage. These functions include
forming a stable complex with DNA ligase IlIa, (Caldecott et al., 1994; Nash et al.,
1997), bridging the steps in BER through protein interaction (Kubota et al., 1996), directly
detecting breaks, co-ordinating the binding and polymerase activity of DNA polymerase ~
(and perhaps its efficiency) (Kubota et al., 1996), and possibly regulating PARP
(Caldecott et al., 1996; Masson et al., 1998).
XRCC 1 gene expression has been examined in rat, mouse and baboon tissue (Yoo et al.,
1992., Walter et al., 1994., Zhou and Walter, 1995). The XRCCI protein is constitutively
expressed in the entire normal mouse brain, but has a regional predominance in the
hippocampus and the caudate-putamen (Fujimura et al., 1999). Its activity has been
studied in models of neuronal energy-depletion producing ambiguous results.
A reduction of XRCC 1 was observed in the lateral caudate putamen but not in the cortex of
the rat after ten minutes of reperfusion following 1 hour of focal cerebral ischaemia (FCI).
This reduction was sustained at 4 and 24 hours. (Fujimura et al., 1999). Double staining
with XRCC 1 and TUNEL, 24 hours after FCI, showed a significant amount of TUNEL-
positive cells with the characteristic features of apoptosis, however, none of these cells
showed XRCCI immunoreactivity. On the other hand, some cells had a faint expression of
XRCC1, but none were TUNEL positive (Fujimura et al., 1999). This indicates that early
reduction of XRCC 1 precedes the occurrence of DNA fragmentation in the ischaemic area
and that the reduction of XRCC 1may contribute to DNA-damaged cell death after FC!.
A significant reduction of the XRCCI expression was observed in a model of cold injury-
induced brain trauma (CmT) after fifteen minutes. The reduced expression remained until
24 hours after the insult, and again the reduction of XRCCI preceded the occurrence of
DNA fragmentation in the traumatised tissue (Fujimura et al., 2000). In hypoxic rat brains,
mRNA levels for XRCCI decreased significantly after five minutes of hypoxia, but
increased significantly after 15 minutes (Chiappe-Gutierrez et al., 1998). This could
suggest that the expression of XRCCI is affected by the type of DNA damage the cell
receives. Also, a decrease in XRCCI mRNA in response to agents that damage DNA was
found in vitro models (Yoo et al., 1992):
It is conceivable that a selective decrease of XRCC 1 protein synthesis, or a difference in
post -translational regulation causes XRCC 1 reduction in energy-deprived neurones.
Alternatively, it could be suggested that a reduction in XRCCI does not contribute to
DNA-damage, but that reperfusion initiates the production of ROS, opening the MTP and
releasing cytochrome c and thereby exacerbating DNA fragmentation after FCI (Fujimura
et al., 1999).
4.2.2 ERCC3
An increase in the protein levels for ERCC3 (excision-repair cross-complementing gene 3)
was observed in the brains of patients with Down's Syndrome and AD (Hermon et al.,
1998). ERCC3 may not only reflect increased repair, but may be representing increased
DNA modifying/processing. If increased ERCC3 expression is reflecting increased repair,
this may be due to the permanently ongoing DNA damage, for example, by active oxygen
species, or other forms of DNA stress. However, it is not known whether ongoing DNA
damage is the cause of AD and Down's Syndrome.
However in hypoxic rat brain tissue, mRNA levels encoding ERCC3 never exceeded levels
at normoxaemic conditions during 5 to 20 minutes observation period (Chiappe-Gutierrez
et al., 1998). This suggests that DNA repair genes are selected depending on the stimuli.
4.2.3 MSH2
One of the mismatch recognition components is the MSH2 protein. MSH2 recognises both
single base mispairs and, with a higher affinity, multiple base insertion/deletion mispairs
(Fishel et al., 1994; Drummond et al., 1995).
The expression of MSH2 was investigated in the human neuroblastoma SH-SY5Y cell line
when exposed to doxorubicin, a toxic antibiotic that induces DNA damage and apoptosis
(Tewey et al., 1984). It was shown that this cell line constitutively expressed MSH2
protein, and the level of this protein increased following the exposure to neurotoxic
concentrations of doxorubicin (Belloni et al., 1999a).
In addition, kainate administration resulted in a marked increase of MSH2
immunoreactivity in selective, vulnerable, neurones of the hippocampus (Belloni et al.,
1999b). Also observed was a sparse distribution of MSH2 immunoreactivity in the
striatum. In cerebellar granule cells exposed to toxic concentrations of glutamate, a
dramatic increase in MSH2 expression was observed (Uberti et al., 2000; Grilli and
Memo, 1999). Whether MSH2 induction is a part of a protective response, or is a sign of
suffering cells, remains to be investigated.
However, it is interesting to note that mouse embryonic stem cells containing defective
MSH2 genes fail to efficiently execute apoptosis in response to low-level radiation
treatment (DeWeese et al., 1998). This suggests a possible role of mismatch repair
systems contributing to neuronal cell death viaapoptosis.
4.2.4 DNA Polymerase ~
DNA polymerase ~ is the most predominant polymerase active in the nuclei of adult
neurones (Kuenzle, 1985). It preferentially fills short DNA gaps, and because of this
attribute, it had generally been assumed to be involved in BER. In addition to the DNA
synthesis activity to fill the short gaps generated during repair, DNA polymerase ~ initiates
the activity of necessary components for the DNA ligase to seal the nicked DNA strand
(Matsumoto and Kim, 1995; see review, Budd and Campbell., 1997).
DNA polymerase ~ knockout cells show high sensitivity to (m)ethylating agents (Sobol et
al., 1996), and were not protected against methylmethanesulfonate (Chen et al., 1998b).
In an ischaemia-reperfusion model, a decrease in DNA polymerase ~ gene was observed.
The results indicate that there was an increase in DNA lesions in ischaemic samples
compared with those in normal and sham-operated controls (Liu et al., 1996a).
5. Nuclear Factor Kappa B
Transcription factors provide a crucial link between external stimuli and changes in gene
expression, thus influencing biological responses. Nuclear factor kappa B (NFlCB) is an
unusual transcription factor as it resides within the cytoplasm, enabling it to receive
upstream signals more directly than other nuclear proteins, and actively participate in the
communication of signals from the cytoplasm to the nucleus. NFlCB is activated upon the
arrival of external cellular stimuli and translocates into the nucleus to modulate gene
expression (Figure 1.4). It is now known that numerous stimuli activate NFlCB and
abundant genes are induced due to its activation, characterising the importance of this
protein.
NFlCB was first identified as a nuclear factor in 1986, controlling the expression of the
kappa light chain of B cells of the immune system, hence the origin of its name. It is
generally thought of as a mediator of stress and pathogen response due to the nature of
stimuli that activate NFKB and of the target genes NFKB induces (for review, Siebenlist et
al., 1995; May and Ghosh,1998).
In 1993, NFKB was discovered in cultured cerebellar neurones (Rattner et al., 1993) and
since then the importance of elucidating NFKB's function within the eNS is extremely
evident from the amount of current research. Studies have shown the existence of NFlCB
DNA binding activity in many brain cells, including hippocampal (Meberg et al., 1996),
striatal (Qin et al., 1998), cerebellar (Guerrini et al., 1995), and cortical cells
(Kaltschmidt et al., 1995). NFKB is not homogeneously expressed in the brain. The
cellular distribution of NFKB varies depending on brain region and cell type. It can exist in
an inducible form, i.e. bound within the cytoplasm in soma, dendrites and synapses,
rendered inactive (Kaltschmidt et al., 1993a) or in a constitutive form i.e. present within
the nucleus and capable of DNA binding (Kaltschmidt et al., 1994).
The functional roles of NFlCB in neurones and glia function are associated with processes
such as neuronal development, neuronal plasticity and neurodegeneration, signifying the
significance of this transcription factor.
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5.1 Inhibitory kappa B Regulation
Nuclear factor kappa-B is retained in most cells in an inactive form in the cytoplasm by the
inhibitory protein IKH. This is an extremely important molecule as IKH provides a method
of regulating the activity ofNFKB DNA binding and hence regulating the transcription of
target genes (for review, Matthews and Hay, 1995). A tightly controlled negative feedback
loop exists, involving the degradation ofIKH in the cytoplasm, re-synthesis ofIKH and the
subsequent inactivation of NFKH (Figure 1.4). Activation of NFKB can occur within
minutes of receptor binding.
IKB family members contain multiple ankyrin domains which are essential for the
interaction of IKE with NFKH proteins (Jaffray et al., 1995). The ankyrin domain masks
the nuclear localisation signals (NLS) of the NFKH protein, which consequently inhibits
DNA binding (Liou and Baltimore, 1993). Mutations of the NLS decreases the affmity of
NFKB for IKE and thus the inhibition function ofIKH is diminished (Beg et al., 1992).
Inducing Stimuli
Autoregulated
feedback
loop
NFkB complex
IKKa, IKI<f3,NIK
Phosphorylation, Ubiquitination
and Degradation of IkB
Figure 1.4
Schematic representation of the activation of NFKB upon various extracellular and intracellular stimuli,
degradation of Jill and the translocation of NFill into the nucleus inducing genes encoding ill. These
include the gene encoding Iill which initiates the autoregulated feedback loop.
5.1.1 Phosphorylation of IkB
Following cell stimulation, phosphorylation of the IKB occurs (Figure 1.4). It was shown
that the IlCBmolecule was phosphorylated by a serine specific kinase at its regulatory N-
terminus on serines 32 and 36. Since this finding much research has been involved with
identifying a protein kinase responsible for the regulation of the phosphorylation process.
One main problem is the belief that the kinase may exist as a part of a large complex, thus,
providing difficulty in identifying it (for review, May and Ghosh, 1998; Verma and
Stevenson, 1997; Israel, 1997). Two kinases referred to as IKK-l (hcB kinase-I) and IKK-
2 (hcB kinase-2) were identified. It was demonstrated that the expression of both IKK-I
and IKK-2 in tranfected HeLa cells led to the phosphorylation of serines 32 and 36 of IKB,
and were activated by specific inducer of NFKB.
However, another kinase has been described, called NFKB-inducing kinase (NIK). It was
found that NIK was required for IL-I or TNFa- induced NFKB activation and that NIK
associated with IKKa and IKK~. Mutant forms of NIK have been shown to block
signalling from both IL-I and TNF receptors, suggesting that a convergence of signalling
pathways, induced by these pro-inflamm~tory cytokines leading to NFlCBactivation, might
be at the level of this kinase. In addition, protein kinase A (PKA) has also been reported to
be an alternative candidate (Zhong et al., 1997).
It is possible that the different subunits of the IKE-kinase complex are targets for separate
signalling cascades or that the IKE-kinase complex responds to incoming stimuli by
generating an internal signalling cascade involving kinase and substrate subunits which
leads eventually to the activation of the IKE-phosphorylating kinase.
5.1.2 Ubiquitination
The phosphorylation of IlCBinduces ubiquitination of the molecule on N-terminal lysine
residues, 21 and 22, which targets the protein for rapid proteolytic degradation i.e. 10-15
minutes, allowing NFlCB to translocate into the nucleus. It is thought that the
phosphorylation of the N-terminal serine residues of IKB in some way alters the
conformation of the protein and exposes the lysine-containing sequences that are targeted
by the ubiquitin molecules. Neither phosphorylation or ubiquitination alone is sufficient to
dissociate the NFKB-IKB complex and hence free NFKB is only released after degradation
of IKE.
5.1.3 IkB Autoregulation
After the degradation of IKB, the IKB pool is replenished by a production of the inhibitory
protein transcriptionally regulated by NFKB p65 subunit induced nuclear NFKB, which
causes an up-regulation of IKB mRNA levels due to the presence of NFKB sites in the IKB
promoter (Sun et al., 1993). Newly synthesised IKB can then bind to NFKB in the
cytoplasm, inhibiting further NFKB activation. This ensures target genes are activated only
transiently. It is thought that some newly synthesised IKB remains localised in the nucleus
where it can inhibit DNA binding and the transcriptional activity of NFKB. The presence
of IKB within the nucleus may trigger the transport of the IKB-NFKB complex back to the
cytoplasm where it can respond to new stimuli (Arenzana-Seisdedos et al., 1997).
5.2 Molecular Biology of NFlCBand heB
NFKB dimers are composed of proteins from the NFKB (ReI) family (Table 1). All family
members contain a ReI homology domain (RHD) of about 300 amino acids. The conserved
RHD determines DNA binding, dimerisation, nuclear translocation, and the interaction
with the inhibitory protein IKB. It is thought that a short stretch at the beginning of the N-
terminal domain appears critical for the binding to DNA and the extreme end of the C-
terminal for the nuclear localisation signal (NLS) (for review, Verma et al., 1995;
Baeuerle and Henkel, 1994).
Protein
p50
p65 (ReI A)
NFlCB p52
c-Rel (ReI)
v-ReI
RelB
IKBa
IlCB
IKB~
IKBy
IKBE
Bcl-3
Table I
NFlCB and IlCBProteins nomenclature
Most members of the NFlCB family can form homo- and heterodimers in vitro therefore
various combinations of dimers may exist in different cell types and have distinct
characteristics. The most common functional dimer found is the combination of p50
subunit-p65 subunit. This heteromer binds with a high affinity to DNA sequences, the most
common is 5' -GGGACTTTCC-3'. There. are five members of the IKB family to date
(Table 1) and the two major characterised forms of lleB proteins in mammalian cells are
IlCBa and I1CB~.
5.3 Activators of NFlCB
There are many diverse stimuli which activate NFlCBDNA binding, which suggests that
different upstream signalling pathways converge at some point to degrade IlCBand allow
NFlCB to translocate into the nucleus. Regulation of the DNA binding activity of NFlCBby
different inhibitory proteins and kinases may explain how NFlCB can be induced by such
diverse stimuli.
The induction of the degradation of IKBa and IKB~ depends on the type of NFlCB inducer.
For example lipopolysaccharide (LPS) stimulation results in the degradation of IlCBa and
IKB~, whereas, phorbo-myra-acetate (PMA) stimulation results in the degradation of only
IKBa, thus causing a transient activation of NFKB (Thompson et al., 1995). The following
table displays examples of the type of stimuli which activate NFKB.
NFlCBActivation Stimuli
Glutamate
Nerve growth Factor
Amyloid-B peptide
Nitric Oxide
Calcium
Opioids
Depolarisation
Reactive Oxygen Species
Cytokines
Bacterial and Viral
Products
Ceramide
Ionising Radiation
UV Rays
Table 2
An example of the type of diversity of stimuli which activate NFKB
5.3.1 Excitatory Amino Acids
It was first shown that glutamate and kainate could induce the activation of NF1d3 in
cultured cerebellar granule cells (Guerrini et al., 1995; Kaltschmidt et al., 1995), and
since then it has been shown repeatedly in other neuronal culture types (Simpson and
Morris, 1999). In an in vivo study, an increase in NFKB binding activity in the striatum of
rats administered with quinolinic acid, a glutamate agonist, was observed. The NMDA
receptor antagonist, MK-801, was found to completely prevent any changes in NF1d3
activity (Qin et al., 1998). In astrocytes, however, no NFKB activation could be detected
with glutamate (Guerrini et al., 1995), although a chronic administration of kainate
markedly increased NFKB p65 immunoreactivity (Perez-Otana et al., 1996).
5.3.2 Calcium
Studies using NMDA toxicity to stimulate NFKB have shown that this stimulation is
dependent on calcium entry. NFKB activation was inhibited when calcium chelators were
added to cell cultures, demonstrating that NFKB translocation into the nucleus depends on
calcium influx via mainly NMDA receptors (Guerrini et al., 1995; Ko and Kelly, 1999).
NFKB was also found to be activated by large transient rises in the level of [Ca2+]j in B
cells (Dolmetsch et al., 1997).
5.3.3 Reactive Oxygen Species
An increase in ROS levels activates NFKB (Muller et al., 1997; Schreck et al., 1992b). It
was observed that rnicromolar concentrations of hydrogen peroxide (H202) increased the
level of ROS and specifically increased the DNA-binding activity of NFKB in nuclear
extracts of Jurkat T cells (Meyer et al., 1993), PC12 cells (Tong and Perez-Polo, 1996),
and oligodendrocytes (Vollgraf et al., 1999). Moreover, micromolar concentrations of
antioxidant substances, e.g. PDTC (Schreck et al., 1992b) and thioredoxin (Schenk et al.,
1994) block the activation of NFKB in response to nearly all NFKB inducers, including
H202 (Schreck et al., 1992b). Many inducers of NFKB, such as excessive glutamate and
calcium, TNF, PMA, UV, ILl, are known to cause oxidative stress, implying that the
induction of oxidative stress is a common signal in the pathway to NFKB activation.
Therefore, NFKB has been proposed to act primarily as an oxidative-stress response
transcription factor (Schreck et al., 1991). Additionally, an induction of NFlCB was
detected in striatal cultures exposed to nitric oxide-releasing compounds, i.e. S-nitroso-n-
acetylpenicillamine (SNAP) (Simpson and Morris, 1999).
5.4 Genes Induced by NFKB DNA Binding
It is apparent that more target genes have been identified for NFlCB than any other
transcription factor (Baldwin, 1996). These include genes encoding cytokines, growth
factor, chemokines and neuropeptides (Table 3).
The following table shows a few examples of NFlCBtarget genes.
Inducible Genes
Manganese-Superoxide Dismutase
IKB and NFKB Proteins
Inducible Nitric Oxide Synthase
Neuropeptides-dynorphin,
proenkephalin
Cytokines -IL-l, TNFa.
Cycloxygenase enzyme
Adhesion molecules- ICAM
Viral Proteins- HIV
Table 3
An example of the types of genes induced by NFlCB.
To add further complexities, certain proteins which activate NFKB and are themselves
induced by NFkB, e.g. IL-l.
5.5 The Role of NFlCBin Pathological Conditions
In view of a wide range of genes regulated by NFKB, it is not surprising that NFKB could
play different roles in response to different insults in different cell types. The involvement
of NFKB in the induction of apoptosis has recently been intensely investigated (for review,
Foo and Nolan, 1999; Grilli and Memo, 1999; Baichwal and Baeuerle, 1997). Many
studies suggest that NFKB plays a pivotal role in preventing cell death by inducing the
expression of anti-apoptotic genes, such as Mn-SOD (Wang et al., 1996; Van Antwerp et
al., 1996), whereas other studies suggest a role for NFKB in mediating neurodegeneration
by inducing the expression of potential pro-apoptotic genes, such as inducible NOS
(Kaltschmidt et al., 1993b; Rupee and Baeuerle, 1995).
Increased activity of NF-KB has been reported in many brain structures from patients
suffering from neurodegenerative diseases. A study performed on human post-mortem
tissue of seven patients who had suffered idiopathic Parkinson's disease, showed a 70-fold
increase (compared to controls) in the proportion of dopaminergic cells with
immunoreactive nuclear NFKB, (Hunot et al., 1997). To complement this study, it was
demonstrated that the proportion of neurones displaying nuclear NFKB staining was
identical to that of neurones showing apoptotic characteristics (Hunot et al., 1997). Brain
sections from AD patients revealed that the p65 subunit was activated only in areas
affected by the disease (Terai et al., 1996), and in both neurones and astrocytes
surrounding early stage plaques (Kaltschmidt et al., 1997). Analysis of six post-mortem
human brains following death from an ischaemic insult showed increased immunoreactive
p65 in the core area of the ischaemic tissue, and to a lesser extent in the penumbra in
astrocytes and in some macrophages (Terai et al., 1996).
Several animal models of stroke have provided evidence that NFKB activity is increased in
ischaemic areas of the brain (Gaybriel et al., 1999; Hill et al., 2001). Focal ischaemia-
reperfusion in the cerebral cortex region caused increases in NFKB binding activity that
was observed five days after the reperfusion in the ischaemic area and in the penumbra
(Salminen et al., 1995). It has been demonstrated that this increase in NFKB binding
activity is not transient. In a model of traumatic brain injury in rats, a 250% increase in
levels of NFKB DNA binding activity was seen after 1 day post injury, and carried on
increasing to day 3 post-injury with levels returning to sham levels after 10 days (Yang et
al., 1995). In addition, it was seen that activated NFKB was present in the degenerated
CAl area of the hippocampus 72 hours following global forebrain ischaemia and DNA
fragmentation was concomitant with this NFKB activation (Clemens et al.. 1997a;
Clemens et al., 1997b). However, it cannot be concluded yet that NFKB is the causative
factor for the induction of apoptosis.
The delay in binding activity may be due to a delayed infiltration of inflammatory cells.
Indeed, it is possible that injury leads to an increase in the production of IL-l or TNF,
which then activates NFKB, leading to an induction of the expression of a range of pro-
inflammatory genes. Overexpression of cytokines is observed in the brains of patients
suffering from Alzheimer's disease, stroke and traumatic brain injury (for review,
Toulmond et al., 1996). The increase of NF-KB activity is expected as many of the known
NFKB inducers play a role in these pathophysiological conditions, i.e. ROS, cytokines,
glutamate and calcium, but the fundamental question is whether the increase in NFKB
activation in these conditions is a consequence of the cell employing neuroprotective
mechanisms or a consequence of NF-KB mediating cell death. There is evidence to suggest
both.
5.5.1 NFlCBMediates Neurotoxicity
Compelling evidence suggests that NF-KB is a part of the apoptotic process and promotes
cell death in neurotoxic environments. DNA fragmentation, and a sevenfold increase in
NFKB binding activity, was observed in striatal neurones, 12 hours after exposure to
quinolinic acid. However, when rats were co-administered with a synthetic peptide, SNSO,
which prevents NFlCB nuclear translocation, striatal cell death and DNA fragmentation
were significantly decreased (Qin et al., 1998).
Another convincing set of results demonstrated the ability of aspirin to inhibit NF-KB
activity (Kopp and Gosh, 1994). Subsequently it was reported that aspirin is
neuroprotective in primary cerebellar cells against excitotoxicity in a concentration-
dependent manner (Grilli et al., 1996). Neuroprotection by aspirin was also seen in
hippocampal slices treated with NMDA, and this effect correlated with the inhibition of
EAA release and NF-KB translocation to the nucleus (Moro et al., 2000). It was
determined that this result was independent of events associated with anti-inflammatory
properties (Moro et al., 2000). It was therefore suggested that this prevention of
excitotoxic damage was due to the blockade of NFlCB activity, and that the activation of
NFlCB is necessary for NMDA-induced neurotoxicity in cerebellar and hippocampal
neurones (Grilli et al., 1996).
It has been reported that a caspase-3-like protease contributes to the degradation of IlCB-a
in striatal neurones exposed to quinolinic 'acid, It was demonstrated that quinolinic acid
administration reduced IKB-a protein to about 40% of control levels after 12-24 hour of
drug administration, and that IKB-a degradation was completely blocked by the NMDA
receptor antagonist MK-801 (Qin et al., 2000). In addition, the caspase-inhibitor, Ac-
DEVD"CHO, inhibited quinolinic acid-induced IKB-a degradation and attenuated both
quinolinic acid-induced NFKB activation and DNA fragmentation (Qin et al., 2000). This
provides further evidence for the activation of NF-KB and apoptosis via NMDA receptor
stimulation in striatal neurones.
One gene that has been intensely focused upon is the tumor suppresser protein pS3 which
is a well established modulator of apoptosis. Much evidence has suggested that pS3 is a
pro-apoptotic gene contributing to neurodegeneration (Uberti et al., 1998). For example,
kainic acid induces pS3 expression on neurones exhibiting apoptotic cell death (Sakhi et
al., 1994) and in mice which lack the p53 gene, a systemic injection of kainate acid does
not induce cell death (Morrison et al., 1996). Itwas subsequently proposed that excitotoxic
stimuli-induced NFKB contributes to cell death by switching on the transcription of p53
gene (Uberti et al., 1998). Indeed, increases in NFKB binding activity correlated with a
marked increase in the expression of the p53 gene, suggesting NFKB is promoting the
apoptotic cascade through the upregulation of pro-apoptotic genes, such as p53 (Qin et al.,
1999).
5.5.2 NFlCBMediates Cell Survival
The increase in activation of NFKB in ischaemia and other neurodegenerative diseases,
could be a neuroprotective mechanism. There are NFKB consensus sequences on anti-
apoptotic genes, i.e.Mn-SOD, thus NFKB activation could act to induce transcription of
these antioxidants, preventing oxidative stress.
Evidence surrounding the hypothesis of NFKB acting as a protective agent is through
convincing studies with "knock-out" mice which lack the p65 subunit. These mice died
before birth and showed a massive apoptotic death in liver cells (Beg et aL., 1995). It was
also demonstrated that fibroblasts and macrophage cells from p65 deficient mice and cells
from IKB mutant jurkat cell lines were more susceptible to TNF-a.-induced apoptosis when
NFKB signalling pathway were blocked (Beg and Baltimore, 1996; Van Antwerp et al.,
1996; Liu et al., 1996b). However, the outcome of neurones in these p65 knockout mice
was not observed, therefore NF-KB's role maybe completely different in neurones.
However, in other systems, NFKB activity has been shown to be crucial to the survival of
neurones. For example, the pretreatment of fibrosarcoma cells with IL-l, a cytokine which
stimulates the activation of NFKB, but is not pro-apoptotic, protects the neurones after an
addition of TNF (Van Antwerp et al., 1996). Conversely, TNF-a. has been shown to
prevent neuronal death in experimental models of natural neuronal death and
neurodegenerative disorders (Hagg and Varon, 1993; Middleton et al., 2000; Mattson and
Camandola, 2001), and it has been hypothesised that TNFa. stimulates NF-KB which
protects cells by possibly switching two genes encoding Mn-SOD (Wong et al., 1989) and
the zinc finger protein, A20 (Opipari et al., 1992).
The peptide, A~ is deposited in neuritic plaques. Neurodegeneration occurs around the
plaques and therefore it is proposed that A~ peptide is neurotoxic. An in vitro study
demonstrated a time and concentration-dependent decrease in NFlCB activity in cultured rat
cortical neurones. following the exposure to A~. along with DNA fragmentation (Bales et
al., 1998). Anti-oxidants can block A~ peptide toxicity. suggesting that neurotoxicity
induced by ~ peptide involves the generation of free radicals. It could be proposed that A~
appears to mediate its neurodenegeneration effects by down-regulating NFlCB activity, and
therefore NFlCBis neuroprotective.
It seems apparent that NF-lCB interacts with inhibitory regulators of the apoptotic process.
It was demonstrated that NFlCB activates the transcription of the caspase inhibitor lAP
(inhibitor of apoptosis protein), which suppresses apoptosis (Chu et al., 1997) by binding
to executionary caspases, such as caspase-3 (Roy et al., 1997), and protecting cells from
pro-apoptotic Bc1-2 family members (Orth and Dixit et al., 1997). In addition, NFlCB
activation has shown to block MTP induction, since cells not expressing a repressor of IlCB
degradation did not undergo mitochondrial depolarisation or MTP activation in response to
TNF-(l (Hatano et al., 2001). Finally, caspase 3 can cleave IlCBa in vitro, resulting in a
constitutive NFlCB repressor. suggesting that distal caspases may in tum inhibit NFKB to
promote apoptosis (Barkett et al., 1997).
The functional significance of the increase in activation of NFlCB in ischaemia and other
neurodegenerative diseases is uncertain. as many factors can influence the role of NFKB
whether it be pro-apoptotic or anti-apoptotic. These include the subunit composition of the
NFlCB complex. genetic differences within different neuronal phenotypes, the presence of
other transcription factors, the type and intensity of the stimuli. the existence of multiple
hcB-dependent and IlCB-independent pathways influencing NFKB activity, and whether
there is a functional difference between constitutive and inducible NFKB activity (Grilli
and Memo. 1999). It must also be remembered that protein synthesis is inhibited in areas
of energy depletion, therefore genes may not be induced by NF-KB. Additionally. hd3
synthesis may also be inhibited, consequently decreasing the potential inactivator of the
activated NFKB complex.
6. The Striatum
Dysfunction of the striatum is associated with disorders of movement. In Parkinson's
disease, a loss of striatal dopamine is observed, whereas in Huntington's disease, a
degeneration of striatal neurones occurs. Striatal lesions are also thought to be involved in
the pathogenesis of dystonia and Tourette's syndrome (Salloway and Cummings, 1996).
Striatal dysfunction has recently been implicated in neuropsychiatric conditions such as,
obsessive-compulsive disorders, psychoses and addictive behaviours (Calabresi et al.,
I 997b ). Hence, there is reason for understanding striatal neuronal circuits and striatal
functioning under normal physiological conditions as well as pathological conditions.
6.1 Neural Circuit within the Basal Ganglia
The basal ganglia are a group of interconnected sub-cortical brain nuclei, which are
fundamentally associated with the initiation and the control of movement. The basal
ganglia comprises of the striatum, the globus pallidus, which consists of two segments; the
medial segment (GPm) and the lateral segment (GPI), the subthalamic nucleus (STN) and
the substantia nigra, which is also subdivided, into substantia nigra pars reticula (SNr) and
pars compacta (SNc) (Figure 1.5).
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Figure 1.5
A schematic representation of the basal ganglia, indicating the nature of the interconnections between the
various nuclei. Abbreviations: STN, subthalamic nuclei; GPl, globus pallidus lateral; GPm, globus pallidus
medial; SNr, substantia nigra pars reticula; SNc, substantia nigra pars compacta, GABA; y-aminobutyric
acid, EAA; excitatory amino acid, DA; dopamine; DYN, dynorphin; ENK, enkephalin.
The main input to the basal ganglia arises from the cerebral cortex and terminates in the
striatum, appropriately termed the cortico-striatal projection. The major output pathways
are from the GPm and the SNr to the cortex via the thalamus. There are numerous
neurotransmitters and neuropeptides that are involved, including dopamine, glutamate,
GABA, enkephalin and opioids. Each performs a different role whether it be excitatory,
inhibitory or modulatory.
6.2 Neuroanatomy and Neurochemistry of the Striatum
In the primate, the striatum is divided into the caudate nucleus and the putamen. In the
rodent the striatum is undivided. The putamen is the largest area of the striatum and is
located beneath the cortex lying between the external capsule and the lateral segment of the
globus pallidus.
Striatal neurones receive a myriad of synaptic inputs from different sources. Afferents
from all areas of the cortex and the thalamus represent the important source of excitatory
amino acids, whereas the nigrostriatal pathway and intrinsic circuits provide the striatum
with dopamine, acetylcholine, GABA, nitric oxide and adenosine (Hettinger et al., 2001) ..
The major cell type within the striatum is the medium spiny neurone which comprises over
95% of striatal neurones and is characterised by a high density of dendritic spines. They
have unusual electrophysiological properties in that they show very low levels of
spontaneous discharge and maintain a hyperpolarised state. They discharge phasically in
response to excitatory inputs from the cortex (Kawaguchi et al., 1995; Kawaguchi, 1997).
Medium spiny neurones are GABAergic projecting neurones and are divided into two
major types (Gerfen, 1992). One type stains positive for substance P and/or dynorphin, co-
localises with GABA, expresses principally D-l dopamine receptors and projects to the
substantia nigra pars reticula. The other stains positive for enkephalin, preferentially
expresses D-2 dopamine receptors and provides efferents to the globus pallidus (Bolam et
al., 1985; Gerfen et al., 1990; Graybiel, 1990; Besson et al., 1990; Simpson et al.,
1994).
The remaining 5% of neurones are interneurones, characterised by their morphology and
their cytochemical staining. Large cholinergic aspiny interneurones have large somas,
widespread dendritic trees, receive direct dopaminergic inputs and form most of their
synaptic contacts with medium spiny neurones (Kawaguchi et al., 1995). The postsynaptic
effects of acetylcholine are mediated primarily by muscarinic receptors. Another group of
intemeurones are nicotinamide adenosine dinucleotide phosphate (NADPH) diaphorase
positive, this enzyme localisation being identical to NOS. These also contain somatostatin
and neuropeptide Y (Bolam et al., 1984; Phelps et al., 1985; Oraybiel, 1990; Vuillet et
al., 1990; Simpson etal., 1994; Calabresi etal., 2000).
The striatum is compartmentalised into striosomes which are embedded into a matrix, in
which neurotransmitters and neuropeptides are differentially distributed and each striatal
compartment has slightly different afferents and efferents to each other (Gerfen, 1985). For
example, glutamate receptors are segregated, NMDA and AMP A glutamate receptors are
found largely in the matrix, whereas kainate receptors are predominant in the striosome
zones (Oraybiel & Moratalla, 1989), and calbindin D28K is found in neurones which lie in
the matrix but not in the striosome zone (Kawaguchi, 1997).
The main input to the striatum arises from the cerebral cortex, utilises glutamate as its
transmitter and is excitatory (Figure 1.5). Other glutamatergic afferents to the striatum
originate in the thalamus. Dopaminergic projections from the substantia nigra synapse on
the same striatal neurones as excitatory afferents. Cholinergic systems in the striatum are
very important and a balanced interaction between dopamine and acetylcholine is
fundamental for normal striatal activity.
The main efferent pathways from the striatum project to the globus pallidus and SNr
(Figure 1.5), and these projections are OABAergic. The pathway projecting to the lateral
segment also utilises enkephalin as a co-transmitter, whereas the pathway leading to the
medial segmentJSNr uses substance P and dynorphin as co-transmitters.
7. AIMS
Although hypoglycaemia is known to be associated with severe energy failure, the exact
mechanisms underlying neuronal damage after hypoglycaemic coma or ischaemia are
unknown. Intracellular energy failure is also thought to be an important cofactor of the
neuronal degeneration occurring in diseases such as HD, PD and AD (Rothman and Olney,
1986; Choi, 1988; Beal, 1992). Complelling evidence concerning the involvemnet of
studies using positron emission tomography (PET), e.g. In both AD and HD patients a
significant reduction in glucose metabolism has been reported in brain regions, such as the
cortex and the basal ganglia (Beal, 1992). This reduction may be a consequence of
neuronal loss. However, biochemical studies of HO postmortem tissue show a decrease in
mitochondrial complex II and complex III activity in the caudate nucleus (Browne et al.,
1997) and ultrastructural studies of cortical biopsies from HD patients show abnormal
mitochondria (Goebel et al., 1978). In AD postmortem tissue, a decrease in cytochrome
oxidase activity has been reported (Kish et al., 1992).
Components of the excitotoxicity cascade are implicated in hypoglycaemia as well as in
neuronal damage occurring in neurodegenerative conditions, including dysfunctional
calcium homeostasis (German et al., 1992; Iacopino and Christakos, 1990; Mattson and
Guo, 1999), EAA stimulation (Toulmond et al., 1993; Klockgether and Turski, 1993),
ROS production (Sun and Chen, 1998), K-ATP channel activation (Beal, 1996; Hanna and
Bhatia, 1997), and DNA fragmentation (Clark et al., 1999). Therefore the aim of this
study is to investigate the mechanisms and components involved in hypoglycaemic-
induced injury, to provide further understanding in the hope of improving therapeutic
pharmacological intervention against neuronal damage induced via energy deficiency.
It is difficult to study pure hypoglycaemic toxicity in vivo, as hypoglycaemia in vivo can be
accompanied by consequential alterations in metabolic parameters, including pH,
cardiorespiratory status, and local cerebral blood flow. To circumvent these potential
complicating factors, an in vitro model is used. Using an in vitro model most parameters
can be controlled and therefore the external cellular environment can be manipulated. In
addition the in vitro model of hypoglycaemia is relatively easy to attain and is
reproducible.
The striatum is very vulnerable to energy failure, both in hypoglycaemia (Auer et al.,
1984; Kalimo et al., 1985; Wieloch et al., 1985a), and in transient reversible ischaemia
(Pulsinelli et al., 1982; DeGirolami et al., 1984; Smith et al., 1984). An in vitro model
was therefore designed to investigate primary events occurring in striatal cultures in
conditions of glucose deprivation. It has been well established that despite the absence of
extrinsic inputs, cultured neonatal striatal neurones develop a variety of cell types, synaptic
connections and immunohistochemical and biochemical features of the in vivo striatum
(Freese et al., 1990, Simpson et al., 1994).
Finally, much research in effective therapy for acute energy-deficient disorders and chronic
neurodegeneration has concentrated on the EAA receptor itself but recently the challenge
to intervene in the neurotoxic process at a stage beyond the receptor, at the level of
transcription factors, has seemed more appropriate. Since NFKB was reported to be present
in the brain, it is a strong candidate for this pharmacological regulation, considering the
evidence for its role in excitotoxicity, the nature of genes it induced and the various stimuli
which can be involved in its activation. In view of this evidence linking NF-KB to
neurotoxicity in the striatum, the role of NF-KB in striatal neurodegeneration was also
selected as the focus for further study.
Chapter Two. Materials and Methods
2.1 Materials
2.1.1 Primary Dissociated Cell Culture
All products used in cell culture were obtained from Life Technologies (Invitrogen, U.K)
except Euthatal (Rhone Merieux Ltd, Essex).
2.1.2 Cell Viability Assays
XTT (Molecular Probes, U.S); PMS (Sigma. U.K); MAP2 antibody (Sigma. U.K) .
2.1.3 Immunocytochemistry
Phosphate Buffered Saline (PBS): 1.3M NaCI (Fisher Chemicals, U.K)
Paraformaldehyde (PFA) (Riedel-de Haen, Germany); Normal goat serum (Scottish
Antibody Production Unit (SAPU), Scotland); Triton-XIOO (Sigma, U.K); Activin
Biotinylate Conjugate (ABC) Reagent (Vector Laboratories Ltd, U.K); Vector peroxide
substrate (VIP) kit (Vector Laboratories Ltd, U.K); Ethanol (BDH Laboratory Supplies,
U.K); Histoclear and Histomount (National Diagnostics, U.S).
2.1.4 TUNEL Staining
APOPDETECTTM PeroxidasePlus (The Quantum Biotechnologies Group, Q-Biogene,
U.K); Acetic acid (BDH Laboratory Supplies, U.K); Methyl green (Calbiochem, U.K); n-
buthanol (BDH Laboratory Supplies, U.K).
2.1.5 Preparation of Nuclear Extraction for EMSA
HEPES (Sigma, U.K); MgCh (BDH Laboratory Supplies, U.K); EDTA (Sigma, U.K);
Glycerol (BDH Laboratory Supplies, U.K); DDT (Sigma, U.K); Nonidet-p40 (NP40)
(Sigma, U.K).
2.1.6 Labelling NFKB Oligonucleotide Probe
TE Buffer (pH 8.0): 1M Tris (Sigma, U.K)
0.5M EDTA (Sigma, U.K)
NFKB oligonucleotide (Promega, U.S); T4 polynucleotide kinase (Promega, U.S); T4
polynucleotide kinase lOX buffer (Promega, U.S); 33p_ATP (NEN Life Sciences, U.K);
Chromatography G-25 spin columns (Biorad Laboratories, U.S); Scintillation Fluid
(Ecoscint, National Diagnostics, U.S).
2.1.7 Electrophoretic Mobility Shift Assay
KCI (BDH Laboratory Supplies, U.K); HeLa Cells (5mg/ml; Promega, U.S); 6% DNA
Polyacrylamide gel (Novex, Invitrogen, U.K); TBE Buffer X5 (Novex, Invitrogen, U.K);
Filter paper sandwich nylon membrane (Novex, Invitrogen, U.K); Biomax MR Film
(Kodak, Sigma, U.K).
2.1.8 Fura-2 Calcium Measurements
Artificial Cerebral Spinal Fluid (ACSF): 25mM NaHC03 (Riedel-de Haen, Europe)
115mM NaCI (Riedel-de Haen, Europe)
IOmM D-Glucose (Fluka, Sigma, U.K)
2.5mM csci, (BDH, U .K)
1.2mM MgS04 (BDH, U.K)
2rnM KCl (BDH, U.K)
Fura-2 (Molecular Probes, U.S); Glutamate (Sigma, U.K).
2.1.9 Drugs
CsA [500f.1M stock], TFP [2rnM stock], Ouabain [lOmM stock], PDTC [lOrnM stock],
EGTA [IOmM stock], BAPTA [lrnM stock], nickel [100mM stock] nicardipine [10M
stock], TMB-8 [IOmM stock], dantrolene [lmM stock], MK801 [lOrnM stock], CNQX
[lOmM stock], 2-APB [lOmM stock], A23187 [lOrnM stock], aspirin [18rnM stock] and
parthenolide [l1.8mM stock] were all obtained from Sigma (U.K).
HNE [62mM stock] (Alexis Biochemicals, U.K); Z-DEVD-FMK [1.5mM stock]
(Calbiochem, U.K).
EGTA, BAPTA, A23187, nicardipine, 2-APB, CNQX, diazoxide, Z-DEVD-FMK, fura-2,
parthenolide and HNE were made up in DMSO to form a stock solution and then diluted to
the required concentration in PBS. The final concentration of DMSO never exceeded
0.1%. CsA was made up with ethanol and dantrolene in an alkaline aqueous solution
(NaOH). All other drugs were made up with PBS.
2.1.10 Antibodies
Bax, cytochrome c, caspase-3, caspase-9, p65 and p50 were all obtained from Santa Cruz
Biotechnology (U.S).
XRCCI and DNA polymerase-B (Lab Vision Corporation - Neomarkers). ERCC3 and
MSH2 (Autogen Bioclear, U.K). Secondary biotinylated antibodies (Vector Laboratories
Ltd, U.K). The specificity of the antibodies used was not determined in this study. Data
from other experiments using the same antibodies, at the same concentration, proved that
these were specific for the proteins they were staining (Hara et al., 1996; Liu et al., 1996c;
Srinvasula et al., 1998; Kaufmann et al., 1993; Caldecott et al., 1996; Hermon et al., 1998;
Grilli and Memo, 1999; Seeger et al., 2000). It can also be noted that the immunoreactivity
of the antibody was measured which is not a direct measurement of the protein itself.
Methods
2.2 Primary Dissociated Cell Cultures
Pregnant Wistar rats (200-300g) gestation day 17 (E17) were killed with an overdose of
sodium pentobarbitone (Euthatal), administered intraperitoneally. Embryos (10-12) were
removed from the uterus, decapitated and placed in cold modified essential medium
(MEM, see appendices, Table 1). Brains were removed from the crania and using the optic
chiasm as the posterior marker the dorsal striata were dissected out (Misgeld and Dietzell,
1988). The subsequent procedure was carried under sterile conditions in a laminar flow
hood. Striatal tissue was then minced and washed three times with ice-cold MEM. Cells
were dissociated in 5ml of 2.5% trypsin solution for 45 minutes at 37°C. Trypsin was
inactivated by the addition of 5ml of foetal calf serum and subsequently the tissue was
washed three times again in MEM.
The tissue was triturated through a pasteur pipette in Dulbecco' s modified Eagle's
medium (see appendices, Table 2) with GlutaMAX ITM (1000mg/L) supplemented with
20% horse serum and 5J.lglml penicillin-streptomycin, and seeded at a density of
approximately (0.15 x 106 cells/cm, see Simpson et al, 1994), onto either eight-well
multichamber glass slides or 6-well plates successively coated with poly-D-Iysine (4J.1g/ml)
and mouse laminin (6J.1g/J.1I).The cultures were incubated at 37°C and with 5% CO2/95%
02 in a humidified incubator (leN Flow).
After 72 hours the medium was changed to Neurobasal medium with penicillin-
streptomycin (5J.1g1ml)and B27 supplement added. B27 supplement controls the
proliferation of non-neuronal cells. Every three days thereafter the medium was changed.
Cultures between 14-18 days old were used for experimentation. All experiments were
done at 3rC, excluding fura-2 work which was at room temperature.
2.2.1 Hypoglycaemic and Recovery Conditions
Cultures subjected to hypoglycaemia were washed twice with Dulbecco's MEM (without
glucose and sodium pyruvate) and Neurobasal medium was replaced with the
glucose/sodium pyruvate-free medium. Normoglycaemic (control) cultures were treated
the same with the equivalent Dulbecco's MEM which contained glucose (lOOmg/L) and
sodium pyruvate (llOmgIL). The duration of hypoglycaemia-mediated toxicity was
dependent on experimental procedure.
The recovery phase was determined by returning the glucose content back into the cultures,
using the medium for normoglycaemic cultures. Again, normoglycaemic cultures received
equivalent procedures.
Cultures were stimulated with various drugs and inhibitors for varying lengths of time to
examine neuroprotective effects, as detailed in the following chapters. Initially, the original
duration of the experiment was for 24 hours, i.e. cultures were incubated in glucose-free
medium, with or without drugs, for 24 hours. This length of hypoglycaemia produced a 75
% decrease in XTT staining. However, it was subsequently observed that 4 hours of
hypoglycaemia produced an approximately 50% decrease in XTT staining and that this
percentage was sufficient to experiment with, i.e. there was a significant amount of injury
that would improve if drugs were neuroprotective. Another important factor was that
results were quicker to obtain.
2.3 Cell Viability Assay
2.3.1 Mitochondrial Functioning
XTT (sodium(2,3-bis(2-methoxy-4-nitro-5-sulphophenyl)-2H-tetrazolium-5-carbxanilide)
is a tetrazolium salt which is cleaved and reduced within the active mitochondria of living
cells by the enzyme succinate dehydrogenase to form soluble formazan crystals (Mosmann
et al., 1983). The final concentration of XTT used was lmg/ml. In addition, phenazine
methosulphate (PMS) was added to increase the rate of reduction reaction at a final
concentration of 1.53Jlllml (Goodwin et al., 1995). The XTTIPMS reagent was dissolved
in PBS and added to the medium and incubated at 37°C and 5% CO2/95% O2 in a
humidified incubator, for three hours. These three hours were included within the
experimental period.
Subsequently, the medium was pipetted into a 96 well plate and each sample, in triplicates
was read spectrophotometrically (Dynex Revelation 4.04 software) by an microplate reader
at a wavelength of 450nM (Opsys MR, Dynex Technologies, U.K). Background signals,
obtained from wells containing XTTIPMS in medium not exposed to cells were subtracted
from the sample readings.
2.3.2 Cytoskeletal Marker
Microtubule-associated protein 2 (MAP-2) is present in dendrites and cell bodies of
neurones. Toxic stimuli reduce MAP-2 immunoreactivity (Whittaker et al., 1993; Arias et
al., 1997; Brooke et al., 1999). Cells were treated with specific stimuli and
immunocytochemical analyses were performed using the antibody against MAP-2 (refer to
section 4).
2.4 Immunocytochemistry
Cells were fixed using ice-cold 4% paraformaldehyde in phosphate-saline buffer (PBS), for
30 minutes. After two washes with PBS, blocking serum (PBS with 15% normal goat
serum) was added to the cells for one hour. The blocking serum was removed and the
primary antibody solution (PBS with various specific antibodies (0.2-2Ilg/ml), 3% normal
goat serum and 0.005% Triton-Xl00 was added over night at 4°C in a humidified chamber.
The cells were washed for five minutes with PBS, three times and then were incubated
with the secondary antibody solution (PBS with specific species biotinylated secondary
antibody (Iug/ml) and 15% normal goat serum) for 60 minutes at room temperature.
Following a further three five minute washes with PBS, the cells were incubated with an
ABC reagent (prepared using manufacturer's protocol) for 60 minutes at room
temperature. The cells were washed again three times for five minutes per wash with PBS
and then incubated with the VIP solution (prepared using manufacturer's protocol) for 10-
15 minutes at room temperature, until staining was visible under the light microscope.
After the cells were rinsed once in PBS for five minutes and then in distilled water for a
further five minutes, they were dehydrated gradually in increasing concentrations of
alcohol; 70%, 90% and three times in 100% for 5 minutes per concentration. Cells were
allowed to dry briefly (-2 minutes) and then immersed in histoc1ear overnight. Cells were
preserved by mounting the slides with coverslips using histomount and then left to dry.
2.5 TUNEL Staining
The APOPDETECTTM kit is designed to label the free 3' -OH DNA termini in situ with
chemically digoxigenin labeled and unlabelled nuc1eotides. The nucleotides contained in
the reaction buffer are enzymatically added to the DNA by terminal deoxynucleotidyl
transferase (TdT). TdT catalyses a template-independent addition of nucleotide
triphosphates to the 3' -OH ends of double-stranded or single-stranded DNA. The
incorporated nucleotides form an oligomer to unlabelled nucleotide, and the kit is
optimised to promote anti-digoxigenin antibody binding to the oligomer. DNA fragments
which have been labelled with the digoxigenin-nucleotide are then allowed to bind an anti-
digoxigenin antibody that is conjugated to a peroxidase. The bound peroxidase antibody
conjugate enzymatically generates a permanent, intense, localised stain from chromogenic
substrates, providing sensitive detection in immunocytochemistry. This kit has been shown
to be effective in neurotoxicity models (Qin et al., 1998; Parsadanian et al., 1998).
The APOPDETECTTM manufacturers protocol was carried out, using the reagents
provided within the kit as follows. Cultures were either exposed to normoglycaemia or
hypoglycaemia for a specific duration (refer to relevant chapters) and then fixed in 1%
paraformaldehyde in PBS (pH 7.4) for 10 minutes at room temperature. The fixative was
washed off with two changes of PBS for five minutes each wash. The slides were then
placed into precooled ethanol:acetic acid solution (2: 1) at -20°C for five minutes which
permeabilised the cells. This solution was washed off with two changes of PBS for five
minutes each wash. Excess liquid was tapped off and 13fll/cm2 equilibration buffer was
added immediately to the cells for ten seconds at room temperature. This liquid was then
tapped off and 1.1flllcm2 TdT enzyme (70% reaction buffer and 30% TdT enzyme) added
to the slides for one hour in a humidified chamber at 37°C. Following this incubation, the
slides were agitated for fifteen seconds and incubated for a further ten minutes in
stop/wash buffer (lml stop/wash buffer and 34 ml deionised water (dH20) at room
temperature. The slides were then washed three times in PBS for one minute each wash.
Excess liquid was tapped off before incubating the slides with 131l1/cm2room temperature
anti-digoxigenin peroxidase conjugate for 30 minutes in a humidified chamber at 37°C.
Slides were then washed four times in PBS for two minutes per wash at room temperature
and VIP substrate (refer to section 2.4) was applied for twelve minutes at room
temperature. The slides were washed again three times for one minute in dH20 and then
incubated in dH20 for five minutes at room temperature.
The cells were counterstained by leaving the slides in 0.5% (w:v) methyl green for ten
minutes at room temperature and washed in three changes of dH20, agitating the slides for
the first two washes and incubated for thirty seconds for the third. The slides were then
washed with 100% n-buthanol three times agitating the slides for the first two washes and
incubated for thirty seconds for the third. The slides were finally dehydrated by placing a
series of alcohols and mounted the same as described in section 2.4.
2.6 Preparation of Nuclear Extraction for EMSA
The medium was removed, leaving approximately lml in which the cells were scraped off
and spun at SOOgfor 10 minutes. Subsequently the pellet of cells were lysed with SOJlIof
extraction buffer (SmM HEPES, 1.SmM MgCh, 0.2mM EDTA and 26% glycerol, 300mM
NaCh, 0.1% DDT, 0.025% nonidet-p40 (NP40) and one protease cocktail inhibitor
tablet/Sml). The samples were then homogenised, frozen at -70°C and thawed out at 37°C,
three times and finally centrifuged at 4°C, at 2100g for 20 minutes. Aliquots of the
supernatant containing nuclear protein were frozen at -70°C, until needed.
2.7 Labelling NFKB Oligonucleotide Probe
The probe used for all EMSAs contained the double stranded NFlCB oligonucleotide
(0.6pmollml; 'S-AGTTGAGGGGACTITCCCAGGC-3' and 3' -TCAACTCCCCTGAAA
GGGTCCG-S'), IJ.1lT4 polynucleotide kinase lOX buffer, IJlI T4 polynucleotide kinase,
2.6SJlI deionised water and SJlI 33p_ATP (2000Ci/mmol). This was incubated at 37°C for
10 minutes. The reaction was stopped by adding lul of O.SM EDTA and equilibrated with
39J.11of TE (Tris-EDT A) buffer. The labelled oligonucleotide was then separated from
unincorporated nucleotides by running through a gel chromatography G-25 spin column.
Finally, 2JlI of labelled oligonucleotide was added to 8ml of scintillation fluid and put
through a liquid scintillation analyser (Packard Tri-Carb 2100TR) to determine the
radioisotope concentration of the probe.
2.8 Electrophoretic Mobility Shift Assay
Approximately 4JlI-6JlI (5-lOmg, see Simpson and Morris, 1994) of nuclear protein was
incubated for 30 minutes at 4°C with 4JlI labelled NF-kB oligonucleotide probe in binding
buffer (lOmM HEPES, SOrnM KCI,O.2mM EDTA, 2.5rnM DDT, 10% glycerol, 0.05%
NP40 and a tablet of protease inhibitors/5ml). The total reaction volume was 20J.11.
Labelled samples were loaded into a non-denaturing 6% polyacrylamide gel and run in 0.5
x TBE (Tris boric acid EDTA) buffer for 70-80 minutes at 100 volts/O.OI amps. The DNA-
protein complexes were transferred from the gel to a nylon membrane in 0.5 x TBE buffer
for 120 minutes at 25 volts/0.36 amps. The membrane was then irradiated with UV light
for 1 minute and exposed to Biomax MR film (Kodak) for 14 days. Nuclear protein extract
(2JlI) from the human tumor cell line, HeLa cells, was used as a positive control.
2.9 Fura-2 Calcium Measurements
Cells were grown on poly-D-Iysine and laminin coated coverslips (No. 0, Chance Propper
Ltd, England) within 6-well plates, treated accordingly and loaded with fura-2AM (IJ.1l1ml;
dissolved as a ImM stock in DMSO) for 30 minutes at 37°C and 5% C02/95% O2 in a
humidified incubator. This is membrane permeable such that the cells are able to convert it
into a membrane-impermeable form in their cytosol, i.e. the acetoxymethyl ester (AM)
linkage is cleaved by ubiquitous intracellular esterases.
Small sections of coverslip were placed on a recording bath (No. 0) within a bath filled
with ACSF (approximately lml). Constant perfusion (lml per minute) with ACSF
occurred during the recording at room temperature (-20°C). Glucose-free ACSF was used
with hypoglycaemic-treated cells. Fluorescence measurements were made using a
microfluorimeter consisting of an inverted fluorescence microscope (Nikon Diaphot) and a
photomultiplier tube with a bi-alkali photocathode, as described by McCarron and Muir
(McCarron and Muir, 1999). Single cells were alternatively excited with wavelengths of
340nM and 380nM every 10 ms for 8.5ms at each wavelength to give a ratio at baseline
using a PTI delta scan (photon Technology International Inc, East Sheen, London, U.K).
The binding of calcium to fura-2 increases the absorption at 340nm and decreases the
absorption at 380nm, therefore a ratio of emission from 340nm excitation to emission from
380nm excitation is related to intracellular calcium concentration, and is independent of
variation caused by differences in cell thickness, dye quantity or photobleaching. Baseline
recordings were allowed to run for approximately 1 minute before measuring the ratios.
Glutamate (lmM and 10mM) was' added to the bathing medium to obtain a response to
depolarisation to determine the viability of the cell.
The calibration of the ratios obtained from the fura-2 imaging was performed at the end of
the experiment. Ratios from two different solutions of fura-2, one containing a saturating
concentration of Ca2+ (l00mM), and the other containing zero Ca2+ and EGTA (IOmM)
were obtained.
The following equation, devised by Grynkiewicz et al., was used to calculate the
concentration of intracellular calcium (Grynkiewicz et al., 1985):
Where R is the experimental ratio obtained, Rmin (0.4) the ratio obtained from a solution of
fura-2 lacking calcium, Rmax (8.0) the ratio obtained from a solution of fura-2 containing
calcium, sf2 the emission detected from 380nM excitation from the calcium-free solution,
s~ the emission detected from 380nm excitation of the calcium-containing solution and
Kd (224nM), is the dissociation constant offura-2 for calcium (Grynkiewicz et al .. 1985).
Fluorescence equipment was controlled by PTI Felix software (Photon Technology
International Inc, East Sheen, London, U.K), which also performed the storage and
analysis of the fluorescence.
2.10 Image Analysis and Statistics
The number of individual experiments within each pooled set of data was between three
and five. Individual experiments were obtained from separate animals.
For each experimental culture thirty immunoreactive cells were measured from randomly
chosen fields of view (five cells per field of view). The cytoplasmic area and/or the nuclear
area was isolated and the relative optical density (ROD) of immunoreactive staining was
measured and a mean ROD was calculated. In order to measure MAP2 immunoreactive
staining, a ROD threshold was set and the mean number of pixels per unit area within that
threshold was recorded for each of the fifteen fields of view. A mean area of the specific
range of ROD was calculated. Consistency was maintained by measuring cells within the
same culture and within the same experiment on the same day. All recordings were made
by using Image NIH version 1.52 (Macintosh) software.
Data were converted to percentages of control (except TUNEL staining data) in order to
normalise data (where control was equal to 100%) and the standard error of the mean was
calculated. Using the statistical package Minitab, statistical significance was assessed using
two-way analysis of variance (ANOYA) with post hoc Tukey's test for comparison
between groups. One-way ANOYA with post hoc Fisher's test and the non-parametric
Mann- Whitney test was used for comparison within groups. The 95% confidence intervals
were tested for comparison between treatment groups and control.
Chapter Three.
Components of Hypoglycaemic toxicity
3.1 Introduction
The modulation of specific components active in hypoglycaemic neurotoxicity has been
reported to prevent cell death (Nellgard et al., 1992; Chung and Lee, 1998; Tasker et al.,
1992; Ferrand-Drake and Wieloch, 1985b). In this study a number of these components
were manipulated with defined pharmacological tools, in the effort to determine whether
they were involved in hypoglycaemia-induced cell death in striatal cultured cells. Figure 3
is a schematic diagram showing the site of action of each compound used in the attempt to
promote survival in cells exposed to hypoglycaemia.
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Figure 3
A schematic diagram of the mechanisms involved in hypoglycaemic-induced cell death and the site of
pharmacological action, including glutamate receptors and potassium channels, free radical production and
the mitochondrial permeability pore. Inhibitory factors are shown in red boxes.
Diazoxide is a channel opener for the ATP-dependent K+ channels (K-ATP). It mediates its
stimulatory effect by binding to the sulfonylurea receptor subunit of the K-ATP channel.
Diazoxide is lipid soluble and can activate K-ATP channels regardless of the side of the
membrane to which it is applied (see Ashford review, 1988). The theory is that diazoxide
would increase the activity of K-ATP channels, thereby hyperpolarising the membrane,
reducing excitability and preventing the opening of the VOCe.
MK801 is an anti-convulsant, which shows high antagonist potency for NMDA receptors.
It is a non-competitive NMDA receptor antagonist, which binds to the phencyclidine site
within the channel pore. It is dependent on the presence of glutamate agonists, i.e. it
inhibits NMDA receptor responses by binding when the receptor is in the agonist-activated
open state (Dingledine et al., 1988). Assuming that the membrane is depolarised in the
absence of glucose, MK80l should prevent excitotoxic damage through the NMDA
receptor.
CNQX is a competitive AMPA receptor antagonist (For review, Davies, 1990). It is
thought that by blocking AMPA receptors, the prevention of a glutamate-dependent
sustained depolarisation and secondary excessive influx of calcium will occur, therefore
CNQX will be acting as an early neuroprotectant in the excitotoxicity cascade.
PDTC is a stable derivative of dithiocarbamate. Dithiocarbamate is widely used, from
insecticide to therapeutic agents for alcoholism, metal intoxication and cancer. PDTC has
at least two chemical properties. One is a chelating activity for heavy metals, the other is
an antioxidative activity of its dithiocarboxy group. It is known to inhibit the production of
hydroxyl radicals and inducible nitric oxide (Seaton et al., 1997; Moro et al., 1998). In
normoglycaemic conditions PDTC may exert neuroprotective effects by scavenging the
excess of ROS thus preventing irreversible damage, such as lipid peroxidation.
Cyclosporin A (CsA) is a member of a class of potent immunosuppressants. In human
medicine, CsA is widely used in transplantation to prevent rejection of the transplanted
organ (Keown, 1990; Liu, 1993). CsA is a lipophilic molecule, so can diffuse through the
cell membrane, where it binds to a cytosolic protein termed cyc1ophilin. The receptor for
the cyclophilinlCsA complex is found in the inner membrane of the MTP and therefore it
is thought that CsA blocks the pore by binding to this receptor (Connem and Halestrap,
1994).
Trifluoperazine (TFP) is a known calmodulin antagonist but also inhibits the MTP by
mechanisms not yet understood (Hoyt et al., 1997). Additionally, it was also reported that
trifluoperazine can inhibit mitochondrial Na+/Ca+ exchange in intact neurones (Hoyt et al.,
1997). The hypothesis is, that by blocking the MTP with either CsA or TFP, mitochondrial
swelling and the release of ROS and cytochrome c will be prevented.
Finally, if the ATP-dependent Na+/K+ pump function is inhibited by the ATP depletion
during hypoglycaemia, it can be suggested that pharmacological inhibition of the pump
would produce the same effects as hypoglycaemia, with membrane depolarisation leading
to a toxic influx of calcium. This would be an insight as to whether the removal of glucose
does specifically prevent the normal functioning of the ATP-dependent Na+/K+ pump.
Ouabain is an ATP-dependent Na+/K+ pump inhibitor and if the hypothesis is correct
should have deleterious effects on normoglycaemic cells. It may produce further damage to
hypoglycaemic cells.
In this series of experiments, the above compounds were tested for their effects on
hypoglycaemic neurotoxicity as assessed using either XTT staining (for mitochondrial
respiratory function) or MAP2 immunoreactivity (for cytoskeletal integrity).
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3.2 Results
Cell viability, following the exposure to hypoglycaemia for either 4 or 24 hours was
analysed using the XTT assay. Cell viability was significantly reduced by 43.6% (±16.9)
compared to normoglycaemia after 4 hours and by 74.0% (±8.4) after 24 hours (Figure
3.1).
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Figure 3.1
The effect of hypo glycaemia on striatal cells. The glucose content was removed from cultures for either 4 or
24 hours. Cell viability was measured by XTT staining. There is a significant reduction in the percentage of
cell viability in hypoglycaemic cultures after both 4 and 24 hours compared to normoglycaem ic cultures
(*p<0.05 versus 100%; 95% confidence intervals of the mean). The cell viability of cultures exposed to 24
hours of hypoglycaemia is significantly lower than cultures exposed to only four hours of hypoglycaemia
(one-way ANOVA, F(l,4)=7.86, p<0.05). Data are expressed as percentage of XTT staining in
normoglycaemic cultures (100%) (n=5).
Figure 3.2a compares the morphological changes in hypoglycaemic cells (B) compared to
normoglycaemic cells (A). In hypoglycaemic cultures, the glucose was removed for 24
hours prior to staining for MAP2. Staining shows shortened, fragmented dendrites in
hypoglycaemic cultures compared to normoglycaemic cultures. Clumps of cells can be
observed in hypoglycaemic cultures where it appears cells have migrated towards each
other. In contrast, cells in normoglycaemic cultures are evenly spread with long dendrites
making contact with each other. There are also less cells in hypoglycaemic cultures, and it
is assumed that profoundly sick cells have become unstuck from the adhesive coating
lining the culture chambers and consequently are removed during fixation. The
morphological changes in Figure 3.2a are reflected in Figure 3.2b, which is a quantitative
histogram of MAP2 immunoreactivity in normoglycaemic and hypoglycaemic cultures.
MAP2 immunoreactivity decreased by 59.2% ± 23.3 in hypoglycaemic cultures compared
to normoglycaemic cultures.
Figure 3.2a
MAP-2 immunostaining in cultures treated in normoglycaemic conditions, (A) or hypoglycaemic conditions
for 24 hours (B). The dendrites in hypoglycaemic cultures are retracted or fragmented, there are fewer cells
and the remaining cells appear to be in clumps.
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Figure 3.2b
MAP-2 immunostaining in cultures treated in normoglycaemic conditions or hypoglycaemic conditions for
24 hours. In hypoglycaemic cultures MAP2 immunoreactivity significantly decreases to 59.2% ± 23.3 when
compared with normoglycaemic cultures at 100% (n=5).
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In normoglycaemic cultures, all concentrations of ouabain produced a significant reduction
in cell viability after 4 hours compared to non-treated normoglycaemic cultures. After 4
hours of hypoglycaemia alone, cell viability was significantly reduced from 100% but
there was no further reduction with ouabain. The percentage of cell death remained the
same, regardless of the concentration of ouabain (Figure 3.3).
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Figure 3.3
The effect of ouabain on striatal cells in normoglycaemic and hypoglycaemic cultures. Ouabain was added at
various concentrations to cultures for 4 hours. In hypoglycaemic cultures the glucose was removed just prior
to the addition of ouabain. Cell viability was measured by XTT staining. Removing the glucose produced a
significant decrease in cell viability in the absence of ouabain. There is an effect of hypoglycaem ia but no
effect was seen with ouabain (two-way ANOVA, effect of hypo glycaemia, F(1,16)=43.9, p<O.OOl; effect of
ouabain, F(3,16)=2.8, p=0.08). There is no effect of ouabain in hypoglycaemic cultures (one-way ANOVA,
F(3,8)=0.04, p=l.0) but a significant reduction in cell viability is seen in normoglycaemic cultures at each
concentration (*p<0.05 versus 100%; 95% confidence intervals of the mean). Data are represented as a
percentage ofXTT staining in normoglycaemic cultures without oubain treatment (100%) (n=3).
There were no neuroprotective effects observed with MK801 in hypoglycaemic treated
cells. Cell viability was significantly reduced after 4 hours of hypoglycaemia. However
there was no significant change in cell survival when MK801 was added. Thus, MK801
had no effects on normoglycaemic cultures (Figure 3.4).
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Figure 3.4
The effect of MK801 on normoglycaemic and hypoglycaemic cultures. MK-801 was added at various
concentrations to cultures for 4 hours. In bypoglycaemic cultures, the glucose was removed just prior to
addition ofMK-801. Cell viability was measured by XTT staining. There was a significant reduction of cell
viability in hypoglycaemic cultures (*p<0.05 versus 100%; 95% confidence intervals of the mean) but no
significant effects of MK801, (two-way ANOVA, F(3,24)=0.16, p=0.9, no significant effect of MK801,
F(1,24)=13.2, significant effect of hypo glycaemia, p<O.OOl). In particular, MK-801 did not show significant
neuroprotection against hypoglycaemic cell damage at any concentration (one-way ANOV A, p=0.7). The
percentage of cell viability did not reach normoglycaemic levels. Data are represented as a percentage of
XTT staining normoglycaemic cultures without MK-801 treatment (100%) (n=4).
Similarly the blockade of AMPA receptors, by CNQX, has no neuroprotective effect
against hypoglycaemic-induced injury. A significant decrease in cell viability was
observed in hypoglycaemic cultures, after 4 hours, compared to normoglycaemia cultures
but CNQX showed no significant ability to reduce this effect. Therefore, CNQX had no
effect on normoglycaemic cells (Figure 3.5).
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Figure 3.5
The effect of CNQX on normoglycaemic and hypoglycaemic cultures. CNQX was added to cultures at
various concentrations to cultures for 4 hours. In hypoglycaemic cultures, the glucose was removed just prior
to the addition of CNQX. XTT staining significantly decreased in hypoglycaemic cultures (*p<0.05 versus
100%; 95% confidence intervals of the mean) but there was no significant effect of CNQX (two-way
ANOYA, F(1,16)=16.1, significant effect of hypo glycaemia, p<O.OOl. effect ofCNQX dose, F(3,16)=O.l6,
p=0.9), in particular, there was no significant neuroprotection against hypoglycaemic cell damage when cells
were treated with CNQX (one-way ANOYA, F(1,3)=0.3, p=O.8). Cell viability was measured by XTT. Data
are represented as a percentage ofXTT staining normoglycaemic cultures without CNQX treatment (100%)
(n=4).
After 24 hours of hypo glycaemia, the viability of cells was significantly reduced compared
to cells in normoglycaemic cultures (Figure 3.1). The addition of esA to hypoglycaemic
treated cells had no significant effect at any concentration (O.1JlM - 10JlM). Similarly, esA
had no significant effect on normoglycaemic cells (Figure 3.6). Figure 3.7 shows the effect
of esA on cell viability measured by MAP2 staining. A significant decrease was seen in
MAP2 staining in cells treated with 24 hours of hypoglycaemia, compared to staining
measured in normoglycaemic cells. There was no significant difference in MAP2 staining
between hypoglycaemic cells and hypoglycaemic cells treated with esA (Figure 3.7).
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Figure 3.6
The effect ofCsA on nonnoglycaemic and hypoglycaemic cultures. CsA was added at various concentrations
to cultures for 24 hours. In hypoglycaemic cultures, the glucose was removed just prior to the addition of
CsA. Cell viability was measured by XIT staining. There is a significant reduction of cell viability in
hypoglycaemic cells (*p<0.05 versus 100%; 95% confidence intervals of the mean) but viability was not
affected by CsA concentration (two-way ANOYA, F(1,28)=365.5, significant effect of hypoglycaemia,
p<O.OOl; effect ofCsA, F(6,28)=1.26, p=O.3). CsA did not show neuroprotection against hypoglycaemic cell
damage at any concentration (one-way ANOYA, F(6,14)=0.23, p=0.96). Data are represented as a percentage
ofXIT staining in normoglycaemic cultures without CsA treatment (100%) (n=3).
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Figure 3.7
The effect ofCsA on nonnoglycaemic and hypoglycaemic cultures. CsA was added at various concentrations
to cultures for 24 hours. In hypoglycaemic cultures, the glucose was removed just prior to the addition of
CsA. Cell viability was measured by MAP-2 immunoreactivity. There is a significant effect of
hypoglycaemia on MAP2-immunorectivity, but no significant effect of CsA concentration (two-way
ANOVA, effect of hypoglycaemia, F(1,14)=12.6, p<O.Ol; effect of CsA concentration, F(6,14)=1.46,
p=0.26). There was no significant difference in MAP2 staining between hypoglycaemic cells and
hypoglycaemic cells treated with CsA at any concentration (one-way ANOVA, F(6,7)=0.5, p=0.8). Data are
represented as a percentage ofnonnoclycaemic cultures without CsA treatment (100%) (n=3).
The cell viability of hypoglycaemic treated cultures was significantly reduced after 24
hours compared to normoglycaemic cultures, however TFP had no significant effect, at any
concentration, on hypoglycaemic cultures. In normoglycaemic cultures there was no
significant difference when TFP was added apart from at 50f..1M,where a dramatic
reduction in cell viability was observed (Figure 3.8). Cell viability was also measured
using MAP2 staining. There was no significant difference in MAP2 staining between
hypoglycaemic cells treated with or without TFP. As expected, at 50f..1M,MAP2 staining
significantly decreased in normoglycaemic cells compared to normoglycaemic cells
without TFP treatment (Figure 3.9).
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Figure 3.8
The effect ofTFP on normoglycaemic and hypoglycaemic cultures. TFP was added at various concentrations
to cultures for 24 hours. In hypoglycaemic cultures, the glucose was removed just prior to the addition of
TFP. Cell viability was measured by XTT staining. There was a significant reduction of cell viability in
hypoglycaemic cells and in normoglycaemic cells exposed to 50J-LMTFP (*p<0.05 versus 100%; 95%
confidence intervals of the mean) and a significant effect of TFP (two-way ANOVA, effect of
hypoglycaemia, F(1,28)=384.6, p<O.OOl; effect of TFP, F(6,28)=17.9, p<O.OOI). TFP did not show
neuroprotection against hypoglycaemic cell damage at any concentration (one-way ANOVA, F(6,14)=0.4,
p=0.4). Data are represented as a percentage of XTT staining in normoglycaemic cultures without TFP
treatment (100%) (n=3).
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Figure 3.9
The effect of TFP on normoglycaemic and hypoglycaemic cultures measured by MAP2-immunoreactivity.
TFP was added at various concentrations to cultures for 24 hours. In hypoglycaemic cultures, the glucose
was removed just prior to the addition of the TFP. Cell viability was measured by MAP2 staining. There was
a significant reduction in MAP-2 staining in hypoglycaemic cells and in normoglycaemic cells exposed to
50llM (*p<O.05 versus 100%; 95% confidence intervals of the mean) and a significant effect of TFP (two-
way ANOYA, effect of hypo glycaemia, F(I,14)=10.7, p<O.OI; effect ofTFP, F(6,14)=4.l, p<0.05). TFP did
not show any neuroprotection against hypoglycaemic cell damage (one-way ANOYA, F(6,7)=2.03, p=0.2).
Data are represented as a percentage of MAP2 staining in normoglycaemic cultures without TFP treatment
(100%) (n=3).
Plf'I'C showed no significant effect on cell viability in cultures treated with 4 hours
hypoglycaemia. However, in normoglycaemic cultures treated with 50llM Plf'I'C there was
a significant increase in cell viability compared to normoglycaemic cells incubated in the
absence errrrrc (Figure 3.10).
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Figure 3.10
The effect of POTC on normoglycaemic and hypoglycaemic cultures. POTC was added at various
concentrations to cultures for 4 hours. In hypoglycaemia cultures, the glucose was removed just prior to the
addition of POTC. CeU viability was measured by XTT staining. There is a significant reduction of cell
viability in hypoglycaemic cultures (*p<0.5 versus 100%; 95% confidence intervals of the mean) along with
a significant effect of POTC concentration (two-way ANOVA, F(1,24)=64.8, effect of hypoglycaemia,
p<O.OOl;effect of PDTC, F(3,24)=4.4, p<O.Ol), however, PDTC did not show neuroprotection against
hypoglycaemic cell damage at any concentrations (one-way ANOVA, F(3,12)=0.2, p=0.2). In
normoglycaemic cultures, 50~ POTC significantly increased cell viability (*p<0.05 versus 100%; 95%
confidence intervals of the mean); significant effect of PDTC concentration, F(2,9)=4.7, p<O.5 one way
ANOVA). Data are represented as a percentage ofXTT staining in normoglycaemic cultures without POTC
treatment (100%) (n=5).
Figure 3.11 shows that opening K-ATP channels with diazoxide at various concentrations
had no neuroprotective effect on hypoglycaemic treated cells. Four hours of
hypoglycaemia alone produced a significant reduction in cell viability but no significant
change was observed when hypoglycaemic cells were incubated with diazoxide. Thus,
diazoxide had no significant effect on normoglycaemic cells (Figure 3.11).
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Figure 3.11
The effect of diazoxide on normoglycaemic and hypoglycaemic cultures. Diazoxide was added at various
concentrations to cultures for 4 hours. In hypoglycaemic cultures, the glucose was removed just prior to the
addition of diazoxide. Cell viability was measured by XTT staining. There was a significant reduction of cell
viability in hypoglycaemic treated cells (*p<O.5 versus 100%; 95% confidence intervals of the mean) and a
significant effect of diazoxide (two-way ANOVA, effect of hypoglycaemia, F(I,16)=326.9, p<O.OO1; effect
of diazoxide, F(3,16)=3.4, p<O.5) but the addition of diazoxide did not show any increase in cell viability
(one-way ANOVA, F(3,S)=0.S, p=O.53). Data are represented as a percentage of XTT staining in
normoglycaemic cultures without diazoxide treatment (100%) (n=3).
3.3 Discussion
Hypoglycaemia-induced toxicity caused a significant reduction in cell viability in striatal
cultures after 4 and 24 hours (Figure 3.1). This is consistent with previous studies
(Williams et al., 1995; Nakao et al., 1995; Calabresi et al., 1997a) and suggests that an
alteration in mitochondrial functioning has occurred by 4 hours. Indeed, it has been
reported that twelve minutes after oxygen and glucose deprivation, dysfunctional
mitochondria are observed in hippocampal slice cultures (Taylor et al., 1999). It is
interesting that the difference in the percentage of cell viability between 4 and 24 hours of
hypoglycaemia, although significantly different, is relatively small and that the percentage
does not reach zero (Figure 3.1). It could be assumed that either there is a specific type of
neurone or neurones within the culture which are relatively resistant to hypoglycaemic cell
damage. For example, it is known that cholinergic interneurones are much less vulnerable
to hypoglycaemia compared with medium spiny neurones (Calabresi et al., 1997a). This
could have been tested via neurochemical markers such as choline acetyltransferase which
would have specifically stained cholinergic interneurones. Thus, following 4 hours of
hypoglycaemia, the majority of medium spiny neurones may have ceased to function but
after 24 hours, all of the medium spiny neurones may have stopped functioning, leaving
the resistant interneurones, which can still reduce XTT. However, 95% of the cell
population within the cultures are the same so it may be postulated that even after 24 hours
of hypoglycaemia, ATP production is not totally depleted due to the surviving
mitochondria within all cells. It could be that within these functional mitochondria the
energy production is low, possibly due to TCA cycle alterations from utilising alternative
substrates, such as glutamate.
The hypothesised initial event in hypoglycaemia is a dysfunction of the Na+ /K+ ATPase
pump, a result of the progressive decline in ATP concentration. In normoglycaemic
cultures the addition of ouabain produced a significant reduction in cell viability (Figure
3.3). This is expected as inhibiting the Na+ /K+ ATPase pump, disrupts the ionic gradients
and causes the membrane to depolarise. These results are similar to other studies, although,
it has been shown that at low concentrations of ouabain (l-3J.lM), the membrane potential
of medium spiny neurones in slice cultures did not alter (Calabresi et al., 1995). This
discrepancy could be due to differences in the microenvironment between slice cultures as
used by Calabresi et at. and primary cell cultures as used here. The fact that the cell
viability of normoglycaemic cultures incubated with ouabain was not reduced to levels
observed in hypoglycaemic cultures incubated with ouabain, suggests either that the cell
viability reduction in hypoglycaemic cultures is not solely as consequence of Na+ IK+
ATPase pump inhibition, or that membrane depolarisation in normoglycaemic cultures is
not as detrimental to cellular functioning as in hypoglycaemic cultures. This may be due to
other factors associated with glucose deprivation influencing the outcome of survival.
It is also interesting to see that ouabain did not produce any additive deleterious effects in
hypoglycaemic cultures (Figure 3.3). Ouabain has been shown to produce a dose-
dependent increase in NMDA- and AMPA-induced membrane depolarisation (Calabresi et
al., 1995; Westerink et al., 1989), an absence of a graded response with ouabain suggests
that in hypoglycaemia the Na+ /K+ ATPase pump is inhibited independent of ouabain's
actions.
It has been previously suggested that because the Na+ IK+ ATPase pump requires most of
the cell's energy, if the pump was partially inhibited without damaging consequences in
times of energy depletion, energy could be conserved (Whittam, 1962). It is possible that
the concentrations of ouabain used in this experiment were too high and provided full
inhibition, whereas a lower concentration may have provided a neuroprotective effect by
partially inhibiting the pump and distributing energy to other functions, such as protein
synthesis.
Most studies have found that MK801 has a neuroprotective effect on hypoglycaemic-
induced cell damage in the striatum (Williams et al., 1995; Wieloch et al., 1986). It is
possible that a higher dose of MK801 in this system may have shown neuroprotective
results as in Figure 3.4 XIT staining begins to increase, although there is no significant
differences between each dose. In addition, it is possible that the concentration of
magnesium present in the culture medium effected the NMDA receptor activity. However,
other studies show the presence of magnesium at concentrations comparable with
concentrations used in this study to have no overall effect (Williams et al., 1995). It
should also be noted here that all potential neuroprotective compounds in Chapter One and
Chapter Two (and in Chapter Seven) gave the same results regardless of whether cultures
were pre-incubated with them or incubated with them on the onset of glucose-deprivation.
This proves that the addition of the drugs was not too late.
Studies have reported MK801 being ineffective in other systems such as, in transient
ischaemia (Nellgard et al., 1991) and global ischaemia (Block and Pusinelli, 1987; Lanier
et al., 1990). Discrepancies between results have been attributed to temperature
(Minamisawa et al., 1990), the density and duration of ischaemia (Siesjo, 1988) and pH
(NMDA receptors are inhibited at low pH) (Giffard et al., 1990). It is therefore possible
that MK801 was ineffective in protecting the cells even though EAA-induced damage is
important during the hypoglycaemic insult.
Alternatively, it could be proposed that EAA are not released in this hypoglycaemia model
and cell death is attributable to other glutamate receptor-independent mechanisms. It has
been shown that hypoglycaemia causes neuronal damage when calcium is excluded from
the extracellular medium (Nedergaard, 1991), suggesting that cell death was not via a
direct calcium-mediated excitotoxic mechanism.
Studies using slice cultures or in vivo models maintain excitatory extrinsic inputs into the
striatum, whereas in vitro striatal cultures do not possess extrinsic inputs, have few or no
intrinsic glutamatergic neurones and possess predominantly inhibitory neurones (Freese et
al., 1990). It could be assumed that under hypoglycaemic conditions, membrane
depolarisation does not release toxic amounts of glutamate or aspartate because GABA is
the predominant neurotransmitter within the presynaptic terminals. Indeed it has been
shown that GABA can provide protection from the effects of ischaemia (Shuaib et al.,
1993).
Many studies, investigating the effects of hypoglycaemia use cortical, hippocampal or
cerebellar cultures which possess glutamatergic neurones. In addition, it has been proposed
that the excitation input from the cortex and lor thalamus to the striatum appears to
promote the maturation of glutamate receptors on striatal neurones (Chen et al., 1999). It
is possible that striatal cells in cultures do not possess fully mature and functional
glutamate receptors due to the absence of the excitatory input (Chen et al., 1999).
However, other groups would suggest this unlikely as excitotoxicity has been reported in
striatal cultures (Williams et al., 1995; Peng et al., 1998) and excessive toxic levels of
glutamate and aspartate have been reported to be released in hypoglycaemia-induced injury
within striatal cultures (Williams et al., 1995).
CNQX also proved to be ineffective in protecting cells against hypoglycaemia. This is in
line with other studies showing the ineffectiveness of CNQX (Hara et al., 1993). Again,
this suggests that either CNQX did not provide complete antagonism of AMPA receptors.
However, it has been reported that CNQX is a glycine antagonist between concentrations
10-30 J..lM(Lester et al., 1989) which would provide further EAA receptor blockade.
Therefore it is more likely that AMPA receptors are not involved in the mechanism of cell
damage or that cell damage is independent of glutamate and aspartate. The concentration
of CNQX used in these studies is sufficient to block all AMPA receptor-mediated
transmission (Garthwaite and Garthwaite, 1989). CsA has potent neuroprotective effects in
many energy deprived systems (Yoshimoto and Siesjo, 1999; Matsumoto et al., 1999;
Seaton et al., 1997), but it showed no protective effects in this system, detected either by
XTT or MAP2 staining (Figures 3.6 and 3.7). This suggests that either CsA is not effective
in inhibiting the opening of the pore or that the pore does not initially open and cell
damage is independent of MTP activity. In addition. it has been reported that CsA
possesses toxic properties in rats (Tanaka et al., 1993; Famiglio et al., 1989), neuronal
cultures (Stoltenburg-Didinger et al., 1992; Martin et al., 1988; Seaton et al., 1998; Ryu
et al., 1999) and humans (Walker and Brochstein, 1988; Berden et al., 1985), highlighting
the magnitude of properties associated with CsA.
It is known that the MTP plays a role in cell death in most neurones (Kroemer et al., 1998;
Lemasters et al., 1998; Taylor et al., 1999), with the notable exception of cerebellar
granular cells (Castilho et al., 1998), verifying that the same inducer of cell death can
induce different mechanisms depending on cell type. The CsA data in this study suggests
that the cell death pathway involving the MTP is not the predominant pathway in striatal
cells exposed to hypoglycaemia Indeed, it has been shown that in conditions of restricted
oxidative activity, calcium-induced mitochondrial depolarisation occurred without
concomitant swelling and MTP opening (Brustovetsky and Dublinsky, 2000). Therefore, a
disruption of mitochondrial functioning could occur in the absence ofMTP activity.
If the MTP was not open. it is possible that toxic levels of calcium could efflux from the
mitochondria via the Na+/Ca2+ exchanger and not the MTP. The importance of Na+/K+
exchange varies considerably between tissues (Duchen et al., 1990). This has already been
reported in ischaemic rat hippocampal dendrites (Zhang et al., 1999), in cultured rat dorsal
root ganglion neurones (Baron and Thayer, 1997) and in glutamate stimulated cultured
cortical neurones (White and Reynolds, 1996). However TFP, is an apparent Na+/Ca2+
exchanger inhibitor and MTP inhibitor (Hoyt et al., 1997). Hence, neuroprotection would
be seen with TFP according to this theory. Figures 3.8 and 3.9 show no evidence of TFP
preventing cell damage.
In addition. CsA is an inhibitor of calcineurin and TFP inhibits calmodulin. In contrast to
other studies (Ruiz et al., 2000), these results suggest that calcineurin and calmodulin play
no role in hypoglycaemic-induced toxicity in striatal cells. It could also be assumed that
the reduction of cell viability in striatal cultures is not due to lipid peroxidation of the
membrane as TFP has been shown to protect cells by inhibiting lipid peroxidation (Kuroda
et al., 1997).
PDTC has been shown to have anti-oxidant properties in many different types of cells
(Seaton et al., 1997; Seaton et al., 1998; Moro et al., 1998). However, it was shown to
have no significant effect on reducing cell viability of hypoglycaemic-induced cell death
(Figure 3.10). This suggests that PDTC is not an effective ROS scavenger, or that the
production of ROS was too extensive for PDTC to cope with. It should be noted that the
doses of PDTC used here are sufficient \0 produce profound neuroprotective effects in
other culture systems (Moro et al., 1998; Seaton etal., 1997). It has been reported that
antioxidants are only effective in cultures with low cell densities (Banker, 1980). However,
striatal cultures used in these experiments were 14-18 days old and therefore the cell
density is quite high, providing a possible explanation why PDTC is ineffective.
Another possibility is that ROS do not playa part in the mechanisms of cell damage in this
system. If the MTP is not open then there would be no release of ROS from the
mitochondria, however, MTP opening has been reported to be downstream from ROS
production in cortical cells treated with toxic levels of glutamate (Ruiz et al., 2000).
Therefore, it can be concluded that ROS production independent of MTP also does not
occur or does not play a part in hypoglycaemic-induced cell death in cultured striatal cells.
This is in contrast to studies where ROS production was inhibited using free radical spin
traps and lipid peroxidation inhibitor which protected striatal cells from glucose
deprivation (Nakao et al., 1996).
It is interesting to note an increase of cell viability in normoglycaemic cultures with the
highest concentration of PDTC (Figure 3.10). One explanation for this observation is that
under normal physiological conditions, ROS are produced as a by product of respiration
but are buffered to prevent damage, however, if an extra anti-oxidant such as PDTC, is
added to the culture, it is possible that a more efficient buffering system could be expected.
An alternative explanation is that PDTC increases basal respiration in normoglycaemic
cultures.
Medium spiny neurones possess K-ATP channels (Schwanstecher and Bassen, 1997) but
diazoxide did not show any effects on hypoglycaemia toxicity in striatal cells although the
concentrations of diazoxide used in this study have been shown to be neuroprotective in
other culture systems (Zawar and Neumcke, 2000). However, ambiguous results show that
diazoxide can be ineffective (Calabresi et al., 1997), protective (Koretz et al., 1994; Liss
et al., 1999) or toxic in cells under glucose deprived conditions, suggesting that K-ATP
channels are not implicated in the neuroprotection of hypo glycaemia.
One reason for the ambiguous actions of diazoxide is that there are five different putative
K-ATP channels, which have different pharmacological properties and display varying
sensitivities to K-ATP channels openers. It is also apparent that a single neurone can
express different types of K-ATP channels and that these channels can exhibit significant
differences in metabolic sensitivities (Gribble and Ashcroft, 2000).
In addition, diazoxide has been shown to be 2000 times more active for the mitochondrial
K-ATP channels (Garlid et al., 1996a) compared to the plasma membrane K-ATP
channels and has been reported to cause mitochondrial depolarisation, increasing the
matrix volume and inducing a release of cytochrome c (Debska et al., 2001). One study
demonstrated that moderate opening of the mitochondrial K-ATP channel by diazoxide
contributes to a more efficient formation of ATP, by accelerating the electron transport
through the inner mitochondrial membrane, whereas full opening results in the uncoupling
of oxidative phosphorylation (Garlid, 1996b).
It appears that the mechanisms and components theorised to be essential in other models of
hypoglycaemic cell death are not relevant in this in vitro model of hypoglycaemia. These
results suggest that the lack of involvement of NMDA and AMPA glutamate receptors
indicate that glutamate toxicity is not implicated. The MTP, ROS toxicity and K-ATP
channel activity are also not involved. Further investigation into how cell functioning is
perturbed is essential as well as a new revised hypothesis explaining what are the
mechanisms of cell death in hypoglycaemia. It is therefore proposed that the removal of
glucose from the medium depletes the ATP concentration available to cells and causes the
plasma membrane to depolarise via Na+ /K+ ATPase pump dysfunction. Calcium enters the
cell through the VGCC which consequentially causes a release of calcium from
intracellular stores. This overload of calcium exceeds the rate of intracellular sequestration
and cell death is via calcium-dependent necrosis. Therefore, an examination of the
behaviour of calcium ions during hypoglycaemia is the next logical step in this study.
Chapter Four.
Calcium Modulation in Hypoglycaemic toxicity
4.1 Introduction
Calcium plays an important pathogenic role via mechanisms such as activating calcium-
dependent enzymes including phospholipases, proteases, and endonucleases and by
changing the phosphorylation state of proteins (Farooqui et al., 1991; Arends et al.,
1990). Therefore, it seems likely that if the levels of intracellular calcium were reduced
during hypoglycaemic toxicity via a blockade of either extracellular or intracellular
calcium stores, cells would have a better chance of survival. Figure 4 is a schematic
diagram showing the site of action of each calcium modulating compound used in the
attempt to promote survival in cells exposed to hypoglycaemia.
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Figure 4
A schematic diagram of the site of pharmacological action of the various calcium-modulating compounds,
including extracellular chelators, VOCC blockers and antagonists of intracellular stores. It shows the
insertion of the ionophore, A23187 and the Fura-2 calcium indicator dye within the cytoplasm.
Extracellular calcium chelators, EGTA and BAPTA have a binding cavity within their
structure specific for calcium and other divalents ions. Itmust be noted that the magnesium
concentration within the culture medium was not compensated for when EOTA and
BAPT A were added to the cultures.
BAPT A has two advantages over EOTA. It is insensitive to pH and is a faster buffer,
important in chelating transient calcium responses (Tsien et al., 1980). The cell membrane
impermeable form of BAPT A was used to see if reducing the extracellular calcium levels
in hypoglycaemic conditions would be protective for the cells.
It is thought that L-type channels are the dominant pathways for calcium influx (Ikeda et
al., 1997) and are believed to play unique roles in enduring changes in neuronal structure
and function (Tsien et al., 1989). Therefore nicardipine, a L-type voec blocker, was
used (Figure 4). However, T-type voce have been implicated in neurotoxicity, therefore
nickel, a competitive antagonist of the T-type voce (Mlinar and Enyeart, 1993), was also
assessed (Figure 4). It was hypothesised that blocking voces would produce a
neuroprotective effect by preventing excessive calcium influx if the membrane is
depolarised during hypoglycaemia
Ryanodine and IP) receptors are expressed by medium spiny striatal neurones (Sharp et
al., 1993), whereas only ryanodine receptors are present extensively within aspiny
neurones (Martone et al., 1997). TMB-8 was one of the first compounds to be described as
an exclusive intracellular calcium antagonist (Malagodi and Chiou, 1974). It is thought to
block the release of intracellular bound calcium ions at the IP) store (Figure 4). However, it
also acts as a general calcium antagonist on the calcium channels located on the plasma
membrane (Doutheil and Paschen, 1999). A more recent IP) receptor antagonist, 2-APB,
was found to be more specific as it does not affect the calcium influx from outside the cell
(Maruyama et a/., 1997). 2-APB does not inhibit the binding of IP3 to its receptor and
presumably binds to a recognition site different from the IP3 recognition site (Maruyama et
al., 1997)(Figure 4).
Dantrolene has been used clinically since 1974 to treat malignant hyperthermia and muscle
spasticity. It acts by inhibiting calcium release from stores via the ryanodine receptor
(Ward et a/., 1986; Simpson et a/., 1995; Mody and McDonald 1995) (Figure 4). By
antagonising intracellular calcium store receptors during hypoglycaemia, intracellular
calcium released in response to calcium influx would be inhibited and this could
potentially prevent a perturbed calcium homeostasis and possibly cell death.
The calcium ionophore, A23187, forms a lipid soluble complex with calcium ions, thereby
permitting their transport across the membrane and increasing intracellular calcium
concentrations (Schaffer et al.. 1973) (Figure 4). Adding A23187 to normoglycaemic cells
provides information to determine whether calcium alone is toxic to striatal cells
independent of the hypoglycaemic insult.
In this series of experiments, all these compounds were assessed via XTT measurement, to
investigate their effect on hypoglycaemic cells. The final experiment using Fura-2
examines changes in the intracellular calcium levels during hypoglycaemia.
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4.2 Results
Cell viability was measured, using XTT, in normoglycaemic cultures incubated with a
range of concentrations of A23187 for 24 hours. A dose-dependent response to A23187
was observed. Concentrations above 1JlM significantly decreased the XTT staining of the
cultured cells (Figure 4.1).
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Figure 4.1
The effect of A23l87 on the celJ viability of striatal cells. Cultures were incubated with different
concentrations of A23187 (0.1 -1OO~ for 24 hours. Cell viability was measured by XTT staining. A dose-
response curve was obtained. Concentrations of A23187 >1flM cause a significant decrease in cell viability
compared to cultures incubated in the absence of A23187 viability (one-way ANOVA for the effect of dose,
F(6, 14)=19.18, p<0.001; *p<0.05 versus 100%; 95% confidence intervals of the mean). Data are represented
as a percentage ofXTT staining in cultures without A23187 treatment (n=5).
EGTA in the extracellular medium did not have any significant effect on hypoglycaemic-
mediated damaged cells. Moreover, in normoglycaemic cultures the presence of EGTA
produced a significant decrease in cell survival at ImM but not at 5mM(Figure 4.2).
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Figure 4.2
The effect of EGTA on striatal cells in normoglycaemic and hypoglycaemic cultures. EGTA was added to
cultures at varying concentrations for 4 hours. In hypoglycaemic cultures the glucose was removed just prior
to the addition of EGT A. Cell viability was measured by XTT staining. There is a significant effect of both
EGTA and hypoglycaemia (two-way ANOVA; effect of hypoglycaemia, F(1,12)=62.7, p<O.OOI; effect of
EGTA, F(2,12)=8.68, p<O.Ol). There is a significant decrease in cell viability in cells exposed to
hypoglycaemia (*p<O.05 versus 100010;95% confidence intervals of the mean) but no neuroprotection is
observed with EGTA (one-way ANOVA, p=0.35). Moreover, a significant reduction in cell survival was
observed when ImM EGTA was added to normoglycaemic cultures. Data are represented as a percentage of
XTT staining in normoglycaemia cultures without EGTA treatment (100%) (n=3).
There was no neuroprotective effect using BAPTA as an extracellular calcium chelator.
Cultures treated with hypoglycaemia for 4 hours showed a significant reduction in cell
viability and there was no change when hypoglycaemic cells were treated with varying
concentrations of BAPTA. In contrast, the presence of BAPTA in normoglycaemic
cultures, appeared to increase XTT staining compared to staining in normoglycaemic
cultures (shown as 100%) (Figure 4.3).
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Figure 4.3
The effect ofBAPT A on striatal cells in normoglycaemic and hypoglycaemic cultures. BAPT A was added to
cultures at varying concentrations for 4 bours. In bypoglycaemic cultures the glucose was removed just prior
to the addition ofBAPTA. Cell viability was measured by XTT staining. The cell vialibity in hypoglycaemic
cultures is significantly decreased compared to normoglycaemic cultures (*p<0.05 versus 100%; 95%
confidence intervals of the mean) (two-way ANOVA, effect of hypoglycaemia, F(1,16)=46.1, p<O.OOl;
effect of BAPTA, F(3,16)=1.l, p=OA) and no significant effect is seen with BAPTA in hypoglycaemic
cultures (one-way ANOV A, p=O.8). An increase in cell viability is observed in normoglycaemic cultures
with l~M BAPTA (*p<0.5 versus 100%; 95% confidence intervals of the mean). Data are represented as a
percentage ofXTT staining in normoglycaemic cultures without BAPTA treatment (100%) (n=4).
There was a significant reduction in XTT staining in hypoglycaemic cultures but in the
presence of Nifllz, no significant changes were measured. NiCh had deleterious effects on
normoglycaemic cultures. At 5mM, XTT staining significantly decreased compared to
normoglycaemic cultures without NiCh treatment (Figure 4.4).
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Figure 4.4
The effect of nickel on striatal cells in normoglycaemic and hypoglycaemic cultures. Nickel chloride (NiCI2)
was added to cultures at varying concentrations for 4 hours. In hypoglycaemic cultures the glucose was
removed just prior to the addition of NiClz. Cell viability was measured by XTT staining. There is a
significant effect of both NiCl, and hypoglycaemia (two-way ANOV A, effect of NiClz, F(3,8)=6. 7, p<O.05;
effect of hypoglycaemia, F(I,8)=9.6, p<O.05). Hypoglycaemia produced a significant decrease in cell
viability (*p<0.05 versus 100%; 95% confidence intervals of the mean). NiCIz did not show a significant
difference in cell survival (one-way ANOVA, p=O.2), moreover, in normoglycaemic cultures at 5mM, NiCh
causes a significant decrease in cell viability (*p<0.05 versus 100%; 95% confidence intervals of the mean).
Data are represented as a percentage of XTT staining in normoglycaemia cultures without NiCIz treatment
(100%) (n=3).
The blockade of L-type VGCCs with nicardipine showed no neuroprotective effects. In
fact at higher concentrations nicardipine was toxic itself. There was a significant reduction
in XTT staining in hypoglycaemic treated cultures after 4 hours but no significant increase
was observed with the presence of nicardipine. Similar to NiCh, nicardipine significantly
decreased XTT staining in normoglycaemic cultures at 10 and 100f.lM (Figure 4.5).
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Figure 4.5
The effect of nicardipine on striatal cells in normoglycaemic or hypoglycaemic cultures. Nicardipine was
added to cultures at different concentrations for 4 hours. In hypoglycaemic cultures the glucose was removed
just prior to the addition of nicardipine. Cell viability was measured by XTT staining. Both nicardipine and
hypoglycaemia produce an effect in cultures (two-way ANOY A; effect of nicardipine, F(3, 16)=21 0.6,
p<O.OOI; effect of hypo glycaemia, F(I,16)=462.7, p<O.OOI). There is a significant decrease in cell viability in
hypoglycaemic-treated cultures (*p<0.05 versus 100%; 95% confidence intervals of the mean). Nicardipine
produces a significant effect on both hypoglycaemic (one-way ANOYA, F(3,8)=6.9, p<O.OI) and
normoglycaemic cultures (one-way ANOYA, F(2,6)=283, p<O.OI). The cell viability of hypoglycaemic
cultures treated with 100~ nicardipine is significantly reduced compared to hypoglycaemic cultures treated
with no nicardipine or l~ nicardipine (tp<0.05, Fishers post-hoc test). The cell viability of
normoglycaemic cultures treated with lOf..LMand 100f..LMnicardipine is significantly decreased from
normoglycaemic cultures treated with I f..LMnicardipine (#p<0.05, Fishers post-hoc test). Data are represented
as a percentage ofXTT staining in normoglycaemia cultures without nicardipine treatment (100%) (n=4).
TMB-8 had no significant effect on hypoglycaemic or normoglycaemic cultures. There
was a significant decrease in cell viability from cultures treated with hypoglycaemia but no
significant change when incubated with TMB-8 (Figure 4.6).
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Figure 4.6
The effect ofTMB-8 on striatal cells in normoglycaemic and hypoglycaemic cultures. TMB-8 was added to
cultures at different concentrations for 4 hours. In hypoglycaemic cultures the glucose was removed just prior
to the addition of TMB-S. Cell viability was measured by XTT staining. Hypoglycaemia produces a
significant decreases in cell viability compared to normoglycamia (*p<0.05 versus 100%; 95% confidence
intervals of the mean), however, TMB-8 showed no effect (two-way ANOVA, effect of hypoglycaemia,
F(1,24)=26.7, p<0.001; effect of TMB-S, F(3,24)=O.15, p=O.9). TMB-8 did not show significant
neuroprotection in bypoglycaemic cultures (one-way ANOVA, p=O.S). Data are represented as a percentage
ofXIT staining in normoglycaemia cultures without TMB-8 treatment (100%) (n=5).
In agreement with TMB-8 data, 2-APB did not significantly increase cell survival in
hypoglycaemic-treated cells. Moreover at 100J..lM,2-APB significantly decreased cell
viability in normoglycaemic cultures (Figure 4.7).
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Figure 4.7
The effect of 2-APB on striatal cells in normoglycaem ic and hypoglycaemic cultures. 2-APB was added to
cultures at varying concentrations for 4 hours. In hypoglycaemic cultures the glucose was removed just prior
to the addition of 2-APB. Cell viability was measured by XTT staining. There is a significant effect of 2-
APB and hypoglycaemia (two-way ANOVA; effect of2-APB, F(3,8)=16, p<O.OOl; effect of hypo glycaemia,
F(J,8)=94.4, p<O.OOl). There was a significant decrease in XIT staining in cultures treated with
hypoglycaemia (*P<0.05 versus 100%; 95% confidence intervals of the mean). Hypoglycaemic cultures
treated with 2-APB show no difference in XIT staining (one-way ANOVA, p=0.3). In normoglycaemic
cultures, 100f..LM2-APB significantly decreased cell viability (one-way, F(2,3)=14.4, p<0.05). Data are
represented as a percentage of XTT staining normoglycaemia cultures without 2-APB treatment (100%)
(n=3).
Dantrolene showed no neuroprotective effects in hypoglycaemic-damaged cells. There was
a significant decrease in cell viability in hypoglycaemic-treated cells compared to
normoglycaemic cells but the addition of dantrolene, had no significant effect on cell
viability. Moreover, dantrolene significantly decreased the cell viability of
normoglycaemic cells (Figure 4.8).
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Figure 4.8
The effect of dantrolene on striatal cells in normoglycaemic and hypoglycaemic cultures. Dantrolene was
added to cultures at different concentrations for 4 hours. ill hypoglycaemic cultures the glucose was removed
just prior to the addition of dantrolene. CeU viability was measured by XTT staining. Both hypoglycaemia
and dantrolene produce a significant effect (two-way ANOVA, effect of hypoglycaemia, F(I,16)=38,
p<O.OOl; effect of dantrolene, F(3,16)=4.3, p<0.05), however, dantrolene has no effect on cell viability in
hypoglycaemic cultures (one-way ANOVA, p=O.9). A significant decrease in cell viability is seen
normoglycaemic cultures with each concentration of dantrolene (*p<0.05 versus 100%; 95% confidence
intervals of the mean). Data are represented as a percentage of XTT staining in normoglycaemia cultures
without dantrolene treatment (100%) (n=3).
Itwas proposed that a neuroprotective effect might be observed when several components,
thought to be involved in hypoglycaemia were manipulated. A combination of drugs were
used in normoglycaemic and hypoglycaemic cultures. Firstly, the XTT staining of cultures
exposed to hypoglycaemia for 4 hours was significantly decreased compared to
normoglyaemic cultures. The antioxidant, PDTC and BAPT A provided no neuroprotective
effects neither did the combination of the MIP inhibitor, CsA, 2-APB and BAPT A.
Finally, all four compounds, PDTC, BAPT A, CsA and 2-APB in combination also had no
significant effect on hypoglycaemic-mediated damage in striatal cultures. Interestingly,
each combination significantly decreased XII staining in normoglycaemic cultures
(Figure 4.9).
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Figure 4.9
The effect of the combination ofPDTC (5~M), BAPTA (1~, CsA (l~M) and 2-APB (1~M) on striatal
celJs in normoglycaemic and hypoglycaemic cultures. Various combinations of the compounds were added to
cultures at varying concentrations for 4 hours. In hypoglycaemic cultures the glucose was removed just prior
to the addition of drugs. Cell viability was measured by XTT staining. Both the addition of the coektail of
drugs and hypoglycaemia produces a significant effect (two-way ANOV A; effect of cocktail, F(3,16)=74.3,
p<O.OOI; effect of hypo glycaemia, F(l,16)=285.7, p<O.OOI). There is a significant decrease ofXTT staining
in hypoglycaemic-treated cells. The combination ofBAPTA, CsA and 2-APB and the combination ofPDTC,
BAPTA, CsA and 2-APB produce significantly greater effects on XTT staining than hypoglycaemic alone
(one-way ANOVA, p<O.OOI; tp<O.05, Fishers post-hoe test). In norrnoglycaemic cultures, all combinations
of compounds causes a significant decrease in XTT staining compared to normoglycaernic cultures without
any treatment (*p<0.05 versus 100%; 95% confidence intervals of the mean) and the combination of
BAPT A, CsA and 2APB and PDTC, BAPT A, CsA and 2-APB again produced the most damaging effects
(one-way ANOV A, p<O.OI; #p<0.05, Fishers post-hoe test). Data are represented as a percentage of XTT
staining in normoglycaemia cultures without drug treatment (100%) (0=3).
Free intracellular calcium was measured in cells treated with 24 and 48 hours of
normoglycaemia or hypoglycaemia by the change in the fura-2 signal. After 24 hours, the
mean calcium concentration for cells incubated in normoglycaemic conditions was 162nM
± 47, whereas the mean concentration for cells incubated in hypoglycaemic conditions was
158nM ± 47. Therefore there was no significant difference in the levels of cytosolic
calcium between normoglycaemic and hypoglycaemic cells. After 48 hours, the mean
calcium concentration in hypoglycaemic cells decreases by 31nM compared to
normoglycaemic cells. However this change in the levels of cytosolic calcium was not
significantly different (Figure 4.10).
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Figure 4.10
The percentage difference in [Ca2+]i from striatal cells exposed to either 24 or 48 hours ofnormoglycaemia
or hypoglycaemia. Intracellular calcium levels were measured by the change in the fura-2 signal. There was
no significant change in levels of calcium in hypoglycaemic cells relative to levels of calcium measured in
normoglycaemic cells after 24 hours and 48 hours (one-way ANOVA, p=l.O). Data are represented as a
percentage of cultures in normoglycaemic conditions for 24 hours (100%).
4.3 Discussion
An excessive influx of calcium into cultured striatal cells causes a significant decrease in
XTI staining, which is regarded as a precise index of cell viability (Figure 4.1). Low
concentrations (0.1J.LM- IJlM) of A23187 produced no effects on cultures, whereas higher
concentrations did significantly affect cell viability which is consistent with previous
studies (Emery and Lucas, 1995). This result suggests that striatal neurones can cope with
a specific calcium concentration range but when exceeded beyond a critical point, buffer
systems are overloaded and [Ca2+]j levels rise to toxic levels. The binding of calcium ions
to buffering molecules is an energy-independent process, whereas a slower process,
requiring energy, then transports calcium ions up their concentration gradients into
organelles or out of the cells. It is possible that at high concentrations of A23187 [Ca2+]j
levels simply exceed the intracellular extrusion capacity of the cell. It is also possible that
energy failure occurs either due to excessive activation of calcium-dependent proteases.
These act on neural membrane phospholipids resulting in the accumulation of free fatty
acids which can disrupt ATP synthesis within mitochondria and damage the extrusion
system to transport calcium ions out of the cell (Ward et al., 2000).
It has been repeatedly demonstrated that an attenuation of calcium influx protects neurones
from various toxic insults. Both extracellular calcium chelators, EGTA and BAPT A had no
effect in this system. EGTA provided no significant increase in cell viability in
hypoglycaemic neurones and in fact, at ImM EGTA became toxic in normoglycaemic
cultures (Figure 4.2). The data show that the lowest concentration of EGTA provides
maximal effect and a lower contration in micro mole may have provided more information
pharmacologically. This calcium chelator has been known to dramatically change the pH
of the culture medium, depending on the concentration (Tsien, 1980). It is possible that the
pH change reduced the cell viability in normoglycaemic cells but was masked by the
effects of hypoglycaemia, hence no further decrease in cell viability was seen in
hypoglycaemic cultures.
BAPT A is reportedly a superior calcium chelator to EGTA, which does not affect the pH
of the culture medium (Tsien, 1980). However, no neuroprotection was seen with any of
the concentrations used (Figure 4.3), a result that has previously been reported in
hippocampal cultures during excitotoxic exposure (Dubinsky, 1993). The results of both
EGTA and BAPT A suggest that either these compounds are not effective in chelating toxic
amounts of calcium or that the concentrations used were not high enough to provide
complete extracellular calcium chelation. However, the doses of these compounds used
here are sufficient to produce profound neuroprotection in other culture systems (Hara et
al., 1993; Tsubokawa et al., 1994; Tekkok et al., 1999). Another reason could be that cell
damage is dependent on increased [Ca2+]j and therefore extracellular calcium
concentrations are irrelevant. In this case it would have been interesting to observe any
differences between BAPT A and BAPT A-AM as BAPT A-AM passes into the cell cytosol
where it chelates [Ca2+]j.
Nickel has previously been described as a "dirty" pharmacological tool as it affects other
systems and does not only block T-type VGCC but R-types as well (Kobayashi et al.,
1992). It is clear, that at high concentrations (5mM), nickel shows toxic effects in
normoglycaemic cultures and has an additive toxic effect in hypoglycaemic cultures
(Figure 4.4). This is probably due to its non-specific behaviour as opposed to toxic effects
caused by blocking T-type VGCC. On the other hand, nicardipine belongs to a family of
compounds which specifically block L-type channels and has shown to be neuroprotective
in many models, including in vitro hypoglycaemia (Hayashi et al., 1993). Again, lower
concentrations of both nickel and nicardipine should have been used to observe a dose-
response profile of both drugs (this also refers to TMB-8 and dantrolene data). However, in
this model no neuroprotection was observed (Figure 4.5). In agreement with this data,
previous reports have described a lack of protection with nicardipine and other L-type
channels blockers, against glutamate (Godfraind et al., 1986; Hochstrate et al., 1995),
combined oxygen and glucose-deprivation (Goldberg et al., 1993) and in vivo
hypoglycaemic brain damage (Ohta et al., 1991). At high concentrations (lO~M and
l00~M) nicardipine was markedly toxic in normoglycaemic cultures. It has been reported
that low cytosolic calcium levels can be detrimental to neuronal survival (Dubinsky, 1993)
and in this study it is evident that striatal cells in normoglycaemic conditions are very
sensitive to alterations in calcium concentrations. Figures 4.2, 4.3, 4.4, 4.5, 4.7 and 4.8
show XTT measurements that have decreased from control levels when calcium-
modulating compounds have been added to the cultures.
The explanation for nickel and nicardipine being ineffective m hypoglycaemia at
concentrations not toxic in normoglycaemic cells, could be that other VGCC, such as P-,
Q- or N-type channels play a more predominant role hypoglycaemic-induced damage in
striatal cultures. Their ineffectiveness may indicate either that the VGCCs do not open
because the membrane does not depolarise sufficiently or that the rise in [Ca2+]j is caused
by the release of calcium from intracellular stores and the calcium influx from the VGCC
is insignificant in comparison (Himmel and Ravens, 1990). This has previously been
shown in other in vitro models (Murchison and Griffith, 2000).
However, there was no prevention of hypoglycaemic-induced cell death by intracellular
calcium store antagonists. The IP3 antagonist, TMB-8, possesses diverse effects in different
systems, for example, it has shown to be an antagonist at nicotinic acetylcholine receptor
subtypes (Bencherif et al., 1995), to inhibit the ATP-sensitive K+ channel (Szewcyk et al.,
1992) and to inhibit mitochondrial ATP production and global protein synthesis (Brand
and Felber, 1984; Doutheil et al., 1997). In addition TMB-8 has been shown to exhibit an
intrinsic toxicity in neuronal cultures (Malcolm et al., 1996) and it has been demonstrated
that the blocking effect of TMB-8 on the depletion of IP3 stores was only transient and
thereafter TMB-8 produced an even more pronounced increase in [Ca2+]j (Doutheil and
Paschen, 1999). The ineffectiveness of TMB-8 to protect cells could be due to the
compound acting on other sites, as described above. However, 2-APB has been shown to
be much more selective than TMB-8 for IP3 stores but again it shows no effect apart from
an undesired toxic effect on normoglycaemic cells at a high concentration (Figure 4.7).
Similar results were seen with dantrolene (Figure 4.8).
It has been shown that medium spiny neurones contain both IP3 and ryanodine receptors
(Sharp et al., 1993). This suggests that both IP3 and ryanodine stores are not involved in
the toxicity produced by hypoglycaemia, assuming that these drugs are antagonising the
receptors efficiently. Alternative methods to determine whether the release of calcium from
intracellular calcium stores is predominant in hypoglycaemic-induced toxicity would have
been to inhibit the ER SERCA-pump using thapsigargin (Nguyen et al., 2002) or by the
reversal of SERCA pump mechanism with cyclopiazonic acid (Kahlert and Reiser, 2000).
Data from this study is in contrast to studies reporting that calcium release from
intracellular stores is the major source of calcium during glucose deprivation in PC 12 cells
(Chung and Lee, 1998). Another possibility as to why no protection was seen with
dantrolene is that there was an absence of an intracellular calcium influx to trigger the
release of calcium from the ryanodine stores. This would be consistent with the results
obtained using EGTA, BAPT A, nicardipine and NiCh.
The idea that only one pathway is active in hypoglycaemic cell damage is implausible,
considering the complexity and the numerous components involved. It is possible that
blocking a combination of these components would potentiate the likelihood of obtaining
protection. Figure 4.9, shows a combination of drugs used to block ROS generation
(PDTC), extracellular calcium (BAPTA), MTP activity (CsA) and intracellular calcium
levels (2-ABP) had no effect on hypoglycaemic-induced cell death. Although the
combination of these components did prove to reduce cell viability in normoglycaemic
cultures (Figure 4.9), these results consolidate previous data suggesting that these
components might not be involved in hypoglycaemic-induced cell death in striatal cultures.
One of the most interesting and informative experiments showed data measuring the levels
of intracellular calcium. After 24 and 48 hours of hypoglycaemia no change in [Ca2+]j was
seen in surviving cells when compared to normoglycaemic cells (Figure 4.10) contrary to
most other studies (Mattson et al., 1993; Knopfel et al., 1990; Tekkok et al., 1999;
Cheng et al., 1991; Harris et al., 1984). This provides a crucial insight to the effect on
cells exposed to glucose deprivation and explains why none of the drugs used were
effective in preventing the attenuation of cell viability. The fact that there is no calcium
influx into the cells after 24 hours of hypoglycaemia is evidence that the cell membrane is
not depolarised as the VOCC have not opened, explaining why nickel and nicardipine
having no effect. This does not rule out the possibility that the membrane may have been
depolarised sometime during the hypoglycaemic insult. If there were no depolarisation, no
VOCC opening and no calcium influx, there would be no trigger to release calcium from
internal stores. This provides reasons why EGTA, BAPTA and ER store antagonists
provided no change to hypoglycaemic cells. In addition, there would be no calcium-
dependent release of EAA, no sustained depolarisation via AMPA receptors and no
calcium influx via NMDA receptors, therefore CNQX and MK801 showed to be
ineffective. However, the lack of EAA release in hypoglycaemic striatal cultures is more
likely because 95% of cells in striatal cultures are GABAergic and not glutamatergic but
PDTC, CsA and TFP were also ineffective in preventing cell death. This is possibly
because if there was no calcium influx, the MTP would not open and there would be no
release of ROS.
This lack of change in [Ca2+]j during hypoglycaemia has been reported previously. In
mouse striatal neurones, the [Ca2+]j level of cells exposed to 30 minutes of hypoglycaemia
was not significantly different from normoglycaemic cells but changes occurred after 30
minutes (Williams et al., 1995).Williams et al., did not measure [Ca2+]j at 24 hours but it
may be assumed that at 24 hours changes in [Ca2+]j would be observed as cells death was
measured after 4 hours. In myocytes, exposed to severe ATP depletion, little or no increase
in [Ca2+]j was also observed (Cobbold and Bourne, 1984;Haworth et al., 1987).
What is causing a reduction in cell viability in these striatal cultures exposed to
hypoglycaemia, if it is not calcium elevations and calcium-dependent processes? Why is
the cell not depolarised after 24 and 48 hours of hypoglycaemia and how is glucose
exerting its regulatory effect if not by increases in calcium? It has been previously
suggested that ATP depletion can directly lead to the collapse of mitochondrial membrane
potential independently of an elevation of [Ca2+]j (Lemasters et al., 1987). However, it is
interesting to note that after 48 hours of hypoglycaemia, the levels of [Ca2+]j have not
decreased below nonnoglycaemic levels (Figure 4.10), suggesting that the membrane is
still intact as there is no calcium leakage due to disrupted membrane.
In conclusion, it is apparent that altered calcium homeostasis is not a key factor in
hypoglycaemia-induced cell death in striatal cells, therefore the hypothesis must be once
again amended. The depletion of glucose from the medium causes a decrease in ATP
concentration, which triggers a calcium-independent dysfunction of the mitochondria.
Consequently, the mitochondria releases apoptotic inducing factors which initiate the
cascade for apoptosis. It has been reported that some cells can undergo apoptosis under
essentially calcium-free conditions (Lennon et al., 1992). Therefore the next step in this
study is to investigate whether apoptosis is the mechanism of cell death in this model of
hypoglycaemia.
Chapter Five.
Apoptosis in Hypoglycaemic toxicity
5.1 Introduction
Terminal deoxynucleotidyl transferase-mediated dUTP-biotin nick end labeling (TUNEL)
examines DNA fragmentation (Gavrieli etal., 1992). The DNA strand breaks are detected
by enzymatically labelling the free 3' -OH termini with modified nucleotides. It was
hypothesised that hypoglycaemic-induced insults might induce apoptotic cell death,
characterised by DNA damage, hence an increase in TUNEL staining would be observed.
The mature caspase-3 enzyme is formed from 17kDa (pI7) and 12kDa (pI2) subunits,
which are produced from a 32-kDa precursor. In the 32-kDa caspase-3 precursor protein,
there are two cleavage sites for the production of the pl7 and pl2 subunits (Han et al.,
1997). Z-DEVD-FMK, is a caspase-3 activity inhibitor which appears to prevent the p17
subunit being cleaved (Han et al., 1997).1t is proposed that if downstream caspase activity
is inhibited by prevention of caspase-3 activation, this will prevent the onset of the
execution stage of apoptosis and, therefore promote cell survival during hypoglycaemia.
Immunostaining for Bax, cytochrome c, caspase-9 and caspase-3 in cells exposed to
hypoglycaemia, is. important in the understanding of whether cells are dying via an
apoptotic mechanism and can be use to confirm TUNEL staining data. It is hypothesised
that the expression of one or more of these components will be increased from basal levels
in hypoglycaemic cells if apoptotic cell death is occurring. Nuclear activity of the two
downstream caspases, caspase-9 and caspase-3 should also be measured as several lines of
evidence suggest that some caspases are translocated to the nucleus and trigger specific
substrates that contributes to nuclear apoptosis (Nakagawara et al., 1997).
In this series of experiments, the assessment of these various apoptotic components and
characteristics were conducted to shed some light upon whether hypoglycaemia produces
apoptotic cell death.
5.2 Results
TUNEL staining was detected in cultures exposed to 24 hours of hypoglycaemia and
compared to normoglycaemic cultures. There was a significant difference in TUNEL
staining between the two conditions. In hypoglycaemic cultures there were significantly
more TUNEL positive cells (40.8% ± 16.6) compared to normoglycaemic cultures (7.4% ±
0.6). (Figure S.la). Figure S.1b is an example of TUNEL positive staining in a culture
exposed to 24 hours of hypo glycaemia.
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Figure 5.1a
The percentage of cells showing TUNEL staining in cultures exposed to either 24 hours of normoglycaemia
or hypoglycaemia. In hypoglycaemic cultures the glucose was removed for 24 hours before fixing for
TUNEL staining. There is a significant increase between the percentage of the cells expressing TUNEL
staining in hypoglycaemic cultures compared to normoglycaemic cultures (one-way ANOVA, F(I,4)=12.S,
*p<O.OS). Data are presented as a percentage of TUNEL positive cells from the total number of cells in
culture.
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Figure 5.1b
TUNEL positive staining in a culture exposed to 24 hours ofhypogJycaernia. Cells with nicked DNA contain
dark nuclei and are surrounded by cells containing no nicked DNA that are counterstained light green.
The caspase-3 inhibitor, Z-DEVD-FMK, did not significantly increase the cell viability of
the hypoglycaemic-treated cultures. In fact, at concentrations used, it appeared to be toxic
itself as the cell viability in normoglycaemic cultures was significantly reduced.
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Figure 5.2
The effect of the caspase-3 inhibitor, Z-DEVD-FMK, on striatal cells in normoglycaemic and hypoglycaemic
cultures. The glucose was removed from hypoglycaemic cultures prior to the addition of the caspase
inhibitor. Different concentrations of Z-DEVD-FMK were added to cultures for 4 hours before cell viability
was measured. Cell viability was measured by XTT staining. Both Z-DEVD-FMK and hypoglycaemia
produce no significant effect (two-way ANOVA; effect of Z-DEVD-FMK, F(2,12)=2.9, p=O.l; effect of
hypoglycaemia, F(1,12)=1.35, p=O.3). There is a significant decrease of XTT staining in hypoglycaemic-
treated cultures compared to normoglycaemic cultures without Z-DEVD-FMK. In norrnoglycaemic cultures
the addition of Z-DEVD-FMK also produces a significant decrease in cell viability compared to
normoglycaemic cultures without Z-DEVD-FMK (*p<0.05 versus 100%; 95% confidence intervals of the
mean). Z-DEVD-FMK showed no neuroprotection against hypoglycaemic-induced toxicity (one-way
ANOVA, p=O.8). Data are represented as a percentage ofXTT staining in normoglycaemic cultures without
Z-DEVD-FMK treatment (100%) (n=5).
Hypoglycaemia had no effect on the expression of cytoplasmic Bax at any of the time
points measured (Figure 5.3).
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Figure 5.3
Cytoplasmic Bax immunoreactivity in normoglycaemic and hypoglycaemic striatal cultures. Cells were
either treated with 24, 48, 72 or 96 bours ofnormoglycaemia or hypoglycaemia. There was no change in Bax
cytoplasmic expression in hypoglycaemic cultures relative to normoglycaemic cultures and there was no
cbange in expression of cytoplasmic Bax over time (one-way ANOVA, p=0.8). Data are expressed as a
percentage ofBax immunoreactivity in normoglycaemic cultures incubated for 24 hours (100%) (n=3).
Cytosolic cytochrome c immunoreactivity appears significantly higher in hypoglycaemic
cells after 24 hours compared to nonnoglycaemic cells. This expression seems to decrease
to non-significant levels (nonnoglycaemic levels) after 48 hours but significantly rises
again after 72 and 96 hours. There were no changes in expression in normoglycaemic
cultures (Figure 5.4).
Cytoplasmic cytochrome c
immunoreactivity measured in
normoglycaemic and
hypoglycaemic striatal cultures
1SD-
* c::::J Normoglycaemia
_ Hypoglycaemia>-(,):t::= =-
m·i2: 0c 1j -= 10D- ------ -- - --e m 5
'fio~o c 0
>. ~::!:: 500.5~
* *
o 48 72 96 24'-- 48 72 96L__
Time (hours)
Figure 5.4
Cytoplasmic cytochrome c immunoreactivity in nonnoglycaemic and hypoglycaemic striatal cultures. Cells
were either treated with 24,48, 72 or 96 hours of normoglycaemia or hypoglycaemia. There is a significant
increase in cytoplasmic cytochrome c expression with time in cultures treated with 24, 72 and 96 hours of
hypoglycaemia (one-way ANOVA, F(3,8)=24.4, p<O.OOI; *p<0.05 versus 100%; 95% confidence intervals
of the mean)). Data are expressed as a percentage of cytoplasmic cytochrome c immunoreactivity in
normoglycaemic cultures incubated for 24 hours (100%) (n=3).
Hypoglycaemia had no effect on cytoplasmic caspase-9 expression at any of the time
points observed. However, after 96 hours, there was a significant decrease in caspase-9
expression in normoglycaemic cultures (Figure 5.5).
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Figure 5.5
Cytoplasmic caspase-9 immunoreactivity in normoglycaemic and hypoglycaemic striatal cultures. Cells were
either treated with 24, 48, 72 or 96 hours of normoglycaemia or hypoglycaemia. There is no change in
caspase-9 cytoplasmic expression in bypoglycaemic cultures relative to normoglycaemic cultures, except at
96 hours. At 96 hours caspase-9 cytoplasmic expression increased in hypoglycaemic cultures
(tp<O.OI,Tukey pairwise comparison). However, in normoglycaemic cultures after 96 hours an significant
decrease in cytoplasmic caspase-9 expression is observed compared to all other time points (one-way
ANOV A, F(2,6)=11.8, p<O.Ol; *p<0.05 versus 100010;95% confidence intervals of the mean). Data are
expressed as a percentage of cytoplasmic caspase-9 immunoreactivity in normoglycaemic cultures incubated
for 24 hours (100%) (n=3).
Similar results were seen when nuclear caspase-9 was measured. Hypoglycaemia had no
effect on nuclear caspase-9 expression but in normoglycaemic cells after 96 hours, a
decrease in nuclear caspase-9 expression was observed (Figure 5.6).
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Figure 5.6
Nuclear caspase-9 immunoreactivity in normoglycaemic and hypoglycaemic striatal cultures. CelIs were
either treated with 24, 48, 72 or 96 hours of normoglycaemia or hypoglycaemia. There is no change in
caspase-9 nuclear expression in hypoglycaemic cultures relative to normoglycaemic cultures (one-way
ANOY A, p=O.4). In normoglycaemic cultures after 96 hours, a significant decrease in nuclear caspase-9
expression is observed compared to all other time points (one-way ANOVA, F(2,6)=12.3, p<O.Ol; *p<O.05
versus 100%; 95% confidence intervals of the mean). Data are expressed as a percentage of nuclear caspase-
9 immunoreactivity in normoglycaemic cultures incubated for 24 hours (100%) (n=3).
There was no change in either cytoplasmic (Figure 5.7) or nuclear (Figure 5.8) caspase-3
expression after 24,48 or 72 hours ofhypoglycaemic treatment.
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Figure 5.7
Cytoplasmic caspase-3 immunoreactivity in normoglycaemic and hypoglycaemic striatal cultures. Cells were
either treated with 24, 48, 72 or 96 hours of normoglycaemia or hypoglycaemia. There is no change in
caspase-3 cytoplasmic expression in hypoglycaemic cultures relative to normoglycaemic cultures and there is
no change in expression of cytoplasmic caspase-3 over time (one-way ANOV A, p= 1.0). Data is expressed as
a percentage of cytoplasmic caspase-3 immunoreactivity in normoglycaemic cultures incubated for 24 hours
(100%) (n=3).
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Figure 5.8
Nuclear caspase-3 immunoreactivity in normoglycaemic and hypoglycaemic striatal cultures. Cells were
either treated with 24, 48, 72 or 96 hours of normoglycaemia or hypoglycaemia. There is no change in
caspase-3 nuclear expression in hypoglycaemic cultures relative to normoglycaemic cultures and there is no
change in expression of nuclear caspase-3 over time (one-way ANOVA, p=0.9). Data is expressed as a
percentage of nuclear caspase-3 immunoreactivity in normoglycaemic cultures incubated for 24 hours
(100%)(n=3).
5.3 Discussion
TUNEL staining was markedly increased in cells subjected to 24 hours of hypoglycaemia
(Figure 5.1) suggesting that glucose deprivation produces DNA fragmentation, a distinct
marker of apoptosis. This has been repeatedly reported in many models, including in vitro
and in vivo models of hypoglycaemia (Lawrence et al., 1996; Ferrand-Drake et al., 1999
REF). The presence of TUNEL staining implies that the DNA has been nicked by specific
endonucleases. It has been reported that calcium-independent endonucleases exist, for
example, Dnase II (Barry and Eastman, 1993), so that it is plausible that in this model
DNA nicking enzymes are active. In addition it has also been reported that ATP is required
for caspase activation but not for DNA fragmentation (Leist et al., 1997). Therefore, it is
possible that even if ATP levels in hypoglycaemia have diminshed DNA fragmentation can
still occur.
The caspase-3 inhibitor, Z-DEVD-FMK, produced no neuroprotective effect in
hypoglycaemic cultures (Figure 5.2). This suggests that either Z-DEVD-FMK is not
specific and inadequately inhibits caspase-3 or that caspase-3 is not involved in the
apoptotic pathway initiated by the removal of glucose. However, it is becoming
increasingly evident that apoptotic-features are found when cells are treated with caspase-
inhibitors (Nicotera et aI., 2(00) and it has been described that some caspase inhibitors
can prevent the appearance of certain, but not all features of apoptosis in certain model
systems (McCarthy et aI., 1997). Z-DEVD-FMK did not increase survival in striatal
neurones undergoing apoptosis in a Huntington disease model (Kim et al., 1999a) and
DNA fragmentation caused by traumatised brain injury was also not affected by the
administration of Z-DEVD-FMK (Yakovlev et al., 1997; Allen et al., 1999). Z-DEVD-
FMK was shown to be toxic to normoglycaemic cells, suggesting that either this compound
inhibits other enzymes or that caspase-3 is involved in physiological as well as
pathological processes. It has been reported, in other cell types, that caspase-3 is activated
in the absence of cell death (Miossec et al., 1997), indicating that caspase-3 has functions
distinct from executing cell death. However, it has also been reported that concentrations
of Z-DEVD-FMK used in this experiment can inhibit all caspases. It is therefore possible
that inhibiting all caspases, even members of the family which are not involved in
apoptosis, could be detrimental to healthy cells.
The non-specific background staining of the Bax, cytochrome c, caspase-9 and caspase-3
antibodies used, were determined by designing a control experiment where
immunocytochemistry procedure is identical but the primary antibodies were are omitted.
In these experiments no staining was observed suggesting that the antibodies were specific
for the particular protein. In addition, these antibodies are used in most experimental
studies investigating apoptotic machinery (Femandes-Alnenari, 1996; Liu et al., 1997;
Hockenbery et al., 1991).
After 24 hours of hypoglycaemia, the expression of immunoreactive Bax remained at
baseline levels (Figure 5.3). This suggests that either Bax is not activated by the removal of
glucose or that the optimum time for the expression of Bax was prior to 24 hours, hence a
change was not detected. However, it was shown that in transient forebrain ischaemia, the
expression of Bax protein peaked at 72 hours following the insult (Hara et al., 1996).
Cytochrome c expression increased in cultures treated with hypoglycaemia for 24 hours,
compared with normoglycaemic cultures (Figure 5.4). It is not necessary for Bax to
translocate to the mitochondria, in order to release cytochrome c suggesting that although
no increase in Bax expression was observed in hypoglycaemic cells, apoptotic-related
changes in cytoplasmic c expression can still occur. The gradual increase in cytochrome c
expression maybe a result of mitochondrial membrane depolarisation or the interaction of
other Bcl-2 pro-apoptotic family proteins, such as Bid (Li et al., 1998) which translocate
to the mitochondria upon the onset of the hypoglycaemic insult.
After 96 hours immunoreactive caspase-9 expression in both the cytoplasm and the nucleus
is decreased in normoglycaemic cells (Figures 5.5 and 5.6). However no change in either
the cytoplasmic or nuclear expression of caspase-3 in hypoglycaemic cells compared with
normoglycaemic cells was observed (Figures 5.7 and 5.8). This is in contrast to the
majority of literature describing caspase-3 as the major apoptotic executing factor, and a
report where caspase-9 has been shown to peak at 24-72 hours in the striatum after
ischaemia (Chen et al., 1998). It is possible that apoptosis independent of these specific
caspases is initiated. It is difficult to interpret why a decrease in caspase-9 expression was
observed after 96 hours of normoglycaemia. It would be postulated that if there were any
change in caspase expression then an increase would be expected due to apoptosis
occurring triggered by a lack of neurotrophic support after 96 hours. It is not certain that
this decrease has any functional significance.
Depending on the cell type, the stimuli and the severity of the stimuli, different caspases
may be employed. For example, the overexpression of caspase-12 induces apoptosis and is
associated with the stresses induced to the ER in neurones, for example by A23187 or
amyloid-ji protein (Nakagawa et al., 2000). It was observed that although other caspases
may be activated downstream from caspase-12, caspase-12 appears to be necessary for
apoptosis (Nakagawa et al., 2000). Caspase-9 also cleaves and activates caspase-6 and -7
as well as caspase-3. It is apparent that caspase-8 can also activate caspase-3, -6, -7 and
Bid (Figure 1.1) (Muzio et al., 1996; Luo et al., 1998; Li et al., 1998). Caspase-
dependent pathways, which are independent of mitochondria, have also been described.
For example, caspase-8 trans locates from the receptor within the plasma membrane to the
cytoplasm where it initiates the death cascade by proteolytic activation of. downstream
caspases (Cryns and Yuan, 1998). It is therefore very plausible that a different, not well
established, cascade might be active in hypoglycaemic-induced cells. Therefore, the lack of
evidence for caspase-3 and ,capase-9 activation in hypoglycaemia does not rule out the
possibility that apoptosis is occurring.
There has been much debate over whether caspase-independent apoptosis exists (Nicotera
et al., 2000). The discovery of other proteases, unrelated to caspases, involved in the
programmed cell death pathways, have provided evidence for the reality of multiple
converging pathways (Hirsch et al., 1997; Sarin et al., 1997; Xiang et al., 1996). It has
been suggested that serine proteases, cathepsin and calpains may be active in apoptosis
(Nicotera et al., 2000). In addition, gene knockout mice studies have shown that mice
lacking cytochrome c, apafl and caspase-s exhibit apoptosis (Kuida et al., 1998; Li et al.,
2000).
Recently, another pathway linking the mitochondria to apoptosis has been reported, which
is independent of caspases but dependent on a molecule termed apoptosis-inducing factor
(AIF) (Josa et al., 2(01). AIF is localised in the mitochondria, similar to cytochrome c,
and is released in response to death stimuli, but is not associated with Apafl or caspase-9
(Josa et al., 2(01). It has been cloned in embryonic stem cells and provides strong
evidence that components other than those previously described exist in neurones.
The endonuclease that is essential for the intemucleosomal fragmentation of DNA is DNA
fragmentation factor 45 (DFF 45). It is apparent that DFF 45 is cleaved by caspase-3 but
once cleaved it can induce DNA fragmentation in the absence of caspase activity (Liu et
al., 1997). Transgenic mice lacking DFF 45 or its caspase cleavage site have significantly
reduced DNA fragmentation. However, these mice still show DNA fragmentation and are
phenotypically normal (Li et al., 2001). Another nuclease has been characterised, termed
endonuclease G. Once released from the mitochondria triggered by apoptotic stimuli, it
translocates to the nucleus and cleaves DNA independently of caspases (Li et al., 2001).
It has been repeatedly disputed that TUNEL staining is not an accurate indicator of
classical apoptosis and that DNA fragmentation does not necessarily imply cell death will
be apoptotic (Takei and Endo, 1994). Studies have shown TUNEL staining labelling and
DNA fragmentation in necrotic cells (de Torres et al., 1997; Collins et al., 1992).
Indeed, apoptosis is an energy requiring process. Therefore if ATP is depleted during
hypoglycaemic injury it would be assumed that the mode of cell death would switch to an
ATP-independent mechanism, namely necrosis (Leist et al., 1999). For example, it has
been suggested that glucose-deprivation would affect apoptotic pathways by preventing the
binding of Apaf-l to procaspase-9 protein (Zou et al., 1999) which is dependent on ATP,
so what the subsequent activation of downstream degradative processes including caspase-
3 activation and PARP cleavage would also be precluded.
Apoptosis and necrosis have been reported to coexist in the same damaged tissue and more
interestingly, that cells dying from a type of cell death comprise of both apoptotic- and
necrotic-like characteristics, such as mitochondrial swelling and cellular shrinkage
(Ferrand-Drake et al., 1999). This provides further complications when assessing whether
cultured striatal cells exposed to hypoglycaemia die due to apoptosis or necrosis or both.
In conclusion, it seems that the integral apoptosis process, observed in most neurotoxic
models, is not involved in hypoglycaemia measured by XTT staining and MAP2 staining.
It is possible that the process of apoptosis may be halted in the absence of glucose as ATP
is required to drive apoptotic components. However, DNA nicking has occurred
introducing the possibility that cell demise occurring in this model is one that cannot be
classified into apoptosis or necrosis. Therefore if classic apoptosis is not the mode of cell
death in this model and calcium-dependent necrosis is not involved, what is the primary
mechanism triggering the reduction in cell viability and DNA fragmentation? It is plausible
to suggest that the cells are metabolically and structurally damaged but not actually dead.
The next section of this study focuses on whether the cells can recover from the
hypoglycaemic-insult, which indicates that the cells are not dead. It also examines the
possible repair mechanisms involved.
Chapter Six.
The Recovery of Hypoglycaemic cells
6.1 Introduction
It has been demonstrated that the re-introduction of glucose into a previously energy-
deficient system is less beneficial to the survival of neurones than would be expected
(Siesjo, 1992; Tasker et al., 1992; Almeida et al., 1995). It has also been demonstrated
that after a period of hypoglycaemia in both in vitro and in vivo models that EAA-receptor
activation and EAA release occurs when the glucose content is replaced (Tasker et al.,
1992; Linden et al., 1987). It has also been suggested that a re-introduction of glucose
initiates opening of the MTP and triggers the formation of ROS (Almeida et al., 1995;
Kristian and Siesjo, 1996). It is therefore hypothesised that after 24 hours, neuronal
survival will not increase upon the replacement of the glucose content. The duration of the
return to normoglycaemia (recovery) is an apparent consequential factor, hence the effect
of different lengths of recovery on the outcome of neuronal viability are observed.
It is also unclear what effect re-introduction of glucose would have on the process of
apoptosis. Hence it is interesting to see whether any apoptotic machinery is employed
during the recovery stage, since when glucose is added, the system has energy to switch on
the ATP-dependent death-promoting components which can subsequently influence the
fate of the cell.
DNA damage can occur as a result of many exogenous stimuli, such as oxidative stress. It
is hypothesised that during hypoglycaemia, DNA damage occurs, detected by TUNEL
staining, but it is of interest to observe whether DNA damage is exacerbated by the re-
introduction of glucose. In this study, it is postulated that an increase in the expression of
DNA repair proteins will be observed in association with decreased TUNEL staining,
suggesting that the repair proteins are attempting to preserve the DNA structure.
In this series of experiments, the consequences of re-introduction of glucose on the
viability of cells in hypoglycaemic cultures was assessed. In addition, experiments were
designed to assess the activity of components of the apoptotic cascade, along with DNA
fragmentation and DNA repair proteins during this recovery phase, in an attempt to
determine the mechanisms involved in the recovery phase post-hypoglycaemia.
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6.2 Results
There was a significant decrease in XTT staining in cells treated with hypoglycaemia for
24,48, 72 and 96 hours. There was no significant difference observed in the percentage of
cell viability between the difference lengths of hypoglycaemia (Figure 6.1).
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Figure 6.1
The effect of removing the glucose for 24, 48, 72 and 96 hours compared to normoglycaemic cultures. All
durations of hypoglycaemia studied produce a significant decrease in XTT staining (two-way ANOV A,
F(I,16)=105.1 significant effect of hypoglycaemia, p<O.OOI, effect of time F(3,16)=0.7, p=0.6; *p<0.05
versus 100%; 95% confidence intervals of the mean) but there was no difference with time (one-way
ANOVA, p=O.5). Data are presented as a percentage ofXTT staining in normoglycaemic cultures incubated
for 24 hours after the onset of treatment (100010) (n=3).
Cultures treated with 24 hours of hypoglycaemia showed a significant decrease in cell
viability compared to normoglycaemic cultures. However, when the glucose was replaced
for 24 hours, XTT staining dramatically increased to normoglycaemic levels. Glucose
replacement for a further 24 and 48 hours sustained the increased levels of cell viability
(Figure 6.2a). The cell viability in normoglycaemic cultures had significantly decreased
after 24 and 48 hours of recovery but not after 72 hours.
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Figure 6.2a
The effect of replacing the glucose in cultures exposed to 24 hours ofnormoglycaemia or hypoglycaemia. In
hypoglycaemic cultures the glucose was removed for 24 hours and then replaced for either 24, 48 or 72
hours. Cell viability was measured by XTT staining. Both glucose replacement and duration of glucose
replacement produce significant effects (two-way ANOVA, effect of glucose replacement, F(1,16)=7.1,
p<0.05; effect of recovery time, F(3,16)=6.2, p<O.Ol). The XTT staining ofhypoglycaemic cultures after 24
hours (0 recovery period) is significantly decreased compared to normoglycaemic cultures (*p<0.05 versus
100%; 95% confidence intervals of the mean). After glucose replacement for 24, 48 and 72 hours in
hypoglycaemic cultures, cell viability significantly increases (one-way ANOVA, F(3,S)=S.2, tp<O.Ol).
However, a significant decrease in XTI staining in normoglycaemic cultures is observed after 24 and 48
hours of replacing the glucose. At 48 hours XTI staining in normoglycaemic cultures is significantly
decreased compared to hypoglycaemic cultures (tp<O.Ol, Tukeys pairwise comparison). Data are presented
as a percentage ofXIT staining in normoglycaemic cultures incubated for 24 hours (100%) (n=5).
Figure 6.2b
A morphological observation of striatal cells after 24 hours of hypoglycaemia followed by 24 hours of
recovery. The dendrites have spread out connecting the remaining cells and there are more glia present which
may provide crucial metabolic support. Cells are stained with cytochrome c antibody.
A significant increase in TUNEL staining in cultures treated with hypoglycaemia for 24
hours was observed when compared to nonnoglycaemic cultures. Nevertheless, when
glucose was replaced in these cultures, TUNEL staining significantly decreased to
normoglycaemic levels. After 48 and 72 hours of recovery, TUNEL staining was still
reduced in comparison to staining in hypoglycaemic cultures (Figure 6.3).
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Figure 6.3
The percentage of cells showing TUNEL staining in cultures exposed to 24 hours of normoglycaemia or
hypoglycaemia and subsequently either 24, 48 or 72 hours of glucose replacement. In hypoglycaemic
cultures the glucose was removed for 24 hours and then replaced. Both treatment and time produce a
significant effect (two-way ANOVA, effect of glucose replacement, F(1,16)=l0.28, p<O.Ol; effect of
recovery time, F(3,16)=lO.81, p<O.OOl). Cultures exposed to 24 hours of hypo glycaemia show a significant
increase in TUNEL staining compared to normoglycaemic cultures (*p<O.OOI, Tukey pairwise comparison).
This staining is significantly reduced when glucose is re-introduced for 24 hours (p<O.OOl, Tukey pairwise
comparison), 48 hours (p<O.OOl, Tukey pairwise comparison) and 72 hours (p<O.Ol, Tukey pairwise
comparison). Data are presented as a percentage of the total number of cells in culture (n=4).
Figures 6.4 to Figure 6.9 show cytoplasmic or nuclear immunostaining of either bax,
cytochrome c, caspase-9 or caspase-3 in cells recovered from hypoglycaemia. At all the
time points studied, there was no significant changes between the conditions.
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Figure 6.4
Cytoplasmic bax immunoreactivity in normoglycaemic and hypoglycaemic striatal cultures. In
hypoglycaemic cultures the glucose was removed for 24 hours and then replaced for either 24, 48 or 72 hours
There is no change in the expression of cytopasmic bax in recovered cells relative to hypoglycaemic cultures
(one-way ANOVA, p=OA). Data are expressed as a percentage of cytoplasmic bax immunoreactivity in
normoglycaemic cultures incubated for 24 hours (100%) (0=3).
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Figure 6.5
Cytoplasmic cytochrome c immunoreactivity in oorrnoglycaemic and hypoglycaemic striatal cultures. In
hypoglycaemic cultures the glucose was removed for 24 hours and then replaced for either 24, 48 or 72 hours
There is no change in the expression of cytopasmic cytochrome c in recovered cells relative to
hypoglycaemic cultures (one-way ANOVA, p=O.7). Data are expressed as a percentage of cytoplasmic
cytochrome c immunoreactivity in normoglycaemic cultures incubated for 24 hours (100%) (n=3).
Cytoplasmic caspase-9
immunoreactivity measured in
recovered striatal cultures
24 48 72 0 24 48 72
Duration of Recovery (hours)
c:J Normoglycaenia
_ 24hrs Hypoglycaemia
+ recovery
Figure 6.6
Cytoplasmic caspase-9 immunoreactivity in normoglycaemic and hypoglycaemic striatal cultures. In
hypoglycaemic cultures the glucose was removed for 24 hours and then replaced for either 24, 48 or 72
hours. There was no change in the expression of cytopasmic caspase-9 in recovered cells relative to
hypoglycaemic cultures (one-way ANOVA, p=O.7). Data are expressed as a percentage of cytoplasmic
caspase-9 immunoreactivity in normoglycaemic cultures incubated for 24 hours (100%)(n=3).
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Figure 6.7
Nuclear caspase-9 immunoreactivity in normoglycaemic and hypoglycaemic striatal cultures. In
hypoglycaemic cultures the glucose was removed for 24 hours and then replaced for either 24, 48 or 72
hours. There was no change in the expression of nuclear caspase-9 in recovered cells relative to
hypoglycaemic cultures (one-way ANOVA, p=O.8).Data are expressed as a percentage of nuclear caspase-9
immunoreactivity in normoglycaemic cultures incubated for 24 hours (100%) (n=3).
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6.3 Discussion
Replacing the glucose in the culture medium after 24 hours of hypoglycaemia, markedly
increases the XTT staining of the cells (Figure 6.2a), compared to hypoglycaemic cultures
without glucose replacement (Figure 6.1). This strongly suggests an increase in cell
survival that is prolonged and not a transient effect, as after 72 hours of recovery, the cell
viability of these cultures is still at normoglycaemic levels (Figure 6.2a). It is also possible
to suggest the dramatic increase in hypoglycaemic cultures when glucose is replaced is
partly associated with the removal of toxic elements, such as ROS, as well as the re-
introduction of glucose. In Figure 6.2b, recovered cells have regained long processes and
are more spread out compared to Figure 3.2b. Although the staining is cytochrome c
immunoreactivity (no MAP2 staining was done on these cells) and therefore is not uniform
throughout the cell's structure it does provide a morphological picture of recovery in
surviving cells. It also shows an increase in glia proliferation indicating that the prevention
of glia cells is more difficult in older cultures and suggests that glia may have a pivotal role
in neuronal recovery. Figure 6.2b complements the XTI results shown in Figure 6.2a.
This is in contrast to many studies which have reported biochemical, morphological and
genetic alterations to cells upon the re-introduction of energy that are detrimental to cell
survival (Taylor et al., 1999; Goldberg and Choi, 1993; Prakasa Babu et al., 2000). For
example, during the recovery period following insulin-induced hypoglycaemia, membranes
of hippocampal cells ruptured, and mitochondrial densities and condensation of the nucleus
was observed (Auer et al., 1985b). It is also well documented that during the recovery
phase there is an increase in mitochondrial production of ROS, as a consequence of injured
mitochondria (White and Reynolds, 1996), and also a release of cytochome c causing DNA
fragmentation (Fujimura et al., 1999). However, it has been demonstrated that during
apoptosis the mitochondria remain morphologically intact (Portera-Caillau et al., 1997;
Martin et al., 1994; MacManus et al., 1993) and that mitochondrial function can be
restored and cell survival maintained if glucose is replaced before the late elevation of
[Ca2+]j (Mattson et al., 1993).
Indeed, one study showed that upon the replacement of glucose, a transient increase in
viability, after 24 hours of hypo glycaemia in hippocampal cultures was observed (Mattson
et al., 1993). After 8 hours of recovery, the percentage of neurones surviving had
increased by roughly 70% and [Ca2+]j had decreased from 500nM to 100nM but after a
further four hours neuronal survival had decreased concomitantly with a progressive
increase in [Ca2li(Mattson et al., 1993). In this model, there is no elevation of [Ca2+]i ,
suggesting that mitochondrial functioning will not be irreversibly damaged. In addition. in
response to glutamate, a dramatic elevation in [Ca2+]i' was observed in recovered cells,
suggesting membrane integrity and normal receptor functioning within these cells (Figure
6.15).
It is also interesting to observe the decrease in cell viability in normoglycaemic cultures
after 24 and 48 hours of recovery. This suggests that changing the medium. i.e. removing
elements, such as tropic factors, appears to have an adverse effect in normoglycaemic cells,
but cells which are initially hypoglycaemic, are resistant to this effect. Results also show
that this effect is only transient as cell viability in normoglycaemic cells return to baseline
levels after 72 hours of recovery (Figure 6.2a).
Remarkably, TUNEL staining reduces concominantly with glucose replacement,
suggesting that as ATP levels rise in the culture, this repairs the DNA fragmentation via
energy-dependent repairing mechanisms (Figure 6.3). A decrease in TUNEL staining was
observed after up to 72 hours of recovery. This is in disagreement with other studies
(Prakasa Babu et al., 2000; Ferrand-Drake et al., 1999). For example, DNA fragmentation
induced by severe insulin-hypoglycaemia was not observed after 3 hours of recovery in
hippocampal dentate granule cells. However TUNEL staining was seen after 24 hours and
was markedly enhanced after 48 hours of recovery (Ferrand-Drake et al., 1999)
The reintroduction of glucose initiates the production of energy-dependent mechanisms,
such as apoptosis. For example, the apoptotic pathway may have already begun during
early stages of ATP depletion but halted when energy levels were too low. This process
may re-initiated itself when energy was put back into the system. It is also possible that
apoptosis is initiated upon the re-introduction of glucose. However, there are three sets of
data suggesting that this does not occur. Firstly, that mitochondrial functioning has
increased to normal levels (Figure 6.2a), secondly, that TUNEL staining decreases to
normal levels (Figure 6.3) and finally, that caspase activity is not observed, i.e Bax,
cytochrome c, caspase-9 and caspase-3 did not change from normoglycaemic levels in
recovered cells (Figures 6.4 - Figures 6.9).
Levels of expression of four different DNA repair proteins, implicated in preventing
cellular death, were monitored during up to 72 hours of recovery. The levels of these
proteins have all been shown to increase during periods of DNA repair (Uberti et al.,
2000; Ahlers et al., 1999; Grilli and Memo, 1999). Considering that TUNEL staining had
returned to normoglycaemic levels by 24 hours, it would be assumed that the DNA repair
proteins had already performed their function. However, no change in the expression of
XRCC1, ERCC3, MHS2 and DNA polymerase-B was observed at any of the time points
before 24 hours and no delayed change in expression was seen between 24 and 72 hours of
recovery (Figure 6.10 - Figure 6.13).
It is possible that other DNA repair proteins, not assessed in this study exist, which are
specific for the repair of DNA fragmentation in cultured striatal neurones exposed to
hypoglycaemia. Also, it is conceivable that the repair proteins have been irreversibly
damaged after 24 hours of glucose deprivation but this seems unlikely due to the cell
regaining function after recovery as shown by XIT measurement (Figure 6.2a).
One reason for the observed lack of change in these proteins could be that during
hypoglycaemia, no [Ca2+]j change occurs (Figure 6.14) as it has previously been
demonstrated that a calcium-trigger, via a calcium ionophore, is sufficient for the induction
of DNA polymerase ~ (Ahlers et al., 1999), therefore there is no trigger for the
upregulation of DNA polymerase ~ in this system.
It is interesting to observe that the [Ca2+]j levels In cells treated with 24 hours of
hypoglycaemia followed by 24 hours of recovery, should decrease by approximately half
(Figure 6.14). Previous studies have reported a dramatic increase in [Ca2+]j levels after 24
hours of glucose replacement (Taylor et al., 1999). In some studies a decrease is observed
but for only a few hours before the levels rise above normoglycaemic levels (Mattson et
al., 1993; Tymianski et al., 1993). However, in this study even after 48 hours of recovery,
[Ca2+]j levels still had not exceeded normoglycaemic concentrations (Figure 6.14).
It is possible that the cell up-regulates its buffering systems during the initial stages of
hypoglycaemia before the ATP levels have fallen to a particular threshold. For example,
the cell may detect, via some glucose-responsive receptor (Ashford, 1990), that the
concentration of glucose has decreased and signals for an up-regulation of calcium-binding
proteins such as calbindin-Dae. In this system there is no calcium influx, during
hypoglycaemia(Figure 6.14) so the calcium-binding proteins have nothing to buffer and
with ATP levels declining, an inhibition of protein synthesis activity occurs. Subsequently,
during the recovery period, ATP levels increases, protein synthesis is initiated and the up-
regulation of calcium buffering systems causes an unregulated extensive sequestration, or
extrusion of calcium out of the cell and the [Ca2+]j is dramatically reduced. Indeed, the
traces shown in Figure 6.15, indicates that in the recovered cell a faster extrusion
mechanism is activated as the time taken for the intracellular calcium level to return to
baseline after glutamate administration is markedly shorter when compared to
normoglycaemic cells. However, the trace is recorded from an individual cell and can not
be interpretated as a representation of all cells. This should also be kept in mind when
observing the higher resting level of [Ca2+]j in Figure 6.15b and recovery cells in Figure
6.14.
Another possibility is that the membrane is hyperpolarised during hypoglycaemia but upon
recovery the membrane depolarises (Ashford et al., 1990). This membrane depolarisation
causes influx of [Ca2+]j, of non-toxic magnitude, but the ATP-dependent processes, such as
the internal calcium stores and the Na+/Ca2+ exchanger are altered by the initial ATP
depletion and begin to chelate calcium, regardless of the [Ca2+]j concentration. The net
result is an abnormally low concentration of [Ca2+k It is also conceivable that an altered
gene expression after DNA damage could be responsible for cell death at a later time
(Zhang et al., 1994) which perturbs the ER calcium homeostasis and causes a disarray of
calcium buffering signals or an over expression in calcium binding protein synthesis.
However, it could be speculated that the near significant difference in TUNEL staining
between 24 hours of recovery and 72 hours of recovery (one-way ANOVA, p=0.05; Figure
6.3) indicates that after 72 hours of recovery death promoting processes are being initiated,
in line with observations seen in other energy replenishment paradigms. Therefore if the
recovered cells were observed after 96 hours, TUNEL staining may have increased to
levels comparable to hypoglycaemic cultures, signifying an extremely delayed cell death.
In addition, the [Ca2+]j levels after 48 hours of recovery begin to increase to
normoglycaemic levels (Figure 6.14). Thus, after 96 hours of recovery [Ca2+]j levels may
have progressively increased to toxic concentrations. However, it is possible that like
normoglycaemic cultures after 72 hours of recovery, TUNEL staining has increased in
recovered cells (Figure 6.3), indicating that DNA fragmentation occurs via intrinsic
processes, such as lack of neurotrophic factors.
Overall, these results suggest that a decrease in XTT staining and an increase in TUNEL
staining does not signify death as affected cells can recover function and DNA integrity
when glucose is replaced. Mechanisms of DNA repair remain to be elucidated. They may
involve different DNA repair proteins or unidentified processes which regenerate DNA
structure in cells destined not to die.
It is possible that by investigating components associated with both the promotion of
neuronal survival and the mediation of neurotoxicity may provide an insight into whether
a single component possesses the power to decide cell fate, i.e. death versus survival. One
possible component is the transcription factor, NF-KB, which has been proposed to possess
a dual role in neuronal survival. It could be possible that transcription factors are the
primary 'candidates in deciding which pro- or anti-apoptotic genes to switch on in the event
of glucose deprivation. The next section investigates the role of NF-KB in hypoglycaemic
cell death.
Chapter Seven.
The Role of Nuclear Factor-kappa B
7.1 Introduction
In view of the emerging concept of NF-KB as a key mediator in neurodegenerative and
neuroprotective processes, studies were designed to test the hypothesis that NF-KB
modulates hypoglycaemia-toxicity. A highly specific, non-toxic NF-KB inhibitor would be
an important tool in the investigation of the role of NF-KB in particular scenarios. There
are NF-KB inhibitors available as well as reagents which have been reported to inhibit NF-
KB as one of their properties.
The inhibition of NF-KB has been reported to be a property of aspirin and salicylic acid
(Grilli et al., 1996). Aspirin is usually prescribed as an anti-inflammatory agent which
irreversibly inhibits cyclooxygenases, enzymes responsible for the control of the
production of prostaglandins. Their mechanism of action is thought to involve the specific
inhibition of I1cBkinase-B (IKK-~) which catalyses the transfer of phosphate from ATP to
IKB (Yin et al., 1998). Therefore, if aspirin binds to IKK-~, which in turn reduces ATP
binding, NF-KB would remain sequestered by IKB in the cytoplasm.
High doses of aspirin (and salicylic acid), have been shown to inhibit the translocation of
NFkB into the nucleus in human Jurkat T cell lines (Kopp & Ghosh, 1994; Yin et al.,
1998), mouse pre-B cell lines (Kopp & Ghosh, 1994), primary rat cerebellar granule cells,
hippocampal slices (Grilli et al., 1996) and within an in vivo rat model (Yin et al., 1998).
The antioxidant, POTC, has been repeatedly reported to be an inhibitor of NFkB activation
(Sherman et al., 1993; Xie et al., 1994; Schreck et al., 1992a). POTC provided a specific
and dose-dependent inhibitory effect on the inducibility of NFkB DNA binding. It does not
affect the level of the cytoplasmic NFkB-IkB complex and does not interfere with DNA
binding or nuclear uptake of NFkB. Its most likely inhibitory mechanism of action is
blocking the release of IkB from NFkB. This reaction seems to require metal ions and
hydroxyl radicals (Schreck et al., 1992a).
Parthenolide, a sesquiterpene lactone, is used as an anti-inflammatory and has been shown
to prevent the degradation of IKB-a. and IKB-~, thus inhibiting NF-KB activity at
concentrations from 5J.1Mto 40J.lM (Hehner et al., 1998; Hehner et aI., 1999). This
inhibition has been shown in HeLa cells (Hehner et al., 1999), Jurkat T cells (Hehner et
al., 1998), aortic smooth muscle cells (Wong and Menendez, 1999) and human
hepatocarcinoma HepG2 cells (Sobota et aI., 2000).
4-Hydroxy-2-nonenal (HNE), is analdehydic product of lipid peroxidation. It has been
reported that HNE prevents NF-KB activation in a dose-dependent manner, with a marked
inhibition at 25J.1Mand complete inhibition at 50J.lMby preventing the degradation of IKB-
a. and IKB-~ in human monocytic cells (Page et al., 1999).
It has also been reported that the caspase-3 inhibitor, Ac-DEVD CHO, inhibited h::B-a. in a
dose-dependent manner, in response to quinolinic acid (Qin et al., 2000). In this study, a
different caspase-3 inhibitor, Z-DEVD-FMK, was used.
In this series of experiments, the activity of NFKB is observed, in order to investigate
whether this transcription factor has a potential role in hypoglycaemia. In most of the
experiments the· NF-KB subunits, p50 and p65, were measured, via nuclear
immunoreactive staining using specific antibodies to these subunits. In addition NF-KB
DNA binding activity was detected via the electrophoresis of nuclear extracts containing
the oligonucleotide specific for the NF-KB DNA binding site consensus.
The NF-KS inhibitors discussed are employed to test whether NF-KB plays a significant
role in the reduction of cell viability associated with hypoglycaemia. The calcium
ionophore, A23187, induces NF-KS activity. This is a reliable, reproducible stimulus to
activate NF-KB, and it is used to investigate whether aspirin significantly inhibits NFKB
protein translocation. Finally, NF-KB activity was monitored in cells recovered from
hypoglycaemia, in order to investigate the possibility that NF-KB is involved in the
recovery process.
7.2 Results
The expression ofp65 and p50 NF-KB subunits was observed during a period of2 hours in
either normoglycaemic or hypoglycaemic conditions. The expression of both the subunits
was measured at time 0 before the medium was changed to either hypoglycaemic or
normoglycaemic.
Hypoglycaemia produced a significant effect on the induction ofp65 (Figure 7.1). At 15
and 30 minutes, hypoglycaemia increased the expression of p65 compared to
normoglycaemia. At 60, 120, 180 and 240 minutes, there was no significant difference in
p65 expression between hypoglycaemia and normoglycaemia. In normoglycaemic cultures,
at 15, 30, 60 and 120 minutes of normoglycaemia, p65 expression had significantly
decreased from time O. At 180 and 240 minutes, normoglycaemic levels had returned to
time 0 levels (Figure 7.1).
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Figure 7.1
The nuclear expression of the NFKB p65 subunit immunoreactivity in striatal cultures exposed to different
durations of hypoglycaemia In hypoglycaemic cultures the glucose was removed for either, 15 minutes, 30
minutes, 1,2, 3,or 4 hours before fixing. There is a significant effect of hypoglycaemia (two-way ANOVA,
effect of hypoglycaemia, F(1,84}=24.0, p<O.OOI; effect of time, F(6,84)=2.I9, p=O.052). Hypoglycaemia
produces a significant increase in p65 expression compared to normoglycaemia after 15 (tp<O.OOI, Tukey's
test) and 30 minutes (tp<O.Ol, Tukey's test). In nonnoglycaemic cultures, at all time points except 180 and
240 minutes, p65 expression was significantly less than time 0 (*p<0.05 versus 100%; 95% confidence
intervals of the mean). The data are represented as a percentage of change in p65 expression from
normoglycaemic cultures at 0 time point (100%) (n=4).
yBoth time and normoglycaemia had a significant effect on the induction p50. After 15, 30
and 120 minutes, hypoglycaemia significantly increased the expression ofp50 compared to
normoglycaemia. In normoglycaemic cultures, p50 induction was significantly suppressed
from the level at time 0 after 15, 30, 60 and 120 minutes but not after 180 and 240 minutes
(Figure 7.2).
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Figure 7.2
The nuclear expression of the NFKB p50 subunit immunoreactivity in striatal cultures exposed to different
duration's of hypo glycaemia. In hypoglycaemic cultures the glucose was removed for either, 15 minutes, 30
minutes, 1,2, 3,or 4 hours before fixing. There is a significant effect of both norrnoglycaemia and time (two-
way ANOYA; effect of hypoglycaemia, F(l,56)=56.0, p<0.001; effect of time; F(6,56)=4.49, p<O.OOI).
Hypoglycaemia produces a significant increase in p50 expression compared to normoglycaemia after 15
(tp<0.05, Tukey's test), 3D (tp<O.OI, Tukey's test) and 120 minutes (tp<O.Ol, Tukey's test). After 240
minutes hypoglycaemia causes a significant decrease in p5D expression compared to norrnoglycaemia (one-
way ANOYA, F(1,12)=J3.6, tp<O.Ol). In normoglycaemic cultures, at all time points except 180 and 240
minutes, p50 expression was significantly less than time 0 (*p<0.05 versus 100%; 95% confidence intervals
of the mean). The data are represented as a percentage of change in p50 expression from normoglycaemic
cultures at 0 time point (100%) (0=4).
The measurement of NF-lCB DNA binding activity shows that cells incubated in
hypoglycaemic conditions for 30 minutes produced an increase of 9.5% ± 66.3% in DNA
binding compared to normoglycaemic cells and cells incubated for 60 minutes produced a
3.2% ± 53.5% decrease. This indicates that 30 and 60 minutes of hypoglycaemia did not
significantly change NF-lCBDNA binding. Figure 7.3a shows an example of an experiment
awhere hypoglycaemia at 30 and 60 minutes did increase NF-KB binding activity. However
Figure 7.3b presents all the individual data which exhibits the variability within the data.
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Figure 7.3a
An example of differences in the density of the NF-KB specific protein-DNA complexes from nuclear
extracts from cells exposed to either 30 or 60 minutes of hypoglycaemia or normoglycaemia. The different
lanes indicate samples of nuclear extracts from cells with different treatment, where 1 is 30 minutes of
normoglycaemia, 2 is 30 minutes of hypoglycaemia, 3 is 60 minutes of normoglycaemia and lane 4 is 60
minutes of hypoglycaemia. The first band indicates non-specific protein-DNA complexes and the second
band indicates the NF-KB DNA binding. In this experiment an increase in NF-KB DNA binding activity is
observed in cells exposed to hypoglycaemia for 30 and 60 minutes (111% and 35% increase respectively).
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Figure 7.3b
The effect of hypoglycaemia on NF-KB DNA binding. The scatterplot shows data from individual
experiments from cells either treated with normoglycaemia or hypoglycaemia for either 30 or 60 minutes.
Data are expressed as a percentage ofnormoglycaemic cells
Aspirin (3mM) had no neuroprotective effect on A23187-induced toxicity. Cultures
incubated with A23187 and aspirin and cultures incubated with A23187 and SN50 showed
similar pattern in the decrease in cell viability to cultures incubated with A23187 alone
(Figure 7.4).
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Figure 7.4
The effect of aspirin on A23187-induced toxicity in striatal cells. Cultures were preincubated with aspirin for
30 minutes prior to the addition of varying concentrations of A23187 for 24 hours. Cell viability was
measured by XTI staining. A dose-response curve is observed. There is no significant effect of aspirin on
cell viability. At 3J.1M, 10J.1M,30~M and 100~ A23187, cell viability significantly decreases compared to
cultures without A23187 treatment, regardless of whether aspirin is added (*p<0.5 versus 100%; 95%
confidence intervals of the mean). Data are presented as a percentage of XTT staining in cultures incubated
in the absence of A23187(IOO%) (n=3).
There was a significant effect of A23187 on the expression of nuclear p65. At
concentrations 1J.!M, 10J.!M and 100J.!M, A23187 induced a significant increase in p65
induction compared to cultures incubated in the absence of A23187. If aspirin specifically
inhibits NF-KB, a decrease in the expression of p65 is expected. However, in cells
pretreated with aspirin and then IJ.!Mof A23187, p65 expression increased (Figure 7.5),
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Figure 7.5
The measurement of nuclear p65 immunoreactivity in striatal cultures treated with A23187 and aspirin.
Cultures were treated with different concentrations of A23187. Aspirin (3mM) was added to cultures for 30
minutes prior to the addition of A23187 for one hour. Aspirin produces a significant effect on the expression
of p65 but A23187 did not (two-way ANOVA, effect of aspirin F(1,24)=9.64, p<O.Ol, effect of
A23187,F(2,24)=1.38, p=0.27). A23187 alone causes a significant increase in the p65 expression at lOIlM
and 1OO~ concentrations and cells treated with all concentrations of A23187 and aspirin causes a
significant increase relative to cultures incubated without A23187 (*p<0.05 versus 100%; 95% confidence
intervals of the mean). The p65 expression in cultures treated with 1~ A23187 is significantly lower than in
cultures treated with 10~ and IOOIlM A23187 (tp<0.05, Fisher's post-hoc test). The administration of
aspirin causes an increase in p65 expression in cells treated with 111M A23187 (#p<0.01, Mann-Whittney
test). Data are presented as a percentage ofp65 expression in cultures with no drug treatment (100%) (n=3).
PDIC had a significant effect on p65 expression. In normoglycaemic-treated cells the
expression of p65 was suppressed with IOM-M and 50M-M PDIC compared to
normoglycaemic cells in the absence of PDIC. There were no significant changes in the
expression of p65 in hypoglycaemic cells treated with PDIC, moreover, there was no
changes in p65 expression in hypoglycaemic cells prior to PDIC treatment (Figure 7.6).
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Figure 7.6
The effect ofPDTC on the expression of nuclear p65 subunit immunoreactivity in striatal cultures exposed to
one hour of hypoglycaemia Glucose from hypoglycaemic cultures was removed just prior to the addition of
PDTC. In normoglycaemic cultures treated with PDTC, at concentrations of lO~M and 50~, a significant
decrease in p65 expression is observed compared with normoglycaemic cultures without PDTC treatment
(*p<O.05 versus 100010; 95% confidence intervals of the mean). However, no significant change is observed
in hypoglycaemic cultures treated with PDTC. Data are presented as a percentage of p65 expression in
normoglycaemic cultures without PDTC treatment (100%) (n=3).
In hypoglycaemic conditions, 10J-LMPDTC significantly increased the expression of pSO
compared to normoglycaemic and hypoglycaemic conditions in the absence of PDTC.
PDTC had no effect on pSO expression in normoglycaemic cells (Figure 7.7).
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Figure 7.7
The effect of PDTC on the expression of nuclear p50 subunit in striatal cultures exposed to one hour of
hypoglycaemia. Glucose from hypoglycaemic cultures was removed just prior to the addition of PDTC. In
hypoglycaemic cultures treated with 1O~ PDTC, a significant increase in p65 expression is observed
compared to hypoglycaemic cultures (tp<0.05, Fisher's post-hoc test) and normoglycaemic cultures without
PDTC treatment (*p<O.05 versus 100%; 95% confidence intervals of the mean). PDTC had no effect on p50
expression in normoglycaemic cultures. Data are presented as a percentage of p50 expression in
normoglycaemic cultures without PDTC treatment (100%) (n=3).
Parthenolide had no effect on the cell viability of hypoglycaemic cells or normoglycaemic
cells (Figure 7.8).
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Figure 7.8
The effect of parthenolide on the cell viability of striatal cultures exposed to hypoglycaemia. The glucose
was removed from hypoglycaemic cultures just prior to the addition of parthenolide and then incubated for 4
hours. Cell viability is measured by XTT staining. Hypoglycaemia causes a significant effect on XTT
staining (two-way ANOVA, effect of hypoglycaemia, F(1,24)=14.2, p<O.OOl; effect of parthenolide,
F(3,24)=0.6, p=O.7). XTT staining was significantly lower in hypoglycaemic cultures compared to
normoglycaemic cultures (*p<0.05 versus 100%; 95% confidence intervals of the mean). There is no
significant protection by parthenolide against hypoglycaemia-induced toxicity, at any concentration (One-
way ANOVA, F(3,12)=O.07, p=1.0). Data are presented as a percentage ofXTT staining in normoglycaemic
cultures without parthenolide treatment (100%) (n=3).
There was a suppression of p65 expression in hypoglycaemic cells treated with 2J.lM
parthenolide compared to normoglycaemic cells treated with 2J.lM parthenolide. All other
concentrations were ineffective. However, the expression of p65 was significantly
suppressed by 2J.lM and 5J.lM of parthenolide in hypoglycaemic cells when compared to
normoglycaemic levels in the absence of part henolide (Figure 7.9).
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Figure 7.9
The effect ofparthenolide on the expression of nuclear p65 subunit in striatal cuJtures exposed to one hour of
hypoglycaemia. Glucose from hypoglycaemic cultures was removed just prior to the addition of parthenolide.
Hypoglycaemia produces a significant effect (two-way ANOVA, effect of hypoglycaemia, F(I,8)=19.5,
p<O.Ol, effect of parthenolide, F(3,8)=1.05, p=O.4). There is no significant difference in p65 expression
between hypoglycaemic cells and hypoglycaemic cells treated with parthenolide (one-way ANOVA,
F(3,4)=4.9, p=0.08). However, 2J.lM and 5J.1Mparthenolide significantly decreases p65 expression in
hypoglycaemic cultures relative to normoglycaemic cultures without parthenolide treatment (*p<0.05 versus
100%; 95% confidence intervals of the mean). There is a significant increase in p65 expression in
normoglycaemic cultures treated with 2J.1Mparthenolide compared with hypoglycaemic cultures treated with
2J.lM (tp<0.05, Tukey pairwise comparison). Data are presented as a percentage of p65 expression in
normoglycaemic cultures without parthenolide treatment (100%) (n=3).
HNE had no significant effect on the cell viability of hypoglycaemic cultures but in
normoglycaemic cultures HNE had a significant neurotoxic effect at 50l-1Mcompared to
the cell viability of normoglycaemic cultures incubated in the absence of HNE. (Figure
7.10).
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Figure 7.10
The effect of HNE on the cell viability of striatal cultures exposed to hypoglycaemia. The glucose was
removed from hypoglycaemic cultures just prior to the addition of HNE and then incubated for 4 hours. Cell
viability was measured by XTI staining. Hypoglycaemia causes a significant effect (two-way ANOV A,
effect of hypoglycaemia, F(I,24)=4.4, p<0.05; effect of HNE, F(3,24)=1.9, p=O.l6). XTI staining in
hypoglycaemic cultures is significantly decreased from normoglycemic cultures (*p<0.05 versus 100%; 95%
confidence intervals of the mean). The addition of HNE to hypoglycaemic cultures has no significant effect
(one-way ANOVA, F(3,12)=0.3, p=O.84). In normoglycaemic cultures, 50llM HNE significantly decreases
cell viability compared to normoglycaemic cultures incubated without HNE (*p<0.05 versus 100010;95%
confidence intervals of the mean). Data are presented as a percentage of XTI staining in normoglycaemic
cultures without HNE treatment (100%) (n=3).
There was no significant difference in the expression of p65 between normoglycaemic and
hypoglycaemic cultures, except for a decrease in expression in normoglycaemic cultures
with 5J.!MHNE and the addition ofHNE produced no significant effects in hypoglycaemic
cultures (Figure 7.11).
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Figure 7.11
The effect of HNE on the expression of nuclear p65 subunit in striatal cultures exposed to one hour of
hypoglycaemia. Glucose from hypoglycaemic cultures was removed just prior to the addition of HNE. There
is no significant change in p65 expression in hypoglycaemic cultures incubated with HNE treatment (one-
way ANOV A, F(3,4)=O.86, p=O.5). HNE produces a significant decrease in nonnoglycaemic cultures at 5J.1M
(*p<0.05 versus 1000/0; 95% confidence intervals of the mean). Data are presented as a percentage of p65
expression normoglycaemic cultures without HNE treatment (100%) (n=3).
In this experiment, the expression of p50 in hypoglycemic cultures has increased compared
to normoglycaemic cultures. In hypoglycaemic cultures, lINE decreased p50 expression at
51lM and 50IlM. lINE had no effect on p50 expression in normoglycaemic cultures (Figure
7.12).
00
pSO nuclear immunoreactivity in
control and hypoglycaemic cells
treated with HNE
150-
*
C=:J normoglycaemia
_ hypoglycaemia
100- ------ -- --- --M------
o --
5 10 50 0 5 10 50
[HNE]f.LM
--------t---
Figure 7.12
The effect of HNE on the expression of nuclear p50 subunit in striatal cultures exposed to one hour of
hypoglycaemia. Glucose from hypoglycaemic cultures was removed just prior to the addition of HNE. In
hypoglycaemic cultures a significant increase in p50 expression compared to norrnoglycaemic cultures is
observed (*p<0.05 versus 100010; 95% confidence intervals of the mean). In hypoglycaemic cultures, HNE,
caused a significant decrease in p50 expression at concentrations of 5flM and 50flM (one way ANOYA,
F(3,4)=17.0, tp<O.OI, Fishers post-hoc test). HNE produces no significant changes in normoglycaemic
cultures. Data are presented as a percentage of p50 expression in norrnoglycaemic cultures without HNE
treatment (100%) (n=3).
A significant decrease was observed when hypoglycaemic cultures treated with either
50J-lM, IOOJ-lMor 200J-lM Z-DEVD-FMK were compared with normoglycaemic cultures
incubated without Z-DEVD-FMK. In normoglycaemic cultures, Z-DEVD-FMK at
concentrations of 50J-lMand 100J-lMproduced a significant increase in p65 expression but
at 200J-lM, a decrease was observed (Figure 7.13).
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Figure 7.13
The effect ofZ-DEVD-FMK on the expression of nuclear p65 subunit in striatal cultures exposed to one hour
of hypo glycaemia. Glucose from hypoglycaemic cultures was removed just prior to the addition of Z-DEVD-
FMK. There is a significant effect on p65-immunoreactivity produced by hypoglycaemia as opposed to
normoglycaemia but not by Z-DEVD-FMK concentration (two-way ANOVA, effect of hypoglycaemia,
F(I,12)=64.3, p<O.OOI; effect of Z-DEVD-FMK, F(2,12)=0.76, p=0.5). In hypoglycaemic cultures, the p65
expression was significantly decreased compared to normoglycaemic cultures (*p<0.05 versus 100%; 95%
confidence intervals of the mean) and also relative to the levels ofp65-immunoreactivity in normoglycaemic
cultures at the same concentrations of Z-DEVD-FMK (Fisher's posthoc test tp<0.05). Z-DEVD-FMK did
not show any dose-dependent effect on p65 expression in hypoglycaemic cultures (one-way ANOVA,
F(3,8)=2.4, p=0.14). The p65 expression in normoglycaemic cultures treated with all concentrations of Z-
DEVD-FMK is significantly different from normoglycaemic cultures without Z-DEVD-FMK (*p<0.05
versus 100%; 95% confidence intervals of the mean). Data is presented as a percentage ofp65 expression in
normoglycaemic cultures without Z-DEVD-FMK treatment (100%) (n=3).
There was no significant effect on the expression of p65 or p50 in cells which have been
recovered from hypoglycaemia. There was no change in the expression of either subunit
after 24 hours of hypoglycaemia or 24 hours of hypoglycaemia and 30 or 60 minutes of
glucose replacement (Figure 7.14 and Figure 7.15).
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Figure 7.14
The effect of replacing the glucose on the expression of nuclear p65 subunit in striatal cultures exposed to 24
hours of hypo glycaemia. Glucose from hypoglycaemic cultures was removed for 24 hours and then replaced
for either 30 or 60 minutes. There is no significant difference in p65 expression in hypoglycaemic cells
compared to either cells which have been recovered for 30 or 60 minutes (one-way ANOVA, F(2,6)=1.26,
p=OA). Data are presented as a percentage ofp65 expression in normoglycaemic cultures (100%) (n=3).
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Figure 7.15
The effect of replacing the glucose on the expression of nuclear p50 subunit in striatal cultures exposed to 24
hours of hypo glycaemia. Glucose from hypoglycaemic cultures was removed for 24 hours and then replaced
for either 30 or 60 minutes. There is no significant difference in p50 expression in hypoglycaemic cells
compared to either cells which have been recovered for 30 or 60 minutes (one-way ANOVA, F(2,6)=1.8,
p=O.3). Data are presented as a percentage ofp50 expression in normoglycaemic cultures (100%) (n=3).
7.3 Discussion
The specificity of the p65 and p50 antibodies was determined by designing a control
experiment where the immunocytochemistry procedure is identical but the primary
antibodies are omitted. In these experiments no staining was observed suggesting that the
antibodies were specific for p65 and p50. In addition, these particular antibodies are used
in most experimental studies investigating NF-KB subunits (Simpson and Morris, 1994;
Qin et al., 2000).
The removal of glucose from cultures increases the expression of both the p65 and p50
subunits of NFlCB (Figure 7.1 and Figure 7.2). This increase is only observed up to 120
minutes, thereafter, the expressions of these subunits return to normoglycaemic levels. This
is in line with previous reports which have demonstrated that hypoglycaemia and
ischaemia activate NF-KB (Seegers et al., 2000; Moro et al., 2000; Takuma et al., 1999;
Clemens et al., 1997a; Clemens et al., 1997b; Tong et al., 1995).
A number of components associated with the theory of hypoglycaemia-induced damage
are potent activators of NF-lCB,Le. glutamate (Sandberg et al., 1986), calcium, (Glazner et
al., 200 1), ROS (Sun et al., 1979) and nitric oxide (Alagarsamy et al., 1994) and
therefore it is not surprising that an increase in nuclear NF-KB is detected. However, in this
study no increase in [Ca2+]j was measured and there is no EAA receptor activation but it is
possible that ROS production via the dysfunction of mitochondrial respiration during
hypoglycaemia does occur (which is unaffected by PDTC). Alternatively, other
constituents, not yet identified, may activate NF-KB and be triggered by glucose
deprivation.
In most studies measuring NF-lCB activation, significant increases in nuclear detection are
observed between 30 minutes and two hours, after the onset of the stimuli. Optimum
expression is dependent on cell type and the type of stimulus, however these results are
consistent with other reports. Between two and three hours, both p65 and p50 expression,
in hypoglycaemic cells, no longer exceed normoglycaemic levels. There are two reasons
for this, firstly, it could be suggested that after two hours of hypoglycaemia, protein
synthesis is inhibited within the cell and consequently there is an inhibition of translocation
of NF-lCB to the nucleus and the synthesis of new NF-KB and IKB subunits. Secondly, the
decrease in NF-KB expression after two hours could be due to the transient activation of
NF-KB. It is translocated to the nucleus where it targets specific genes and is subsequently
inhibited via a specialised autoregulatory mechanism (Arenzana-Seisdedos et al., 1997).
This explanation is most probable as, in the early event of a toxic stimulus, gene
transcription factors are required to switch on particular genes which will determine the
final cellular outcome.
Itwas not possible to have the same time scale for NFlCB activation and XTT staining. The
XTT staining incubation was for three hours, whereas no change in NFlCB subunit
expression would have been observed after two hours. However, it can not be assummed
that a decrease in XTT staining in hypoglycaemia cultures would have occurred within the
first two hours but it is important to observe changes preceding mitochondrial failure, i.e.
NFlCBprotein expression.
Within these first two hours, normoglycaemic levels of nuclear p65 and p50
immunoreactivity in normoglycaemic cultures, measured at 15, 30, 60 and 120 minutes,
are significantly lower than levels detected in normoglycaemic cultures at time 0, i.e. in
cultures where medium has not been changed. This suggests that changing the medium has
a profound effect on the induction ofNFlCB in normoglycaemic cells and that this effect is
only transient as p65 and p50 subunit expression returns to levels equivalent to
normoglycaemic cells without medium change and hypoglycaemic cell with medium
change, after 2 hours. How is changing the medium affecting NFlCB activation? It is
possible that a slight temperature and/or pH difference in the new medium causes a
suppression of basal NF-lCBactivation. It is equally plausible that the stress associated with
the medium changing procedure suppresses NFlCB basal levels for a short period and then
returns to normal when the homeostasis of the cell is equiliberated. Alternatively, cultured
cells secrete growth factors into the medium, and changing to fresh medium may remove a
growth factor receptor-mediated induction ofNF-lCB.
It is interesting to observe that medium change does not appear to affect NF-lCB activity in
hypoglycaemic cells. This suggests that events associated with hypoglycaemic
neurotoxicity, mask the effect of changing the medium It would be understandable if in
hypoglycaemia, the cell is being bombarded with an overload of NF-lCB stimuli, namely,
calcium, EAAs and ROS, this would override the suppression of NF-lCB caused by
changing the medium. Although, in this study no increase in [Ca2+]i is detected, the
dysfunction of mitochondrial respiration during hypoglycaemia may directly or indirectly
activate NF-lCBand override the medium changing effect. In addition, the behaviour of the
p65 and the p50 subunits are similar upon the cell's exposure to hypoglycaemia.
In the following set of experiments, there are discrepancies in the results as to whether NF-
lCBsubunits after 60 minutes of hypoglycaemia are induced above 100% (normoglycaemic
levels at time 0). In Figures 7.1, 7.2 and 7.12, hypoglycaemia increases the expression of
NF-KB subunits, whereas in Figures 7.6, 7.7, 7.9, 7.11 and 7.13 a decrease in subunit
expression is detected. The inconsistency is hard to interpret as all cultures and
experimental conditions remain the same. There are a few possibilities, such as the age of
the tissue varied occasionally. Also, inaccuracies may have occurred during the dissection
to obtain the tissue, therefore different population of cells from different structures
surrounding the striatum were incorporated into the cultures altering the behaviour of NF-
KB subunits in response to hypoglycaemia. Alternatively, it is possible that NF-lCB does
not play a key role in the effects of hypoglycaemic toxicity, hence no consistent induction
is observed.
Data obtained from NF-lCBDNA binding studies also confirm this inconsistent activity of
NF-KB induced by either 30 or 60 minutes of hypoglycaemia (Figure 7.3b). The data
shown in Figure 7.3a shows an increase in DNA binding activity after both 30 and 60
minutes of hypoglycaemia. However, it is clear in results from individual experiments that
the NF-KB DNA binding activity varies considerably, complementing results observed
with p65 and p50 subunits induction.
There have been various reports, stating that aspirin (Grilli et al., 1996), PDTC (Xie et al.,
1994), parthenolide (Hebner et al., 1998), HNE (Page et al., 1999) and caspase-3
inhibitors (Qin et al., 2000) inhibit NF-lCB activity. If NF-lCB activity can be specifically
inhibited in neurones, this would provide crucial information on the role of NF-lCB, in
response to neurotoxic stimuli.
A23187 was initially used to investigate whether aspirin inhibited the induction of NF-lCB
subunits because calcium is a critical downstream mediator in cell death and is known to
activate NF-lCB. A23187, at all concentrations, increased nuclear p65 immunoreactivity
(Figure 7.5). There was more nuclear p65 immunoreactivity detected at higher
concentrations of A23187, this suggesting that p65 induction is proportional to [Ca2+Ji_
Cell viability of cultures treated with A23187 is also proportional to [Ca2+]j (Figure 7.4).
However, these' data do not indicate whether this increase in p65 expression is a result of
NF-lCB attempting to promote cell survival or that the increase is due to NF-1(B mediating
cell death.
Aspirin dramatically increased p65 staining, suggesting that not only was it ineffective in
inhibiting p65 induction but that its other properties, such as interactions with
inflammatory proteins, influence p65 activity (Figure 7.5). The high concentration used in
this experiment was taken from the report by Grilli et al., who had tested this
concentration on cerebellular granule cells and who also stated that these high
concentrations correlate with amounts of aspirin in plasma during chronic anti-
inflammatory therapy (Grilli et al., 1996). It is interesting to observe that although aspirin
increases p65 induction, this had no effect on the cell viability measured in these cells
(Figure 7.4). It is possible that NF-lCB, induced by A23187, is not involved in the events
leading to cell death, hence, the increase of NF-KB has no significant effect on cell
viability. It must be noted that although an increase in nuclear p65 expression is seen in
A23187-treated cells, it is not conclusive that NF-KB is affecting gene induction, NF-lCB
ONA binding activity assays are needed to provide decisive evidence.
The A23187 model of toxicity was changed to the hypoglycaemia model as it was thought
that a more subtle, less abrupt form of toxicity would be more appropriate in the
observation of NF- KB subunits.
POTC did not show any inhibitory effects on the nuclear expression of the p65 or p50
subunits in hypoglycaemic cells (Figure 7.6 and Figure 7.7). This is consistent with other
reports (Chung et al., 2(00). In both experiments, hypoglycaemia for one hour alone did
not affect the expression of either subunit compared to their expression in
normoglycaemia. This is in contrast to results seen in Figure 7.1 and 7.2. Thus, it could be
that either POTC is ineffective at inhibiting NF-KB at the concentrations observed or that
there was no inducible activated NF-lCBsubunits for POTC to inhibit because p65 and p50
subunits are at basal levels as hypoglycaemia provided no stimulus to induce NF-lCB
activation. Indeed, previous results have showed POTC alone has no inhibitory effect on
the activation of NFkB, even at concentrations of lOmM. However, in cells pretreated with
PDTC and then stimulated with TNF-a., a dose-dependent suppression of nuclear NF-KB
activity is detected (Herrmann et al., 1997).
However, it does appear to have different effects on p65 and p50 expression ID
normoglycaemic and hypoglycaemic cells. PDTC caused a decrease in p65 expression in
normoglycaemic cells. This could be attributable to POTC's other properties, such as ROS
chelation, which may affect energy competent cells but not energy depleted cells (Figure
7.6). This effect was not seen in the p50 expression of normoglycaemic cells, suggesting
the two subunits can act differently depending on the type of stimuli (Figure 7.7).
Moreover, p50 expression increased in hypoglycaemic cells with 10J.1MPDTC. Again, this
observation could be attributable to PDTC's other properties as this effect was not seen at
any other concentration (Figure 7.7). A dual effect of PDTC on NF-KB DNA binding
activity was recently documented (Chung et al., 2000). It is interesting to note that the
dose-dependent increase in XTT staining in normoglycaemic and hypoglycaemic cultures
(Figure 3.10) does not correspond to any changes in p65 or p50 expression in response to
hypogl ycaernia.
Hypoglycaemia alone did not increase p65 expression and therefore there was no activated
p65 for parthenolide to inhibit. This may have been expected, as parthenolide did not affect
the viability of cells exposed to one hour of hypoglycaemia (Figure 7.8). However,
parthenolide did provide inhibition in p65 expression at 2J.lM in hypoglycaemic cells
compared with nonnoglycaemic cells treated equivalently (Figure 7.9). It is interesting to
see that 2J.1Mand 5J.1Mparthenolide in hypoglycaemic cells caused a significant decrease
in p65 expression compared with normoglycaemic cells incubated in the absence of
pathenolide. This suggests that parthenolide alone has no effect on p65 expression (shown
in normoglycaemic cells) and neither does hypoglycaemia but when parthenolide is added
to hypoglycaemic cells a decrease in expression is detected. This indicates that events
occurring in hypoglycaemic cells, such as the activation of IKB kinases to degrade I1(B
subunit, activates parthenolide to function as an inhibitor IKB degradation and
consequently p65 translocation.
There was no inhibition of the p65 subunit with HNE in hypoglycaemic cells (Figure 7.11).
However, it did inhibit p65 expression, at the lowest concentration, in normoglycaemic
cells, suggesting that may be HNE, which has shown to have neurotoxic properties (Song
et al., 2001), is inhibiting p65 expression via non-specific mechanisms. Although these
toxic non-specific mechanisms do not appear to effect normoglycaemic cells incubated
with 1OJ.1Mand 50J.1MHNE. HNE has been reported only to inhibit NF-KB depending on
what particular stimulus induces NF-KB activation, e.g. HNE inhibits NF-KB when cells
are stimulated by LPS, but not by TNF (Page et al., 1999). It is therefore possible that at
low concentrations of HNE that the p65 subunit is inhibited. In addition, it is possible that
HNE can inhibit p50 and p65 only when there is an increase expression of these subunits in
response to hypoglycaemia.
In the experiment studying the effect of HNE on p50 expression, hypoglycaemia without
HNE causes an increase in p50 nuclear induction (Figure 7.12). HNE had various effects
on p50 expression in hypoglycaemic cells. At 5J.1M and 50J,lM HNE inhibits p50
expression but at 1OJ.1MHNE has no effect. It could be suggested that only the lowest
concentration specifically inhibits the p50 subunit, because at 50J.1M,HNE significantly
decreases the cell viability in normoglycaemic cultures, implying at this concentration
HNE is producing non-specific toxic effects (Figure 7.10). Interestingly, HNE did not have
the same dose-response profile in normoglycaemic cultures. There was no significant
decrease in p50 expression at 50J.1M,whereas Figure 7.10 shows massive reduction in cell
viability. This suggests that glucose deprivation produces an additive detrimental effect on
cells treated with high concentrations of HNE.
The caspase-3 inhibitor, Z-DEVD-FMK, produced different effects on the expression of
the p65 subunit in normoglycaemic and hypoglycaemic cells. In hypoglycaemic cells,
alone, p65 expression was reduced from normoglycaemic levels, providing further
evidence to suggest that the induction of NF-lCB in hypoglycaemic conditions is variable.
There was no effect of Z-DEVD-FMK in hypoglycaemic cells; p65 expression remained
significantly reduced from normoglycaemic levels. In normoglycaemic cells, Z-DEVD-
FMK, caused an increase in p65 expression at low concentrations and then caused an
inhibition at the highest concentration, suggesting that this compound can produce a
multitude of concentration-dependent effects within an energy competent cell.
Finally, both p65 and p50 expression were monitored after 30 minutes and one hour of
glucose replacement. The purpose of this experiment was to investigate whether NF-K8
had a role in the survival mechanisms associated with recovery in striatal cultures. It could
be hypothesised that NF-K8 is induced upon recovery and ATP replenishment which
switches on the relevant neuroprotecting genes, such as, Mn-SOD. However, the
expression of both of the subunits were unchanged from hypoglycaemic cells, suggesting
that NF-K8 is not induced during recovery. However, there are two queries associated with
these experiments, firstly, unlike the data presented in Figures 7.1 and 7.2, there was no
increase in either p65 or p50 during hypoglycaemia. Secondly, the expression of p65 and
p50 in normoglycaemic cells, which had had a medium change (as a control for recovered
cells), did not change from normoglycaemic levels without medium change. Therefore it
seems likely that p65 and p50 do not play key roles in the recovery response.
In conclusion, the removal of glucose from striatal cultures appears to produce a variation
in the expression of p65 and p50 subunits and NF-lCB DNA binding activity. Apart from
this fundamental discrepancy creating difficulty to compare sets of experiments, this
implies that NF-lCB subunits are not a key mediator in hypoglycaemic cell death or
recovery and suggests that this transcription factor is not significantly important in
hypoglycaemia. NF-lCB has been termed an oxidative-stress response transcription factor
(Schreck et al., 1991), therefore it is possible that the hypoglycaemic environment is not
conducive for the induction of NF-lCB. In hypoglycaemia there is a constant availability of
oxygen and in this model ROS have shown not to be involved. It is also possible other NF-
KB subunits are involved and further investigation may confirm this. In addition, none of
the potential NF-KB inhibitors in this study showed adequate inhibition of p65 and p50
subunits without any undesirable effects, perhaps because all possess other properties and
none are specific NF-KB inhibitors.
Chapter Eight. General Discussion
The data collected from this study suggest that hypoglycaemia decreases mitochondrial
functioning (XTT staining) and damages neuronal structure (MAP2 immunoreactivity). In
addition, some signs of apoptosis are present (TUNEL staining) whereas other are not
(Bax, cytochrome c, caspase-9 and caspase-3 immunoreactivity), suggesting that
hypoglycaemia produces a neurotoxic effect with some characteristics of apoptosis.
However, this neurotoxic effect is not produced by calcium, glutamate, MTP activation or
ROS although it is possible that NFlCBactivation is involved. In spite of this apoptotic-like
neurotoxicity induced by hypoglycaemia, cells can recover following the re-introduction of
glucose (XTT staining) and show signs of DNA repair (TUNEL staining).
Data from this study indicate a different type of cell dysfunction occurring in striatal
cultures exposed to hypoglycaemia compared to the generally accepted hypothesis (Siesjo,
1992). Most studies have confirmed that hypoglycaemia produces neuronal cell death as a
consequence of membrane depolarisation, [Ca2+]j overload, excessive EAA receptor
stimulation, MTP activity and an excessive generation of ROS.
There are number of reasons why differences are observed in this model. Striatal neurones
possess glutamate receptors, but in striatal cultures there are no intrinsic glutamate-
releasing neurones and no extrinsic glutamatergic inputs from other brain structures to
stimulate these receptors. Hence a toxic release of synaptic glutamate in response to
hypoglycaemia is unfeasible, thus, glutamate toxicity is not a feature in this specific cell
culture.
Aspiny striatal interneurones possess a wide network of dendrites, synapsing on spiny
neurones and are known to be more resistant to hypoglycaemia than spiny striatal neurones
(Ferreante et al., 1985; Beal et al., 1992). Therefore it is possible that aspiny neurones
provide energy for spiny neurones during hypoglycaemia. Data from this study shows that,
after 24 hours, a reproducible 75% decrease in mitochondrial function occurs in
hypoglycaemic cultures, suggesting that the remaining 25% of the culture possess
functional mitochondria. This 25% could be cells more resistant to hypoglycaemia, such as
interneurones which could process alternative substrates and provide energy for the whole
culture to keep the culture in a suspended animated state. Alternatively, the remaining 25%
could represent viable mitochondria from all cell types within the culture and that each cell
possesses a reduced number of functioning mitochondria. However, the MAP2 staining in
Figure 3.2 suggests that only a certain population of cells survive.
The methods involved in dissociated primary neuronal culture are designed to prevent the
proliferation of glia within the system. However, a pure neuronal population is near
impossible if cultures are incubated for two weeks, and a limited glial population could
influence cultured neurones. It is known that astrocytes can provide important sources of
energy and they appear to have a full complement of enzymes for both glycogenesis and
glycogenolysis. Therefore astrocytes may contribute markedly to fuel homeostatic
mechanisms at times of metabolic stress in the brain, probably by releasing alternative
substrates such as pyruvate, for local neuronal oxidation (Magistretti, 1982; Schurr et al.,
1988; Schurr et al., 1997; Selak et al., 1986; Matsumoto et al., 1994; Edmond et al.,
1987). In addition, it has been reported that glia cells are not affected by hypoglycaemia
(Golberg and Choi, 1993) possibly due to the accumulated glycogen in these cells (Hara et
al., 1989). This attribute of glia could perhaps counteract neuronal vulnerability by
forming a functional energy supply unit and hence exert a protective profound influence on
vulnerable cells exposed to hypoglycaemia. Future experiments could involve comparing
the amount of glia present and the survival of cultures, perhaps by observing the antibody
for glial fibrillary acidic protein.
Hypoglycaemia is known to change the glucose transport system in the brain (Pramming et
al., 1986), suggesting that there should be glucose-regulated mechanisms associated with
the transport of glucose. A neuroprotective mechanism could involve an increase in
glucose-transporters on the aspiny cells surface (LaManna and Harik, 1986; Nagamatsu et
al., 1992). It has been demonstrated that a 4·Jold increase in the level of the glucose-
transporter, GLUT3 mRNA was observed after 48 hours of hypoglycaemia indicating that
glucose starvation effectively activates the transcriptional rate of the GLUT3 gene in
vulnerable neurones (Nagamatsu et al., 1994).
GABA, an inhibitory neurotransmitter, is the predominant neurotransmitter within the
striatum, and has been reported to be both elevated (Sandberg et al., 1986) and decreased
(Engelsen et al., 1986; Paulsen and Fonnum, 1988) during hypoglycaemia, dependent
upon energy deficiency model and cell type is studied. The release of GABA and other
inhibitory transmitters have been shown to protect neurones from damage caused by
energy deficiency (Madl and Royer, 2000; Saeansaari and OJ a, 1997; Johansen and
Diemer, 1991; Shuaib et al., 1993). Since the majority of neurones in the striatum are
GABAergic, it is possible that the release of GABA in this model during hypoglycaemic
neurotoxicity, prevents the membrane from depolarising and is responsible for keeping the
cell in a quiescent state. Alternatively, adenosine, which is also an inhibitory modulator
could have a profound effect on the stability of the membrane. Extracellular levels of
adenosine are elevated during hypoglycaemia and adenosine receptor agonists have been
demonstrated to delay rapid depolarisation by hyperpolarising cells via the activation of K+
channels (Martin et al., 1994; Greene and Haas, 1991; Calaliere et al., 2001). Hence
striatal cells could be protected from irreversible toxicity either by a suppression of
apoptosis (due to energy depletion) or to the presence of high levels of inhibitory
neurotransmitters such as GABA or adenosine.
The intracellular effect following a metabolic insult within a neurone is multifactorial,
therefore it is not surprising that variations of the response to hypoglycaemia differ
substantiall y.
There may be a number of reasons why data in this study do not show cell death induced
by hypoglycaemia and are therefore not in accordance with other studies. Most research is
carried out using cortical, hippocampal and cerebellar cells. Cultures using these cell types
have more of a heterogeneous population, compared to striatal cultures and this could
significantly alter the influence of glucose deprivation (Freese et al., 1990). Discrepancies
in results are also largely due to the differences between in vitro and in vivo studies,
perhaps as a result of intact neuronal networks between different structures and the
presence of a glia network and blood capillaries in in vivo (Minamisawa et al., 1990;
Siesjo, 1998; Matsumoto et al., 1994). C?ther factors include the method of producing
hypoglycaemia. In this study medium containing glucose has been replaced with glucose-
free medium, whereas hypoglycaemia can be induced via chemicals, such as 3-NP which
inhibits succinate dehydrogenase and in in vivo studies administering an overdose of
insulin induces hypoglycaemia is the most common method. The vulnerability of cells to
toxic stimuli has been shown to be dependent on the age of the culture (Freese et al.,
1990), so that culture preparation could influence results. In addition, the insult caused by
glucose deprivation could be unevenly distributed throughout the culture due to differences
in glycogen content between culture regions and between cultures (Tasker et al., 1992).
There a number of questions which need to be addressed, in attempt to clarify what cellular
processes are occurring in striatal cells deprived of glucose.
What is causing mitochondrial dysfunction in striatal cells during hypoglycaemia? The
detection of cell damage is by XTT measurement, and it is assumed that hypoglycaemia is
preventing the succinate dehydrogenase enzyme from functioning within the tricarboxylic
acid cycle. The assumption is that the concentration of ATP is reduced during glucose
deprivation because of the succinate dehydrogenase decrease in activity. However, this has
not formally been demonstrated in these studies. Conclusive evidence would only arise
with experiments measuring the absolute ATP concentration in control and hypoglycaemic
cultures but abundant literature has demonstrated decreases in ATP levels following
hypoglycaemia (Mattson et al., 1993; Madl and Royer, 1999; Santos et al., 1996).
Combining this assumption with the present results, it could be proposed that the
concentraion of ATP is reduced which initiates multiple effects that injury the cell, e.g. the
actvation of a substrate to cleave the DNA.
It appears that the plasma membrane remains intact after 24 hours of hypoglycaemia and it
could be proposed that the mitochondrial membrane also remains intact. Evidence arises
from the lack of MTP activation in hypoglycaemic cells. However, monitoring the
mitochondrial membrane potential would be the only method to test this theory. It is
almost certain that calcium is not the trigger which causes disruption to mitochondrial
function, although [Ca2+]j was not measured until after 24 hours of hypoglycaemia. Each
calcium modulating drug used had no effect when incubated with hypoglycaemic cells. In
addition, it has also been reported that depolarisation of mitochondrial membranes can
occur independently of calcium influx (Now icky and Duchen, 1998). It seems apparent
that ROS are not involved in the dysfunction of mitochondria since PDTC had no effect in
these experiments. It has been proposed that ROS are not formed in hypoglycaemia
because there is sufficient 02 available to accept electrons passed along the mitochondrial
electron transport chain.
What mechanisms are affecting mitochondrial function? It is possible that the brain has
evolved mechanisms for sensing and regulating glucose homeostasis and it could be argued
that proteins or secondary messengers, perhaps yet unidentified, are triggered when the cell
detects a decrease in extracellular glucose content. It has been suggested that the presence
of K-ATP sensitive channels may function predominantly as "gluco-sensing" receptors,
whereby they open, hyperpolarising the plasma membrane (Dunn-Meynell et al., 1998).
This action may trigger proteins to translocate to the mitochondria and signal for either the
preservation of cellular energy, or signal for the cell to undergo an apoptotic-type of cell
death. In this study, the K-ATP channel opener, diazoxide, did not have any
neuroprotective effects. Therefore, it may be proposed that either K-ATP channel are
insensitive to diazoxide or that "gluco-sensing" receptors distinct from K-ATP channels
exist within striatal neurones .
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In addition, apoptotic-like cell death, resulting from glucose deprivation, causing
mitochondrial dysfunction and DNA fragmentation, may be initiated from cell surface
death receptors. These receptors are a family of transmembrane proteins which belong to
the TNFINGF receptor superfamily. Ligand-induced receptor activation would cause the
recruitment of intracellular receptor-associated proteins, and consequently the initiation of
upstream caspase activation. The activation of these upstream caspases could initiate the
proteolytic cleavage of proteins from cytosolic members of the Bel family, which
translocate to the mitochondria, and may cause a disruption in oxidative phosphorylation
when they insert themselves. However, it is not known whether the ligands, which activate
these surface receptors, are present in this model of hypoglycaemia. Still, it is possible that
other cell surface death receptors exist which cause a direct alteration of mitochondrial
integrity when stimulated during conditions of low glucose concentrations.
Neurotrophins are released from cells to condition their environment. It is known that a
withdrawal of growth factors, such as NGF, can cause both apoptosis and necrosis
(Green lund et al., 1995; Castagne and Clarke, 1996; Mignotte and Vayssiere, 1998; Levi-
Montalcini and Booker, 1960). Therefore, it is possible that the effect of the lack of
neurotrophins in the medium after 24 hours of hypoglycaemia, due to decreased energy
available for the production and release NGF, is a trigger for the cell to stop functioning. In
addition, the increase in NF-lCB observed in hypoglycaemic cells, may be indicative of
subsequent attempted transcription of NGF, in the attempt to prevent cells undergoing
apoptosis. NGF has been reported to protect cultured neurones from hypoglycaemia
(Chend et al., 1991; Cheng et al., 1994; Kokaia et al., 1994) but not prevent the
hypoglycaemic-induced reduction in ATP levels (Mattson et al., 1993). It has been
reported that new protein synthesis contributes little to NFKB activation, following
neurotoxicity (Qin et al., 1998). Therefore if protein synthesis is inhibited during
hypoglycaemia, this would not affect NF-lCB's ability to induce genes which regulate
apoptotic proteins but would affect the synthesis of NGF induced by NFKB.
Alternatively, a change in intracellular pH could be the predominant trigger, which causes
mitochondrial dysfunction (Pelligrino and Siesjo, 1981; Norberg and Siesjo, 1976; Agardh
et al., 1981). It is known that intracellular pH levels start to change at a time when ATP
levels are still relatively high as a result of ATP being consumed faster than it is being
produced (Busa and Nuccitelli, 1984). In hypoglycaemia, alkalosis occurs due to the
oxidation of alternative substrates and this change in pH could trigger conformational
alterations of cell surface receptors, thereby initiating a shut down of the mitochondria .
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If DNA fragmentation is a result of mitochondrial dysfunction then what signalling
cascades are employed to initiate substrates which ultimately fragment DNA? It is possible
that caspases other than those monitored in this study are initiated or that unidentified
proteins are triggered. For example, one mechanism might involve apoptosis-inducing
factor (AIF). Various triggers of cell death are known to cause the release of AIF from the
mitochondrial intermembrane space which translocates to the nucleus where it activates
specific endonucleases (Lorenzo et al., 1999). It is known that a Ca2+ -independent
endonuclease exists (Barry and Eastman, 1993), and it is possible that this endonuclease is
activated in this model.
It has been demonstrated that glucose removal depolarises mitochondria long before the
ATP/ ADP ratio changes substantially (Kauppinenn and Nicholls, 1986), hence active
processes such as caspase activation can occur. However, it is possible that only partial
reversible DNA damage occurs in hypoglycaemic cultures because ATP is eventually
reduced to a level that provides insufficient energy required to fully fragment the DNA.
However, it has been reported that DNA fragmentation is an ATP-independent process
(Leist et al., 1997).
There is much debate concerning the nature of death in cells deprived of ATP. It is
generally believed that in severe metabolic conditions the dominant pathway is necrotic
whereas in more subtle metabolic conditions the dominant pathway is apoptosis (Kroemer,
1997). Both necrosis and apoptosis have mitochondrial dysfunction in common (Zamzami
et al., 1997) and DNA fragmentation has been reported in both apoptosis and necrosis.
However, in this model of hypoglycaemia, it could be assumed that necrosis is not
apparent considering the recovery of cells upon glucose replacement. It may be suggested
that the neurones that did not survive, and therefore would not have recovered, could have
died via a necrotic cell death. The lack of caspase activity does not necessarily confirm that
cell death was necrotic as it has been shown that apoptotic cell death can occur even in the
presence of caspase-inhibitors (Borner and Monnet, 1999).
An interesting theory is that protein ubiquitination and aggregation IS the primary
neurotoxic event involved in hypoglycaemia (Hu et al., 2000). Under physiological
conditions, newly synthesised, unfolded or misfolded proteins are quickly removed by the
ubiquitin-proteosome system (Ciechanover et al., 2000). Protein ubiquitination involves a
series of ATP-dependent reactions which ligate ubiquitin to abnormal proteins, forming
ubiquitinated proteins (ubi-proteins). However, under pathological conditions, when ubi-
proteins in cells are produced too much to be degraded, they will aggregate through their
hydrophobic segments which threatens cellular survival and function. Indeed, ubi-protein
aggregations have been consistently observed in both chronic neurodegeneration (Alves-
Rodrigues et al., 1998) and acute brain injuries (Hu et al., 2000).
In a recent study, ubi-protein aggregates were formed in the vulnerable brain regions, .
under conditions of hypoglycaemic coma (Ouyang and Hu, 2(01) suggesting that proteins
were severely damaged after hypoglycaemia. It has been reported that hypoglycaemia
provides optimum conditions to induce the overproduction of unfolded proteins in the ER
and along the protein maturation pathway (Brostrom and Brostrom, 1998). Therefore, it is
possible that DNA fragmentation is not a consequence of mitochondrial dysfunction but a
consequence of the formation of these aggregates which initiates a signal to activate the
apoptotic execution machinery.
How do striatal cells recover from hypoglycaemia? It has been suggested that there are two
forms of cell injury induced by energy failure. The first is reversible and is characterised
by the insufficiency of the Na+/K+ATPase to meet the requirements for maintenance of
membrane potential and normal ion permeability. The second is irreversible and is
characterised by hyperactivity of glutamate receptors (Pissarek et al., 1998). Thus, since
glutamate releasing neurones are absent in striatal cultures, the form of cell damage that
predominates in this model is the former one, a reversible mode of cell injury. Indeed,
energy metabolism and Na+/K+transport have been shown to recover fully from complete
global ischaemia even following prolonged periods (Hossmann et al., 1973; Kleihues et
al., 1975;Nordstrom et al., 1978).
If cell death is reversible, the cell can not be classified officially dead. It was previously
reported, that during hypoglycaemia the mitochondria are not irreversibly damaged. This
suggests that mitochondria shut down temporarily whilst there is a reduction in glucose,
perhaps to preserve energy levels, or perhaps there is insufficient amount of energy for the
mitochondria to function effectively therefore respiration becomes suspended. This may
render the cell not technically dead but electrically quiescent.
It has been reported that hyperpolarisation via K-ATP channel activation is a short-term
method of conserving energy in response to hypoglycaemia (Duchen and Somjen, 1988;
Duchen, 1990; Calabresi et al., 1997; Spuler et al., 1988). Therefore, it could be
suggested that either cells in this model are hyperpolarised or they produce enough energy
to remain at resting potential and remain in a suspended animation state with little
mitochondria functioning. Suspended animation could resemble a hypothermic state. It is
well established that hypothermia protects against delayed neuronal death following
ischaemia (Busto et al., 1987). It is thought that the mechanism of this protective effect is
associated with a slowing of the cells' metabolism by inhibiting oxygen and glucose
consumption in the brain (Bering, 1974; Hagerdal et al., 1975) and by producing a
"membrane-stabilising" effect, perhaps reducing the Na+/K+ leakage.
It was initially thought that the cell is irreversibly damaged by glucose deprivation, which
is in agreement with most other studies. This assumption was based on results with
TUNEL staining. It has been proposed that DNA fragmentation does not necessarily reflect
DNA damage but that the condensation of DNA that follows fragmentation, is the ultimate
feature of cell death, as this is irreversible. This may explain why fragmented DNA can be
repaired within minutes of glucose re-introduction. The initial apoptotic signal could have
triggered DNase proteins, such as endonucleases, to cleave the DNA but under low energy
conditions these proteins function less efficiently and as a result DNA fragmentation is
incomplete. Therefore, is it possible that the original apoptotic death signal, initiated
during early hypoglycaemia, is prevented from proceeding to completion while energy
levels are low, and is redundant when glucose levels are restored? One example is the
controversial role of PARP which has been reported to be involved in DNA repair as well
as being a nuclear caspase substrate involved in cleaving DNA (Kaufmann et al., 1993). Is
it possible that the role of this protein could be altered during the period of energy
deprivation and recovery? For example, during the beginning of hypoglycaemia, PARP is
activated by caspases to fragment the DNA, however, as ATP content reduces and the cell
enters a suspended state and PARP remains jnactive. At the beginning of recovery, signals
could travel to the nucleus, subsequent to the restoration of mitochondrial functioning and
hence cause a change in PARP, allowing PARP to repair the DNA it had already begun to
cleave.
Numerous studies have reported that an inhibition of new protein synthesis protects cells
from apoptosis, possibly by preventing the functions of endonucleases, and consequently
the irreversible DNA damage (Goto et al., 1990) and therefore it is possible that
hypoglycaemia inhibits new protein synthesis. The purpose of DNA fragmentation during
apoptosis is still uncertain. It is possible that it facilitates the breakdown of the DNA upon
the uptake of apoptotic cells by phagocytes or it may serve to destroy the information
content of the cell. Alternatively, it may simply be a by-product of ion redistributions that
occur during apoptosis (Martin et al., 1994). If the latter is the case, it is possible that if
ionic disturbances occur during hypoglycaemia when ionic distribution equilibrates during
recovery DNA fragmentation could be repaired .
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Apoptosis regulators, a family of proteins termed inhibitors of apoptosis (lAP) apparently
set up an endogenous threshold level for caspase activation. It is suggested that the cellular
levels ofIAPs may determine the difference in sensitivities to apoptosis-inducing stimuli in
various cell types. lAPs are also direct targets of transcriptional regulation by NF-KB (Chu
et al., 1997). Therefore, it is possible that in hypoglycaemic cells, lAPs are activated via
NF-KB induction, which then inhibit downstream caspase activity. This could prevent
complete DNA fragmentation and regulate inhibitory caspase activation during recovery
(assuming protein synthesis is not impaired).
Intracellular calcium concentration bas been referred to in toxic conditions as the decisive
element within the cell. Could this be true in recovery conditions? Is a reduction in [Ca2+]i
during recovery a protective mechanism? It is possible that simply a re-introduction of
glucose, initiates the depolarisation of the cell causing an influx of calcium and a fast
sequestration of excess [Ca2li by ER and mitochondria as well as an increase in the
activity in calcium-binding proteins. Alternatively, could the reduction of [Ca2+]i after 24
hours of recovery reflect the increase in activity of calcium-dependent processes, such as
the removal of damaged mitochondria or other intracellular organelles?
It is possible that NF-lCB is involved in the recovery of cells after hypoglycaemic toxicity.
Although data show no NF-KB activation within the early phase of recovery, NF-KB could
switch on genes during early hypoglycaemia when energy levels are not completely
depleted, which later preserves the cell's integrity when the cells return to normal
metabolic functioning. For example, NF-tcB could induced an overexpression of Mn-SOD,
to counter-balance the potential ROS production upon recovery.
It is clear that a new hypothesis is required that is consistent with the data obtained in this
study. When the extracellular source of glucose is removed, the activity of the TCA cycle
decreases and ATP levels fall. The membrane remains at resting potential and VGCC and
EAA receptors are therefore closed. The ATP source required to maintain the resting
potential is provided by the existing concentration of ATP left after glucose removal and
alternative substrates such as glutamate. The cells falls into a suspended animation state
where energy demand is reduced but with sufficient amount of energy to keep the
membrane polarised but not to initiate active processes, namely apoptosis. However, this
disruption of internal energy homeostasis triggers ATP-independent mechanisms resulting
in the activation of endonucleases and fragmentation of DNA. During early
hypoglycaemia. when energy levels are still relatively high, genes are upregulated in the
event of further cellular damage, such as calcium-buffering proteins and possibly DNA
repair systems. However, following transcription of these genes the cell's energy begins to
fall below a specific threshold and consequently these new proteins are not utilised until
energy levels rise. On the re-introduction of glucose, ATP levels rise and cytosolic calcium
is buffered via the previously up-regulated calcium buffering genes, metabolism within the
mitochondria begins to function normally, all respiratory processes normalise, DNA repair
begins, and hence, normal cellular functioning ensues.
This idea could be termed a neuroprotective mechanism employed in striatal neurones
against energy deprivation It is reasonable to suggest that neurones, because of their post-
mitotic nature require complex protective mechanisms and the state of a suspended
animation is possibly one of them. Indeed, it is known that in most cases damage in
hypoglycaemic patients is reversible and irreversible neuronal damage occurs only in
extreme prolonged situations (Herold et al., 1985), suggesting that cells exposed to
hypoglycaemia have effective innate neuroprotective systems preventing irreversible cell
loss. These results also have clinical implications in that the therapeutic window for the
treatment of profound hypoglycaemia may be prolonged. Together with further research
into the mechanism of cellular recovery from glucose deprivation and DNA fragmentation,
it is possible that the outcome of pathological conditions associated with energy
deprivation can be improved .
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Appendices.
Media Fonnulations
Table 1 Dulbecco's Modified Eagle Medium (1X), Liquid (low glucose)
Component
mg/l
CaCh.2H20 264.0
Fe(N03).9H2O 0.10
KCL 400.0
MgS04.7H20 200.0
NaCl 6400.0
NaHC03 3700.0
NaH2P04.2H2O 141.0
D-Glucose 100.0
Phenol Red 15.0
Sodium Pyruvate 110.0
L-Arginine.HCI 84.0
L-Cysteine 48.0
L-Glutamine 580.0
Glycine 30.0
L-Histidine HCL.H2O 42.0
L-Isoleucine 105.0
L-Leucine 105.0
L-Lysine.HCI 146.0
L-Methionine 30.0
L-Pheny lalanine 66.0
L-Serine 42.0
L-Threonine 95.0
L-Tryptophan 16.0
L-Tyrosine 72.0
L-Valine 94.0
D-Ca pantothenate 4.0
Cho line Chloride 4.0
Folic Acid 4.0
i-Inositol 7.20
Nicotinamide 4.0
Pyridoxine HC} 4.0
Riboflavin 0040
--- 1----------------- --- -"._"-"---------
Thiamine HC} 4.0
--_
Table 2 Dulbecco's Modified Eagle Medium (1X), Liquid (no glucose)
Component
mg/l
CaCh (anhyd.) 200.0
Fe(N03).9H2O 0.10
KCL 400.0
MgS04 (anhyd.) 97.67
NaCI 6400.0
NaHC03 3700.0
NaH2P04.H2O 125.0
Phenol Red 15.0
L-Arginine.HCI 84.0
L-Cystine.2HCI 63.0
L-Glutamine 584.0
Glycine 30.0
L-Histidine HCL.H2O 42.0
L-Isoleucine 105.0
L-Leucine 105.0
L-Lysine.HCI 146.0
L-Methionine 30.0
L-Pheny lalanine 66.0
L-Serine 42.0
L-Threonine 95.0
L-Tryptophan 16.0
L-Tyrosine (disodium salt) 104.0
L-Valine 94.0
D-Ca pantothenate 4.0
Cho line Chloride 4.0
Folic Acid 4.0
i-Inositol 7.20
Nicotinamide 4.0
Pyridoxine HCI 4.0
Riboflavin 0.40
Thiamine HCI 4.0
~ .. 1
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